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Chapter 1 
Introduction 
θ 
Chapter 1 
This thesis addresses the preventive management of heart diseases in primary 
care, particularly atherosclerosis-related high cardiovascular risk, coronary heart 
disease, and chronic heart failure. Despite extensive research evidence on the 
effectiveness of preventive treatment and counseling, many patients with heart 
diseases receive suboptimal care. Much remains unclear about successful 
implementation of evidence-based recommendations into clinical practice. Our 
studies focus on the assessment of the quality of care for patients with 
cardiovascular risk or diseases, and the role of specific organizational factors in 
quality of cardiovascular primary care. 
Cardiovascular disease 
Delivering high-quality chronic illness care poses many challenges. Especially in 
developed countries, large and growing numbers of patients suffer chronic 
disorders like diabetes and cardiovascular diseases (CVD). Several developments 
influence the increase in patient numbers. Many chronic conditions are more 
prevalent with increasing age, and as people become older, this demographic 
development is an important factor in the increasing number of patients with 
chronic conditions. Furthermore, effective interventions in acute cardiovascular 
disorders have contributed to higher numbers of patients with a chronic 
cardiovascular condition. 
CVD are worldwide highly prevalent conditions with high mortality and morbidity 
rates. CVD include coronary heart disease (CHD), cerebrovascular disease -
stroke or transient ischemic attack (TIA) -, peripheral arterial disease, or an 
aneurism of the aorta. In The Netherlands the prevalence of CHD is about 50 per 
1000 in males and 30 per 1000 in females; the prevalence of cerebrovascular 
disease is 12 per 1000 for both sexes. 
Data from the World Health Organization showed that about 30% of total mortality 
is caused by CVD, with over 17 million deaths in 2004.1 Across Europe, CVD 
mortality rates are even higher, caused by high rates especially in Eastern 
European countries. In Western Europe CVD account for 30-40% of the mortality 
in men, and up to 50% in women. CHDs are the most frequent cause of death in 
patients with CVD, for both sexes, while cerebrovascular causes are more 
prevalent in women. 
Patients with chronic heart failure (CHF) may also be included in the group with 
CVD, although CHF might be due to a range of underlying causes. In CHF the 
main problem is a disturbed function of the pumping capacity of the heart, causing 
a decline in physical activity tolerance, shortness of breath, fatigue, and signs of 
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fluid retention. CHF has many causes, CHD and hypertension being the most 
prevalent. CHF is a chronic disease, which has a high prevalence, high burden for 
patients, high mortality, and high costs of health care. The prevalence of chronic 
heart failure in the Western world is 1-2% in the general population and 10% or 
higher in the age group of 85 years and older, with high hospitalization and 
mortality rates.2,3 
Many risk factors contribute to the development of CVD. Important risk factors that 
cannot be treated are age and (male) sex. Important risk factors - without being 
exhaustive - that can be treated are smoking status, blood pressure, cholesterol 
levels, physical activity, diet, and weight. In the future, specific biomarkers may 
help to estimate cardiovascular risk more accurately posing new targets for 
treatment. 
According to prevailing clinical guidelines, patients with CVD should be treated to 
reduce their risk of cardiovascular events. Patients without CVD but with the 
presence of one or more risk factors, too, should be offered advice concerning 
their risk profile. In healthy people (with low cardiovascular risk) maintaining a 
healthy lifestyle can be encouraged. 'Cardiovascular risk management' is a term 
that covers advice, counseling and preventive treatment for these three groups. 
Recommendations related to cardiovascular risk management are available in 
international clinical guidelines. Both European and American organizations have 
published guidelines on cardiovascular risk management.4"6 In the Netherlands the 
European guideline is translated and adapted to the Dutch situation.7 In addition to 
this overall cardiovascular risk management guideline, various practice guidelines 
provide recommendations on specific CVD such as acute coronary syndrome or 
TIA.8,9 To support cardiovascular risk management in the Netherlands a 
nationwide platform of health care organizations developed a 'health care delivery' 
guideline, giving recommendations on the organization of care.10 For management 
of chronic heart failure, too, a European practice guideline has been adapted to fit 
into the Dutch health care organization.11,12 
Current practice 
Despite these guidelines with clear recommendations on drug treatment related to 
blood pressure, cholesterol levels, antiplatelet therapy, and lifestyle advice, 
research in various settings showed that the quality of care in cardiovascular risk 
management remains suboptimal.13,14 For instance, European research and 
studies in the USA showed that cholesterol treatment targets are reached in about 
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50% of patients and antiplatelet drug therapy in 80% of patients. However, most 
research was performed outside primary care, while cardiovascular care is mainly 
delivered in primary care, particularly in countries with a strong primary care 
system, such as the Netherlands. 
Dissemination of the available evidence and the clinical guidelines does not 
automatically guarantee that all patients profit from evidence-based treatments 
available. A multifaceted approach comprising of dissemination of the knowledge 
as well as the improvement of the organization of health care delivery may be 
more effective than targeting at one aspect.15 A challenge is to provide large-scale 
and sustainable implementation of recommended treatments. As large numbers of 
patients with chronic conditions receive their treatment mainly in primary care an 
efficient organization of chronic care with sufficient size of scale in primary care is 
an important issue in the improvement of cardiovascular risk management. 
This thesis addresses current practice and improvement of cardiovascular risk 
management and has been divided into three sections. Section I concerns the 
development of performance indicators and the assessment of current practice. 
Section II explores the role of a number of organizational factors in cardiovascular 
risk management, while Section III focuses on improving primary care for patients 
with chronic heart failure. 
Section I Cardiovascular risk management: performance indicators and 
current primary care 
Recent data on the quality of cardiovascular risk management collected in primary 
care were lacking when we initiated our research in 2006. Assessing quality of 
health care in different countries has the advantage that performance can be 
compared across health care systems and that determinants of performance can 
be studied within different health care systems. We performed an international 
research project on cardiovascular risk management, called the European Practice 
Assessment Cardio project (EPA Cardio).16 This international study offered the 
possibility to learn from the differences between countries and to identify factors 
across various types of health care organization. 
Within the EPA Cardio project we collected data on documented risk management 
in three groups of patients: patients with CHD, patients at high risk, and healthy 
adults aged 18 to 45 years. We present the EPA Cardio study protocol, as the 
proceeding studies in this section and several other studies described in this thesis 
are based on EPA Cardio data. Next, we present the results from data collection in 
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the three patients groups evaluated in EPA Cardio: audit data from CHD patients 
and high risk patients and patient questionnaire data from adults aged 18-45 
years. In these studies we provide actual data on the quality of cardiovascular risk 
management in primary care across Europe. 
The EPA Cardio project started with a rigorously performed indicator development 
procedure.17 The clinical indicator set was used in a Dutch program to develop an 
indicator set with the health care delivery guideline on cardiovascular risk 
management.10 Valid indicators are crucial for proper assessment of quality of 
care. Nevertheless, methodological questions remain on panel composition, the 
influence of single panels, and on the procedure at large.18"25 
In this thesis we will present the study in which we performed an indicator set 
development procedure comparing the results of different procedures and different 
panels. One of these procedures was the EPA Cardio procedure and thus we 
performed a validation study of the EPA Cardio indicator set. In the studies on 
quality of current cardiovascular primary care we used this indicator set for data-
collection in large numbers of primary care practices. 
Section II Organization of chronic illness care and prevention 
Good quality of cardiovascular care depends on various factors, starting with a 
thorough understanding of the conditions and therapeutic options. So, to improve 
cardiovascular risk management professional education remains necessary, yet it 
is in itself insufficient for sustainable improvement. A good organization of care is 
mandatory for a complete and sustained implementation of high quality chronic 
care. Despite strong support for specific organizational frameworks, research 
evidence showing the impact of chronic care organization on outcomes of health 
care in patients remains inconclusive.26 In this thesis we will draw attention to 
several aspects of practice organization: the practice size, staff composition, and 
overall organization of primary care practices. Then we will focus on the 
information exchange network between health professionals in general practice, 
which provides a new perspective on chronic illness care. Finally, we will address 
an important feature beyond the scope of the individual practices and consider the 
impact of the strength of primary care within the health care organization. 
Practice size is an organizational characteristic that has been found to influence 
various outcomes.27 31 To manage large patient groups as in cardiovascular risk 
management, supportive staff may be of major importance. Despite research 
related to practice size the optimum number of patients served by a practice is 
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unknown and we lack an actual overview of practice staff composition. We will 
present a study with actual data on practice size and on the number of workers 
within the general practices. 
Various organizational frameworks for the delivery of chronic care provide models 
for an effective organization of primary care practice. Examples are the widely 
used Chronic Care Model and the related Patient Centered Medical Home.32"35 
Characteristics of these frameworks are related to several aspects of care 
organization, among which the use of information technology, availability of 
decision support, and self management support. It is unknown to what extent 
primary care practices in Europe have adopted working processes in line with such 
practice characteristics. We therefore addressed this question in our international 
project and we related organizational characteristics to practice size and to the 
quality indicator scores in the CHD patient group. 
The way in which information within a team of health care professionals is shared 
and passed on may play an important role in chronic care management as several 
professionals from different disciplines are involved. However, information 
exchange networks between the health care providers involved in chronic care 
have hardly been studied. Information exchange networks may differ across 
practices, potentially leading to different degrees of uptake of recommendations. 
We will present a pilot study in which we tested a method to assess the networks 
in primary care practices related to information exchange considering chronic care 
for CHF, COPD and diabetes patients. 
Practice characteristics are partly determined by the national health care system. 
Health care systems vary considering the strength of primary care.36 Some 
countries have a strong primary care with for instance patients being listed and the 
primary care physician as a gatekeeper to specialist care. Examples are the 
United Kingdom, Spain, and the Netherlands. On the other hand in countries with 
a weaker position of primary care, patients are not listed with a certain primary 
care practice or physician and have direct access to specialist care, as is the case 
in for instance Germany and France. 
In all countries programs to improve cardiovascular risk management have been 
implemented, and lessons can be learned from successful programs. It was 
unknown whether and how these differences in strength of the primary care 
orientation of the national health systems relate to the improvement programs. We 
will analyse an international sample of improvement programs in order to identify 
commonly shared features of successful programs for improving cardiovascular 
risk management and prevention, and to assess differences in these programs' 
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content and focus. In addition, we will consider to what extend the focus of these 
programs is related to the strength of primary care. 
Section III Improving primary care for patients with chronic heart failure 
Although evidence-based international and national practice guidelines are 
available, previous research has shown that health care delivery in CHF patients is 
suboptimal. Despite ample evidence for the value of appropriate drug therapy, 
many patients do not receive all drugs indicated in the dosages indicated. 
Previous studies on drug treatment of heart failure patients in general practice 
showed that between 40 to 78% of the heart failure patients were treated with an 
ACE-inhibitor or ARB, and the use of beta-blockers varied from 7 to 32%.37^2 
Various factors can explain this gap between knowledge and practice. In countries 
with a strong primary care system, as in the Netherlands, many patients with CHF 
are treated in primary care. Despite plans from the former Health Minister to focus 
on CHF as one of four diseases that should be dealt with in an integrated care 
model,43 few if any programs for structured primary care for CHF patients yet exist. 
Furthermore, the recommended drug treatment protocol is complex and has been 
changed in recent years. In the first Dutch College of General Practitioners' 
(DCGP's) guideline on heart failure diuretics were recommended for all patients 
and additional drug recommendations depended on symptoms and signs.44 
However, diuretics are considered less important in the management of CHF and 
currently inhibitors of the renin angiotensin system and beta blockers are advised 
for all patients. The 2010 DCGP's guideline is completely in line with the Dutch 
multidisciplinary guideline, the latter being an adaptation of the European 
guideline.11'1245 
Because of the complexity of the recommendations and the changes over the 
years, we developed a program with educational and organizational components 
to improve primary care for CHF. The organizational components comprised 
advice on practice organization, particularly focused on delegation of clinical tasks 
to practice assistants and nurses. This intervention was delivered by a trained 
practice visitor. We performed a pilot study to test the feasibility of the program 
and the impact on patient care. This study was performed in 2007-2008 and aimed 
at implementing the DCGP practice guideline recommendations prevailing at that 
moment.46 
With the lessons learned from this pilot study we made some adaptations to the 
implementation program for instance with respect to collaboration with other health 
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care professionals. For that reason, we did not use the mono disciplinary practice 
guideline as the starting point but the prevailing national multidisciplinary guideline 
launched in the meantime.12 
The original programme did not take into account special barriers perceived by the 
practices. Barrier analysis and tailoring seem to have a modest effect on the 
outcome of the implementation program.47 But there is no evidence for the effect in 
primary care for improvement of CHF care and there is no clear advice on the 
methodology that would be the most effective. Thus we planned a Randomized 
Controlled Trial (RCT) comparing two strategies of implementing an improvement 
of CHF treatment in primary care. This trial compares the adapted standard 
program to a strategy with a barrier analysis and focus on the barriers perceived in 
the various general practices participating. We will assess the effects of the 
program on the guideline adherence related to drug treatment and lifestyle advice 
and on collaboration between health care professionals as the results from the 
pilot test need to be confirmed in a larger study. Furthermore we will assess the 
additional effect from tailoring the intervention. In section 3 we will describe the 
results from the pilot study and the study protocol for the RCT. 
Table 1 summarizes the main research questions and studies presented in this 
Ph.D. thesis. 
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Table 1. Overview of research questions, methods and measures of the studies presented 
in this thesis. 
Research questions 
What is the actual quality of care for coronary heart 
disease patients and patients at high risk in primary 
care practices across countries? 
What is the actual status of self reported 
cardiovascular risk factors and lifestyle in the age 
group 18-45 years and how do demographic data 
and cardiovascular risk factors relate? How does risk 
factor prevalence relate to the number of practice 
visits? 
Do different indicator development procedures give 
different indicator sets for cardiovascular risk 
management? What is the influence of Delphi panel 
composition on the indicator selection? 
To what extent do primary care practices across 
countries have adopted work processes in line with 
the Chronic Care Model and how does this relate to 
practice size? 
What is the actual practice staff composition across 
countries? 
What is the influence of the various domains of 
practice organization on quality of care for patients 
with coronary heart diseases? 
Is it feasible to assess the information network 
related to diabetes, chronic heart failure, and COPD 
within primary care practices with a simple 
questionnaire? Do these network data show variation 
across practices and conditions? 
What are common features in successful 
implementation programs? 
Does the strength of the primary care relate to the 
focus of successful implementation programs on 
cardiovascular risk management? 
Is an implementation program to improve chronic 
heart failure care in primary care feasible in normal 
practice? 
Does a barrier analysis improve the results of an 
implementation program on chronic heart failure care 
in primary care? 
What are the effects of an implementation program? 
Research 
methods 
Observational 
study 
Observational 
study 
Rand modified 
Delphi 
procedure 
Observational 
study 
Observational 
study 
Observational 
study 
Observational 
study 
Prospective 
observational 
study 
RCT, block 
randomization 
design 
Measures 
Medical record 
audit 
Patient 
questionnaire 
Written 
questionnaire 
Practice 
questionnaire and 
interview 
Medical record 
audit, practice 
questionnaire and 
interview 
Questionnaires for 
all staff members 
Reports by key 
informants 
Interviews with 
GPs participating 
in a pilot 
implementation 
programme 
Interviews with 
GPs and data 
from patient 
registration forms 
Chapter 
3 and 4 
5 
6 
7 
8 
9 
10 
11 
12 
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Abstract 
Background: 
Despite important improvements in available prevention and treatment, 
cardiovascular diseases (CVD) remain an important cause of morbidity and 
mortality. Not all high-risk patients and patients with CVD have healthy lifestyles 
and receive the best possible healthcare. Internationally comparative data are 
needed to compare cardiovascular risk management in different countries, and to 
examine the impact of improvement programs and others factors. 
Objectives: 
This study aims to provide internationally comparative data on cardiovascular risk 
management provided in primary care and on health-related lifestyles of patients 
in Europe. The study will also explore the views of doctors and patients on 
innovative preventive services for CVD. 
Design and methods: 
An observational cross-sectional study is planned. In 10 European countries, 
stratified samples of 36 practices per country will be recruited. In each practice, 
three samples of 15 patients each will be sampled: patients with coronary heart 
disease, patients at high risk for CVD, and healthy adult patients. The quality of 
cardiovascular risk management has been specified in terms of 44 performance 
indicators that resulted from an international Delphi procedure with general 
practitioners. Most indicators are based on medical records, and some on a 
structured interview with a contact person of the practice. Lifestyle (smoking, 
physical exercise, diet) will be measured with previously validated questionnaires 
that are completed by patients. Additional measures include practice 
characteristics and exposure to programs to improve cardiovascular care. 
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Background 
Cardiovascular diseases (CVD) have a major impact on the mortality and quality of 
life of human populations across the world, despite improvements in lifestyle and 
innovations in the prevention and treatment of CVD in previous decades.1 
Cardiovascular risk management includes the clinical management of established 
CVD, prevention of CVD in patients at high risk for developing CVD, and 
improvement of health-related lifestyles in the population.2 Though numbers of 
deaths from coronary heart disease (CHD) in developed countries have declined3 
and cardiovascular care may have improved in recent years,4 many eligible 
individuals currently still do not receive the best available treatment and prevention 
for CVD.5 A better insight into cardiovascular risk management in primary care and 
health-related lifestyles of patients could help to develop effective programs for 
improving current practice. 
Data on current cardiovascular risk management and patients' lifestyles are 
needed, both to identify performance gaps and set specific targets for 
improvement, and to identify underlying factors and tailor interventions to relevant 
barriers for change. We do not have specific hypotheses on the quality of 
cardiovascular risk management or patients' lifestyles, except that we expect much 
variation across patients and practices within each of the countries. Inadequate 
delivery of cardiovascular risk management may be related to various factors. For 
instance, it may be related to inadequate perception of cardiovascular risk by 
physicians,4 as well as to concerns about the efficiency and ethical implications of 
providing cardiovascular prevention to individuals at low risk for developing CVD.6 
The clinical benefits and efficiency of primary and secondary prevention are 
continued topic of scientific debate.7 Alternatively, it may be related to 
organizational and financial barriers in practice organizations for providing 
cardiovascular risk management. For instance, organizational characteristics of 
general practices, such as size of scale and teamwork, proved to be associated 
with providing cardiovascular risk management.8 
While data on cardiovascular risk management are available in a number of 
countries, our planned study aims at providing internationally comparative data. 
Such data have a potential advantages compared to national data. Trends and 
associations identified in international datasets may be more robust for the 
confounding influence of national healthcare systems and national cultures. For 
instance, studies in different European studies showed across these countries that 
patient evaluations of accessibility were most positive in small general practices,9 
and that physician workload per 1,000 patients was consistently lower in larger 
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practices. The consistency of these findings makes it more likely that the 
associations were not confounded by characteristics of a specific healthcare 
system or national culture. Furthermore, international comparison of performance 
between different countries can stimulate stakeholders for improvement, although 
country differences can often be attributed to many other factors than those of 
interest. 
Our focus is on primary care, because a substantial part of prevention and chronic 
care for CVD is delivered in this sector. Many countries have large-scale programs 
to improve cardiovascular risk management in primary care, such as disease 
management programs in Germany,11 indicator-based incentive contracts in the 
United Kingdom,3 and practice support in outreach visits in The Netherlands.12 
Interestingly, these programs tend to focus either on risk management in patients 
with established CVD in some countries, and on lifestyle education for the 
population in other countries.13 An important question is what impact exposure of a 
practice to these programs has on the quality of cardiovascular risk management. 
Internationally comparative data can enable a comparison of programs across 
countries. 
Aims and objectives 
This study protocol concerns an international study of cardiovascular risk 
management in primary care in Europe. Its overall aim is to provide insight into the 
current services delivered in primary care to prevent CVD, with the aim to inform 
and support primary care practices as well as national health policies and decision 
makers in this domain. Appendix 1 provides definitions of key concepts in this 
study protocol. 
Key objectives are: 
1. To describe the quality of cardiovascular risk management services provided to 
patients with established CHD and to patients with high risk for developing CVD 
in primary care using performance indicators, and to compare countries in these 
domains. 
2. To describe specific aspects of health-related lifestyle (smoking, physical 
exercise, diet) in high risk patients and in healthy patients in general practice 
across Europe. 
3. To determine the association between exposure of a practice to quality 
improvement programs and the quality of cardiovascular risk management and 
patients' lifestyles. 
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4. To identify associations of the quality of cardiovascular risk management 
provided and characteristics of patients, health professionals, primary care 
practices, and countries with different health care systems. 
5. To describe the experiences and views of general practitioners (GPs) and 
healthy adults on what innovative services a general practice could provide 
regarding primary prevention of CVD. 
Hypotheses 
While the study is mainly descriptive and explorative (aimed at generating 
hypotheses), we tentatively formulated the following hypotheses: 
Hypothesis one: The quality of cardiovascular risk management shows variation 
across countries, general practices, and patients (differences of 15% or more on 
performance indicators). 
Hypothesis two: Better cardiovascular risk management is associated with the 
following practice characteristics: 
1. More structured practice management, including implementation of information 
technology, organization of chronic care and prevention, and structured quality 
improvement. 
2. Involvement of more health professions in the practice in providing 
cardiovascular risk management and in preventive activities in general. 
3. Larger practice size, because of size of scale advantages. 
4. More exposure to and engagement of the practice in cardiovascular quality 
improvement projects and continuing education by health professionals on 
cardiovascular care. 
Hypothesis three: At a country level, better quality of cardiovascular risk 
management in patients with CHD is associated with: 
1. A stronger primary care system in the country 
2. Nationwide programs to improve cardiovascular risk management in general 
practice. 
Design and methods 
The study has a cross-sectional observational design. It is internationally 
comparative (focused on description and comparison of countries) and explorative 
(focused on factors in patients, professionals and practices associated with 
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outcomes). Ethical approval for the study will be sought in each of the participating 
countries, according to national laws and regulations. 
Study populations 
The study includes patients, health professionals, and general practices in 
different countries. 
Countries 
We include 10 countries: Austria, Belgium, England, Finland, France, Germany, 
Netherlands, Slovenia, Spain, and Switzerland. This is a comprehensive sample of 
countries in North, West, South and Central Europe. Although all these countries 
have primary care practices, there is substantial heterogeneity regarding the 
position of primary care in the healthcare system. For instance, primary care 
physicians coordinate access to specialized medical care only in some countries, 
while medical specialists can be consulted directly in other countries. 
Practices 
Stratified random sampling of 36 practices per country is planned. This sample 
size was chosen because it is feasible in the context and budget of this project, 
while experience showed that it has been large enough to give robust results and 
can be considered reasonably representative for a country. A general practice is 
the smallest organizational unit, in which primary care physicians are based in 
their daily work to provide care to patients. The practice may be part of a larger 
organizational network, such as a multidisciplinary health centre or primary care 
trust (for instance to share patient lists, financial risk, legal accountability, support 
staff, etc.). This wider organizational context is not considered in the sampling in 
this project. 
We aim to select representative samples of practices per country. Random 
sampling would be the best method, but the sample is not likely to be 
representative if only a small minority of randomly sampled practices accept the 
invitation to participate in the study. It was considered to be important that the 
sample of practices roughly represents the national situation as closely as 
possible, both for the generalizability of our findings and for drawing policy 
implications. Country partners are instructed to avoid recruiting only a special type 
of practice, such as training practices, academic practices, or practices in a special 
local network. 
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We aim for a stratified random sample, using two factors internationally for 
stratification: practice size and urbanization (See Table 1). The assumption is that 
these factors are prognostic for our main measures of cardiovascular risk 
management - although strong research evidence to support this claim is lacking. 
The definition is as follows: 
Table 1. International stratification scheme. 
Population density 
Practice size Rural/town Urban 
Small A C 
Large Β D 
Practice size 
Small practice size is defined as up to two full-time equivalent (FTE) primary care 
physician, while large practices have more than two FTE primary care physicians 
(regardless of their type of contract and reimbursement; but excluding trainees and 
nurse practitioners). 
Urbanization 
Urban is defined as more than 100,000 inhabitants; rural or town is defined as less 
than 100,000 inhabitants (considering the geographical location of the practice, 
although the patients may come from other areas). 
The actual numbers in the cells (Table 1 A, B, C, and D) are to reflect each 
county's national situation as much as possible, even if this means that in some 
countries some cells have few or no practices. For example, if a country has no 
large practices, cells Β and D would be empty in that country. Country project 
partners are instructed to develop additional criteria for stratifying the sample in 
their country according to practice size and urbanization, particularly if some cells 
in the international stratification table were empty. For example, if most practices 
are larger than two FTE GPs, two strata within the larger practices may be defined 
(e.g., up to four FTE GPs versus five FTE GPs or more). Project partners are 
asked to provide information on the planned and actual stratification table for their 
country. 
Within each of the strata, each country partner is asked to sample randomly from a 
regional or national list of practices. In other words, if a practice declines, a 
similarly sampled practice from the same stratum will be approached. For logistical 
reasons it is acceptable to sample in one or a few geographical areas in a country. 
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The degree to which these regions represent the country as a whole will be 
described qualitatively in terms of health system and population health. 
Health professionals 
The study considers all staff physically working in each general practice, including 
physicians, nurses (nurse practitioners, practice nurses, specialized nurses, 
psychiatric nurses etc.), practice assistants (whether or not with clinical tasks), 
allied health professionals (physiotherapists etc.), psychologists, midwives, 
physician assistants, administrative people, and managers. The staff may be 
employed by the practice or by another organization (e.g., nurses in the practice, 
who are employed by mental health organization). The study excludes staff 
working in the same health centre, or other larger organization, but based in a 
different practice. 
Patients 
The study is focused on three patient samples, which will be identified in each of 
the participating practices: 
Patients with established CHD. This includes myocardial infarction, angina 
pectoris, or vascular surgery (diagnoses based on medical records at the general 
practice). Patients with established diabetes are excluded to enhance the 
homogeneity of the study population. 
Patients with high risk for developing CVD. This includes meeting one of the 
following criteria: 10% CVD mortality risk or 20% CVD morbidity risk in 10 years, 
ideally based on an individual risk assessment using validated CVD risk tables. If 
this is not available, we defined a proxy measure: presence of three out of the 
following four risk factors: hypertension, hypercholesterolemia, smoking, men over 
60 years (cut-off points as defined nationally). Patients with established diabetes 
or established CVD are excluded from this group. 
Patients aged 18 to 45 years (unselected), registered or regular visitors in the 
practice. The underlying argument for focusing on this age group is that we 
assume that health behaviors at younger age tend to be continued at later age. 
Exclusion criteria for all patient samples are: terminal illness, cognitive impairment, 
psychiatric illness, and poor language skills. 
Procedures 
For the first two patient samples (CHD patients and high risk patients) we plan to 
collect data from medical records and from patient questionnaires. Depending on 
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the national context and regulations, different procedures may be used. In 
countries where informed consent is requested, 30 patients will be sent the 
questionnaire with an informed consent form for abstracting medical record data, 
expecting at least 50% informed consent forms will be returned. Then, data are 
abstracted from those patients' medical records. If no informed consent is 
required, a sample of 15 patients will be identified for data-extraction from their 
medical records. A larger sample of patients (n=30), including these 15 patients, 
will be identified and sent questionnaires. These procedures were tested in a pilot 
studies in some general practices in each of the countries, and the results were 
discussed in a plenary international meeting of all researchers in order to 
standardize the sampling procedures as much as possible. 
For the third sample, adults 18 to 45 years, we will take a random sample of a list 
of patients registered at the practice. In countries where there is no patient 
registration, alternative methods will be based on a sample of patients taken from 
a list; e.g., by taking every second or third patient until 40 patients are selected. 
Accuracy of figures 
The accuracy of the figures is focused on the confidence interval associated with 
mean values rather than on differences between countries, practices, or 
subgroups. We will aim for high accuracy of the figures per country, and will use 
n=36 practices per country as the maximum feasible number. We estimate an 
average score of 65% in a specific country, e.g., 65% of patients receive care 
according to a specific indicator (dichotomous outcome) or 65% of the maximum 
score on a continuous outcome (e.g., a fivepoint answering scale). A design effect 
based on ICC = 0.05 is assumed. Power = 0.80 and alpha = 0.05. We will aim for 
95% CI interval of 60 to 70%, so we will need 493 patients per country (n=14 per 
practice). For each indicator and measure data will be collected from 15 patients 
(from records or questionnaires) per practice. The actual number of patients 
approached depends on the procedure and the expected response rate, and may 
therefore vary across countries. 
Measures 
The following measurement methods will be used: medical record audit, patient 
questionnaires, and a questionnaire and an interview guide for a contact person in 
each practice. Specific measures include (see also Table 2.): 
1. The EPA Cardio instrument, which is a set of indicators and related measures. 
The EPA Cardio instrument was based on a modified Delphi procedure to 
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identify relevant indicators. A total of 101 GPs from nine countries (80% of 
those invited) was involved in both rounds of this procedure. These countries 
were included again in this observational study, except for Spain which was 
added later. From an initial list of 650 indicators, 202 indicators were derived, 
from which 44 were rated valid (22%). Only indicators that scored high on 
necessity and feasibility in each of the country panels were included. These 
indicators covered lifestyle (8), clinical performance (27), and organizational 
aspects (9), and are incorporated in the following instruments: abstraction tool 
for a medical record audit in CHD patients; abstraction tool for a medical record 
audit in high risk patients; and an interview guide for an interview with the GP. 
2. Health related lifestyles. In high risk and healthy patients, we will use 
questionnaires for specific aspects of lifestyle, including physical exercise 
(RAPA, 9 items),15 diet (reduced REAP-S, 12 items),16 and smoking (MIDSIZED 
Model, 8 items).17 
3. Other measures on patients. In all patients (CHD, high risk and healthy), the 
questionnaires include items on demographic characteristics, healthcare use, 
chronic diseases, and patient experience with general practice (Europep new 
version, 23 items).18 In CHD and high risk patients, we added the EQ-5D 
(5 items + VAS scale)19 and report on adherence to medication, if relevant 
(4 items).20 In CHD patients, we added the Patient Assessment of Chronic 
Illness Care (PACIC, 26 items).21 
4. Practice engagement in quality improvement programs and education. The 
following items are measured in the interview with the GP or practice manager 
and in the practice questionnaire: practice engagement in cardiovascular quality 
improvement projects; practice engagement in public health projects concerning 
cardiovascular risk; practice engagement in other projects concerning 
cardiovascular risk management (structured lists of projects are used that are 
adapted to the national situation). A structured questionnaire for the GP/practice 
manager includes: questions on exposure to education and campaigns by 
nurses and GPs (five items); the average number of hours of continuing 
education on CVD and diabetes spent by health professionals in the practice in 
the previous two years (five items). 
5. Other measures on practices. A written questionnaire is used to measure 
several practice characteristics: information process technology (EPA 
dimension, 11 items); organization of chronic care and prevention (EPA 
dimension, 19 items); quality improvement (EPA dimension, eight items); 
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practice staff tasks in cardiovascular care (five items for five types of staff); and 
practice size, in terms of listed patients and/or yearly attending patients.22 
6. Innovative preventive services. A questionnaire has been drafted to explore the 
views of GPs and patients regarding what general practice could contribute to 
primary prevention of CVD. These questions are future-oriented, which implies 
that many doctors and patients are expected to have little or no experience with 
specific preventive activities. Also, the research evidence for effectiveness of 
the primary preventive services may be lacking or inconsistent. 
All measures were translated systematically, using a forward and backward 
translation procedure and a testing phase with interviews. The final instruments 
were tested and adapted in a pilot project. In this project, the prototypes were 
tested in five countries in two practices each. This experience led to some minor 
adjustments in the audit forms and questionnaires. The measurements on primary 
prevention and the patient questionnaire for the 18 to 45 year age group was 
added after discussion to broaden the scope of the study: not just patients with 
established CVD (especially CHD) and patients at high risk, but also the generally 
healthy 18 to 45 year age group. 
Table 2. Measurement domains and data collection methods. 
1 Clinical and organizational 
performance in cardiovascular 
prevention (=EPA Cardio 
instrument) 
2 Engagement of the practice in 
quality improvement projects 
3 Practice characteristics, 
including EPA dimensions 
4a.Patient demographics and 
chronic diseases 
4b.PACIC 
4C.EQ-5D 
4d.EUROPEP 
4e.Life style: smoking, physical 
exercise, diet 
5. Views on primary primary 
prevention in general practice 
Data-abstraction 
from sampled 
medical records 
Χ 
Interview and 
questionnaire for 
contact persons 
in the practice 
Χ 
Χ 
Χ 
χ 
Survey in 
CHD 
patients 
X 
X 
X 
X 
Survey in 
high risk 
patients 
X 
X 
X 
X 
Survey in 
healthy 
patients 
X 
X 
X 
X 
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Data-processing and data-analysis 
In each of the participating countries, data will be entered into a database (Excel, 
SPSS, or other data management program). Some participants will make use of 
automated data-entry systems and other participants will use double entry of data 
to reduce errors. All frequency distributions will be checked for errors and the 
number of missing values will be noted. We will attempt to identify signs of 
responder fatigue, e.g., a series of questions that receive the same score. Also, 
we will examine the case mix of different practices in order to identify possible 
selection bias, caused by the sampling procedures. 
Then, the findings will be described for each measure separately on a country-by-
country basis. Appropriate summary measures will be used, such as mean and 
median values. The accuracy of the figures will be expressed in terms of 95% 
confidence intervals, taking into account that the data are nested at two levels: 
patients in practices, and practices in countries. A correction will be made for the 
nested data structure to avoid inappropriately inflated accuracy. We will examine 
qualitatively how the results of each country are related to the assessment of the 
quality indicators by the GP panel in that country. 
Further statistical analysis of comparisons between subgroups in the project 
(defined by patients, practices, or countries) will take this nested data structure into 
account. Therefore, random coefficient regression models will be applied (linear or 
logistic, as appropriate). To reduce the possibility of chance capitalization, we will 
use ρ < 0.01 to indicate significance in explorative analyses and the conventional 
ρ < 0.05 in hypothesis-driven analyses. 
Time frame 
The EPA Cardio project is planned from November 2005 to June 2009. The study 
described in this protocol is planned for March 2008 to April 2009. 
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Appendix 1 - Definitions 
'Cardiovascular diseases' refer in this project to diseases due to atheroscleroris, 
such as angina pectoris, myocardial infarction, and stroke (CVA). Diabetes mellitus 
is also considered CVD by some experts, but this project does not focus on 
diabetes (except that it is recorded as co-morbidity). 
'Cardiovascular risk factors' include age, gender, lifestyle factors (smoking, poor 
diet, overweight, physical inactivity, problematic use of alcohol), and clinical factors 
(diabetes, hypertension and serum cholesterol). The specific definitions of these 
factors, and the cut-off levels for high risk, vary across clinical guidelines. For 
instance, various blood pressure levels have been used to define hypertension. 
Increasingly, policy and practice focus on a patient's global risk rather than 
individual risk factors. 
'Cardiovascular risk management' is used broadly and includes the following target 
groups: the total population, particularly individuals with unhealthy life-styles; 
individuals who have high risk for CVD, which is defined in different ways and may 
be based on one or more risk factors; and patients who have established CVD. 
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Abstract 
Background: 
Primary care has an important role in cardiovascular risk management (CVRM) 
and a minimum size of scale of primary care practices may be needed for efficient 
delivery of CVRM. We examined CVRM in patients with coronary heart disease 
(CHD) in primary care and explored the impact of practice size. 
Methods: 
In an observational study in 8 countries we sampled CHD patients in primary care 
practices and collected data from electronic patient records. CVRM was measured 
on the basis of internationally validated quality indicators. Practice size was 
defined in terms of number of patients registered or visiting the practice. We 
performed multilevel regression analyses controlling for age, sex, and clustering of 
data. 
Results: 
We included 181 practices (63% of the number targeted), stratified according to 
practice size (number of GPs) and size of practice location. Two countries included 
a convenience sample of practices. Patient selection was based on coded 
diagnoses in most countries, some countries used supplemental or other inclusion 
methods introducing potential inclusion bias. In data from 2960 CHD patients we 
found substantial variation on all CVRM indicators across countries. Rates of risk 
factor recording varied from 55% for physical activity to 94% for blood pressure. 
Rates for reaching treatment targets for systolic blood pressure, diastolic blood 
pressure and LDL cholesterol were 46%, 86% and 48% respectively. Rates for 
providing recommended cholesterol lowering and antiplatelet drugs were around 
80%, and 70% received influenza vaccination. Practice size was not associated to 
indicator scores with one exception: In Slovenia larger practices performed better. 
Variation was explained at the practice level more than at the country level. 
Conclusions: 
CVRM showed wide variation within and between countries and can improve in all 
countries involved. Practice size was not found to be associated with higher scores 
except in Slovenia. 
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Introduction 
Many patients with chronic conditions are treated in primary care. This is 
challenging as high quality chronic care asks for an organizational structure 
allowing for population-based management. In previous research larger practice 
size tented to be related to higher quality of care considering various conditions 
with greater diversity of services.1"5 Furthermore, larger practices tended to show 
more features consistent with the delivery of chronic care.6,7 In many countries 
there is a tendency to develop larger practices.8 Increasing size of scale and 
scope may be, up to a certain point, associated with decreasing average costs of a 
service as fixed costs like participation in continued education and hiring additional 
staff are divided by a larger number of patients. From an educational perspective, 
a larger size of scale with more patients may be associated with larger opportunity 
to practice specific procedures, thus steeper learning curves and higher quality of 
performance. On the other hand, a smaller practice size may have advantages in 
terms of more personal care and continuity.9 
Cardiovascular diseases (CVD) have major impact on the mortality and health-
related quality of life of people in both developed and developing countries. 
Despite a declining cardiovascular mortality, improvements in the preventive, 
medical and surgical treatment in previous decades, and widely accepted practice 
guidelines,10"12 CVD is still one of the major causes of death and illness. Primary 
care can play an important role in delivering cardiovascular risk management 
(CVRM) to populations, but previous research showed that not all eligible patients 
receive optimal prevention of atherosclerosis-related CVD.13,14 Many European 
countries therefore have adopted large scale programs for improving CVRM, 
including pay-for-performance in the United Kingdom, disease management in 
Germany and practice accreditation in the Netherlands.15 
While data on CVRM are collected in a number of countries, mostly in specialized 
care settings,13,14 comparable data from primary care, where many patients are 
treated and counselled, was lacking. We conducted a large-scale observational 
study of current CVRM in primary care in eight European countries, focused on 
patients with established coronary heart diseases (CHD).16 In this paper we aimed 
to describe current practice across countries and to explore associations of 
practice size with CVRM. 
Methods 
Data were derived from the EPA Cardio study.16 In this cross-sectional 
observational study countries provided data on CVRM in primary care practices in 
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Austria, Belgium, England, France, Germany, the Netherlands, Slovenia, and 
Switzerland. The country sample was a convenience sample from the countries 
participating within the EQuiP framework which included countries with a strong or 
a weak primary care, and both small and large countries.17 Countries with a strong 
primary care system were England, the Netherlands, and Slovenia; in the other 
countries primary care held a weaker position within the health care 
organization.15,18 Data from patient records were gathered in 2008 and 2009. 
Ethical approval for the study has been obtained in each of the participating 
countries, according to national laws and regulations. A detailed study protocol 
has been published.16 
Stratified random sampling of 36 practices per country was planned, involving two 
factors: practice location (up to versus more than 100,000 inhabitants) and 
practice size (up to two versus two or more full time equivalent physicians working 
in the practice). The relative contribution of each stratum should mirror the national 
situation and each country had the option to add strata in order to better reflect the 
national context. Four countries used this possibility: in England large practices 
were split in up to and more than five general practitioners (GPs); in the 
Netherlands small practices were split in single handed and duo; and in Germany 
and Slovenia the stratum up to 100,000 inhabitants was split in up to and more 
than 40,000 inhabitants. The number of practices - in relation to the patient 
numbers - was based on calculations of statistical accuracy, as described in the 
study protocol based on the detection of significant differences between indicator 
scores between two countries.16 It was calculated that 36 practices per country 
with data on 15 patients per practice would suffice for this goal. Furthermore, 
earlier experiences with international comparative data showed that 30-40 
practices can provide a reasonably good representation of the national situation.19 
Patient population 
We aimed at including 15 patients with established CHD per practice, including 
patients with myocardial infarction, angina pectoris or coronary interventions. 
Patients with diabetes were excluded because diabetes care and care for CHD 
patients are largely congruent. With diabetes patients included our results in part 
would be determined by diabetes care. In each practice a list of eligible patients 
was made, preferably based on coded diagnoses in the data files of patients 
registered with the practice. Then a random sample of 30 patients was taken from 
this list of CHD patients anticipating a 50% response rate. In Belgium, England, 
the Netherlands and Slovenia patient selection was exclusively based on recorded 
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diagnoses. Apart from coded diagnoses, in Germany and Switzerland, the GP 
selected extra patients by recalling CHD patients when not enough patients were 
coded. In the other countries it appeared impossible to select patients based on 
coded diagnoses. In Austria, patient selection was based on going through 
prescription lists. In France, primary care physicians included eligible patients 
when they visited the practice. For this study we excluded practices with data on 
less than 8 CHD patients. 
Measures 
Measures were linked to a set of rigorously developed performance indicators for 
CVRM.20 To develop these indicators we used a RAND Modified Delphi procedure 
with two rounds of consensus, with 101 GPs from nine countries involved in the 
consensus process. From an original list of 650 indicators derived from the 
scientific literature, we first identified and edited 186 unique indicators. After two 
rounds of consensus 17 indicators relevant for patients with established CHD were 
selected; for 11 out of these 17 indicators data could be collected by extraction 
from medical records. These indicators comprised the registration of risk factors 
(smoking status, physical activity capacity, weight or body mass index, blood 
pressure, and serum cholesterol), advice on physical activity, influenza 
vaccination, antiplatelet and statin drug therapy prescribed or offered, systolic and 
diastolic blood pressure below threshold (140 and 90 mmHG respectively). 
Though not identified as a key-indicator we also present data on LDL-cholesterol 
levels because these data are widely seen as an important treatment goal.10"12 All 
measures were systematically translated into the different countries' languages, 
with established procedures of forward and backward translation and a pilot 
testing. The final instrument to collect the data from the patient records was tested 
and adapted in a pilot project in five countries including two practices. 
Analysis 
We calculated descriptive figures per practice providing data on practice size and 
CVRM. For each practice the percentages of patients with a positive score on 
indicators were assessed; patients with a missing value were excluded for this 
outcome measure. We determined the mean scores across practices per country 
with standard deviations, implying that each practice had equal weight irrespective 
of the number of patients included. We tested whether the country means deviated 
significantly from the grand mean, using two-sided t-tests considering Levine's test 
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results. As the analyses of country differences are explorative a threshold value of 
p<0.01 was chosen to reduce the possibility of chance capitalization. 
Based on the reported practice size - patient list size when available, otherwise 
yearly attending patient numbers - using a logistic multilevel regression analysis 
we assessed the association between indicator scores and practice size per 
country with two levels: a patient and a practice level. Age and gender were 
independent variables in the first level (patient level). In these analyses practice 
size was based on patient number as a continuous factor and not on the number 
of GPs in the practice what was used only for easy definition of stratification 
groups. 
Furthermore, we performed a three level logistic regression analysis with country 
as a fixed factor in the third level. For this analysis we standardized practice size 
per country. With this methodology we corrected for the differences in practices 
sizes between the countries as we were not interested in country differences but in 
the effect of practices size across countries. We assessed the association 
between practice size and indicator scores across all countries and across the 
countries with a strong and a weak primary care system apart. Related to practice 
size we hypothesized that larger practices would perform better; for these 
hypothesis driven analyses we used p<0.05 as threshold for significance. 
We assessed the contribution of practices and of countries to the variance in 
scores on the performance indicators. The Intra Class Coefficients were computed 
based on the methodology described by Twisk.21 
SPSS 16 was used for descriptive analysis and t-tests, SAS for random coefficient 
regression modelling. 
Results 
In several countries it appeared impossible to include 36 practices. Finally 232 
practices participated (81% of the number aimed at). We excluded 51 practices 
because they did not provide data on practice size (n=14), included less than eight 
CHD patients (n=33), or both (n=4). In this study we included 181 practices. In 
Austria and Switzerland a convenience sample of practices participated; in 
Belgium additional to practices from a list four practices were included after they 
were personally contacted by the researchers. All other countries worked with 
national or regional practice lists. Practices in Austria, Germany, and Switzerland 
reported on the yearly attending population; in the other countries practice size 
was based on the number of patients listed. 
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The 181 practices included provided data on 2960 patients, on average 16.4 per 
practice. Overall 33% of the patients included were female and the overall mean 
age was 68.7 years (see Table 1). 
Table 1. Practice sample and demographic data. 
Austna 
Belgium 
England 
France 
Germany 
The Netherlands 
Slovenia 
Switzerland 
total 
Practices 
(n) 
23 
18 
32 
9 
13 
34 
35 
17 
181 
Mean practice size 
(sd) 
2878 (1369) 
3035 (2363) 
6573 (3655) 
1417 (754) 
4423 (1608) 
3183 (1215) 
2059 (804) 
3449 (2537) 
3538 (2582) 
Patients 
(n) 
293 
232 
479 
133 
248 
495 
805 
275 
2960 
% female 
36 
25 
39 
26 
35 
29 
36 
24 
33 
Mean age 
(years) 
71.6 
66 7 
68.2 
67 8 
70.0 
69 3 
68.3 
68.2 
68 7 
Cardiovascular risk management 
Regarding cardiovascular risk factor recording, the percentage of missing values 
was consistently 3 to 4%. The mean practice score of recording physical activity 
capacity was, on average, about 50% (see Table 2). Overall, blood pressure 
recording had the highest score (94%), followed by cholesterol levels (87%). 
Standard deviations are indicative of the differences between practices. 
Indicators concerning achievement of target values for SBP, DBP and LDL, 
considering the most recent measurements, are displayed in Table 3. We had data 
of about 90% of the patients. Overall, the mean practice score on the indicator 
DBP below 90 mmHg was 85%, and on SBP and LDL cholesterol about 45%. On 
average the scores on the recommended cholesterol lowering and anti-platelet 
drug treatment were 80%. The practice mean score on influenza vaccination was 
less than 70%. 
Risk factor recording in general was below the mean in the Netherlands; in 
England most factors were recorded significantly more often. The other countries 
showed better results on the various factors (see Table 2). Considering the 
outcomes advice on physical activity, influenza vaccination, antiplatelet and statin 
drug therapy, blood pressure and cholesterol levels (see Table 3), England again 
scored above the mean in 4 of the 7 outcomes. Here the Netherlands and 
Slovenia outperformed on one outcome, respectively influenza vaccination and 
antiplatelet drug therapy. 
42 Chapter 3 
Table 2. Indicator scores: risk factor recording. 
Mean practice scores (%) per country and across countries with standardized variation. 
Scores significantly deviating from the mean of all countries are marked when p<0.01, with 
ρ values displayed. 
Austria 
Belgium 
England 
France 
Germany 
Netherlands 
Slovenia 
Switzerland 
Total 
Mean 
SD 
Ρ 
Mean 
SD 
Ρ 
Mean 
SD 
Ρ 
Mean 
SD 
Ρ 
Mean 
SD 
Ρ 
Mean 
SD 
Ρ 
Mean 
SD 
Ρ 
Mean 
SD 
Ρ 
Mean 
SD 
Smoking 
status 
100 t 
0 
000 
76 7 
29 0 
708 
94 8 t 
100 
000 
79 4 
21 5 
983 
92 5 Τ 
9 9 
001 
57 2 4 
28 3 
000 
76 5 
26 2 
580 
65 4 
38 1 
162 
79 3 
27 5 
Physical activity 
capacity 
50 6 
31 2 
566 
52 6 
345 
805 
64 1 
29 4 
121 
46 0 
39 6 
439 
55 6 
41 5 
933 
41 7 
27 7 
030 
60 0 
29 0 
358 
62 8 
348 
323 
546 
32 2 
Weight / BMI 
614 
33 0 
311 
844 î 
15 1 
001 
82 9 î 
22 1 
003 
90 9 î 
11 0 
000 
65 2 
33 3 
662 
44 6 4 
27 3 
000 
70 8 
25 0 
705 
714 
24 4 
727 
68 8 
28 8 
Blood 
pressure 
94 2 
71 
957 
98 0 t 
4 2 
004 
98 3 t 
34 
000 
96 2 
77 
555 
96 3 
70 
462 
82 0 i 
158 
000 
97 4 
67 0 
021 
96 6 
59 
324 
94 1 
104 
Serum 
cholesterol 
95 7 î 
60 
000 
95 4 î 
67 
000 
94 6 t 
75 
000 
96 4 î 
67 
002 
94 2 
8 9 
016 
67 2 l 
195 
000 
83 6 
14 4 
253 
87 8 
108 
830 
86 9 
160 
Practice size 
In the analyses per country practice size did not consistently correlate to the 
outcomes (data not shown). In Slovenia 4 of the 12 outcomes (recording of 
physical activity capacity and BMI or weight, advice or contraindication for physical 
activity, influenza vaccination) had a significant positive association with practice 
size, 7 outcomes were non-significant positive and one was non-significant 
negative. We found one other significant association: In England practice size and 
the indicator score related to influenza vaccination were negatively associated. 
For the outcome measure recording of physical activity capacity all countries 
showed a positive association, though only in Slovenia significant. 
Across all 8 countries we found no association between practice size and indicator 
scores. In countries with a strong primary care system practice size was positively 
associated with the score on influenza vaccination (OR 1.28, 95%CI 1.01-1.61) 
and negatively with the LDL cholesterol level score (OR 0.86, 95%CI 0.74-0.99) 
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In countries with a weak primary care system we could not detect associations 
between practise size and outcomes. 
Table 3. Indicator scores. 
Mean practice scores (%) per country and across countries with standardized variation. 
Scores significantly deviating from the mean of all countries are marked when p<0.01, with 
ρ values displayed. 
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Austria 
Belgium 
England 
France 
Germany 
Netherlands 
Slovenia 
Switzerland 
Total 
Mean 
SD 
Ρ 
Mean 
SD 
Ρ 
Mean 
SD 
Ρ 
Mean 
SD 
Ρ 
Mean 
SD 
Ρ 
Mean 
SD 
Ρ 
Mean 
SD 
Ρ 
Mean 
SD 
Ρ 
Mean 
SD 
61.1 
30.8 
.062 
39.3 
32.1 
.317 
48.1 
30.7 
.917 
45.7 
39.0 
.876 
56.3 
45.0 
.497 
28 8 1 
22.9 
000 
54.9 
29.5 
.212 
52.3 
38.9 
.567 
47.4 
33.0 
49.9 
29.2 
.012 
90.7Î 
12.2 
.000 
87.3Î 
14.4 
.000 
50.7 
31.9 
.114 
74.9 
31.4 
.520 
96.8Î 
5.8 
.000 
33.31 
32.6 
.000 
56.9 
28 1 
.159 
68.8 
33.5 
86.4 
25.1 
739 
90 1 
12.3 
.553 
90.8 
10.5 
.171 
88.0 
15.3 
.966 
69.3 
25.4 
.023 
82.8 
18.2 
.129 
92.9Î 
8.9 
.010 
94.1 
9.9 
.128 
87.7 
16.9 
78.8 
22.5 
.317 
85.8 
12.2 
.427 
90.2Î 
10.8 
.002 
86.4 
21.4 
.513 
69 51 
17 1 
.006 
77 9 
1 5 9 
.120 
84.2 
13.2 
.612 
84.7 
15.2 
.625 
82 7 
16.3 
46.7 
20.9 
.850 
55.4 
21.3 
.065 
43.3 
14.8 
.404 
61.4 
18.3 
029 
52.3 
20.5 
282 
28.91 
15.6 
000 
46.0 
18.7 
968 
59.8t 
23.4 
.010 
45.8 
20.9 
86.0 
9.5 
.871 
85.0 
12.6 
.870 
95.7 Î 
5.1 
000 
90.2 
10.7 
260 
81.2 
1 0 8 
.204 
81.0 
1 2 7 
.046 
80.2 
12.5 
.018 
87.3 
11 5 
.570 
85.5 
12.1 
59.1 
22.5 
.022 
46.6 
16.3 
816 
65.5Î 
15.1 
000 
38.9 
19.6 
247 
37 1 
1 3 8 
.090 
43 0 
20.8 
.261 
37.8 
20.7 
.016 
41.5 
23.7 
.303 
47.5 
21.8 
1
 SBP below threshold: SBP<140 mmHg 
1
 DBP below threshold: DBPOO mmHg 
' LDL below threshold: LDL<2.5 mmol/l 
We assessed the relative contribution of practices and countries to the variance in 
indicator scores, the ICC scores (See table 4). Of the indicator scores on SBP, 
DBP and LDL about 10% of the variance could be explained at the practice and 
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country level together. In all other indicators more of the variance could be 
explained, about 15-30% at the practice level and up to 18% at the country level. 
Table 4. Intra Class Coefficients. 
11 6 
0.9 
7.6 
16.4 
170 
2.1 
18.2 
6.1 
2.5 
3.4 
38 
3.6 
31 7 
29 1 
24.7 
28.4 
19.3 
28.6 
17.9 
26.1 
15.2 
7.9 
7.4 
6.5 
Indicator Country level Practice level 
Smoke status recorded 
Physical activity capacity recorded 
Weight or BMI recorded 
Blood pressure recorded 
Cholesterol recorded 
Advice or contraindication for physical activity 
Influenza vaccination 
Antiplatelet therapy 
Statin advised or prescribed 
SBP below threshold 
DBP below threshold 
LDL below threshold 
Discussion 
This is, to our knowledge, the first large scale study on CVRM in European primary 
care. We found that scores on quality indicators in general vary from 45% (a 
record of advice on physical activity; SBP and LDL below treatment targets) up to 
about 95% (blood pressure recording) of the maximum score, which indicates 
optimal treatment. As opposed to our expectation, we found little evidence for 
better performance in large practices. In Slovenia larger practices tended to 
perform better. Our study did not explicitly assess the efficiency of delivering 
CVRM. 
Similar to our research, the three EUROASPIRE surveys provide data from 
international research with uniform data collection across countries. But in 
EUROASPIRE a specialist care starting point guided CHD patient selection.22 
Raised blood pressure, defined as SBP>140 mmHg and/or DBP>90 mmHg or in 
diabetics respectively >130 mmHg and >80 mmHg, was prevalent in 58-61% of 
these survey samples. Raised cholesterol was defined as >4.5 mmol/l and 
diminished from 94.5% in EUROASPIRE I, to 76.7% in the second survey and 
finally to 46.2% in the third. Data collected in the most recent EUROASPIRE 
survey in 2006 and 2007 are comparable to our results. In the Pinnacle program, 
data regarding outpatients from cardiology offices, too, show comparable results 
with for instance antiplatelet and statin therapy in 84.9 and 84.3%, respectively.23 
Previous data on CVRM in primary care can be found in various national studies. 
In a Cochrane review the effects of interventions on the organisation of the 
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treatment considering ischemic heart disease patients in primary care are 
studied.24 Data from the control groups could be considered comparable to our 
audit data. Direct comparable outcomes are statin prescription and antiplatelet 
therapy. In the review 50.1 of the control patients received statin therapy, but 
studies dated back till the 1990's. The most recent study, SPHERE, had with 
80.3% a result comparable to 82.7% in our study. Relating to antiplatelet therapy 
the review result was 72.5% compared to 87.7 in our study sample. Again, the 
more recent data were the best, up to 87.0. In the SHERE study SBP was <140 
mmHg in 66.2% (versus 47.5% in our data) and DBP<90 mmHg in 88.6% of the 
patients (comparable to 85.5% in our data).25 In drug trials efficacy of statins varies 
from 60 to 90% in achieving LDL < 2.5 mmol/l.26"29 In our observational study, the 
real life results are on the lower end of this range. In contrast to the optimum 
situation in these drug studies physicians could include every patient known to 
have a CHD, patients without further medical attention, too. The indicator on LDL 
cholesterol treatment target surprisingly was not validated in the Delphi indicator 
development procedure. We can only speculate about the reasons; setting strict 
norms irrespective of the patient's age might be argued by some or the fact that 
this outcome measure very much depends on the patient in contrast to process 
measures as offering a statin. In view of the strong evidence base for the 
relationship between LDL cholesterol and coronary heart disease we anyhow 
decided to include the LDL cholesterol results in our study. 
Since most patients with increased cardiovascular risk are treated in primary care, 
the findings are extremely relevant for improving care in the different countries. 
They show that specific countries scored high on some indicators and low on 
others. Improvements in CVRM are possible in all countries. Our study allowed to 
include all patients with a known diagnosis of CHD. Inevitably, patients treated in 
secondary care could be included, too. Our results give an overview of the 
performance of CVRM related to all patients known in the primary care practice. 
In England high scores on performance indicators were observed, particularly for 
indicators incentivized as part of the Quality and Outcomes Framework (QOF).30 
Physicians in England are forced, by their electronic patient records, to tick boxes 
for QOF-indicators, which might be a strong driver for change in registration, 
enhancing good risk factor registration in England. On the other hand, we found 
relatively low performance scores for some indicators of CVRM, especially risk 
factor recording, in the Netherlands. The only indicator related to a financial 
incentive (influenza vaccination) had very high scores in this country (in 2009 a fee 
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of 9.88 euro was provided for every vaccinated patient). The system parameter 
incentives on a national level and as such as a country characteristic may have an 
important influence relative to practice size as a practice characteristic. 
The DBP indicator scores were much higher than scores for SBP, though the 
importance of the latter is stressed by its role in risk classification schemes. Advice 
on physical activity had low scores, too, although it remains uncertain whether 
such advice had been provided but not recorded. 
Differences between countries may be partly explained by differences in the 
quality of recording as stated above. Medication and blood pressure or cholesterol 
levels are probably well recorded, but this is less the case for smoking status or 
exercise advice. It might be argued that recorded care does not mirror care 
provided. But in chronic care recording is thought to be essential. Risk factor 
recording is a prerequisite to select patients for treatment and chronic care means 
collaboration between various health care professionals, who will need to rely on 
the data in the patient records.31 
In our study practice size seems to have little relation to outcomes. Though in 
previous research on practice size no consistent results were found, in general 
larger practices tend to show better performances and provide more extensive 
services, for instance more preventive activities.1"5 All these studies were based on 
national data. We took into account the fact that we had practices from eight 
countries by entering country as a level in our multilevel analysis. This procedure 
effected chance on significant findings. Taking into account the strength of the 
primary care did not provide relevant findings. 
A larger practice offers opportunities to develop skills by experience and gives 
managerial advantages, especially when specialized staff is required. Structured 
care will be more cost effective with larger patient groups included in a program. 
On the other hand, there seems to be a trade of between high quality clinical care 
and interpersonal care, and access might be better in smaller practices.2,9 
The proportion of variance explained at the practice level was larger than that 
related to the country level, indicating that the practice has more influence on that 
variation than the country. This could stimulate practices to invest in quality 
improvement in their practices as there is little argument that much is determined 
at a higher level out of their reach. A remarkable small part of the variation in 
outcomes is explained at both the practice and the country level considering the 
blood pressure and cholesterol levels. These biological outcomes will be 
determined at the patient level to a greater extend. 
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Strengths and limitations of the study 
A potential source of bias is the selection of practices for this study this was 
random in most countries but a convenience sample in two countries (Austria and 
Switzerland) The procedure for sampling patients, too, showed some variation In 
Belgium, England, the Netherlands and Slovenia patient selection was exclusively 
based on recorded diagnoses, enabling inclusion of patients registered but not 
controlled m primary care or not at all Less strict methods were used in the other 
countries (remembering patients, prescription lists, attending patients) providing 
patient inclusion bias Our practice sample appeared the best feasible within the 
context of our international survey The sample size of 181 practices forms a 
limitation to detect small effects of practice size on outcomes, among others due to 
clustering within countries and differences of possible effects between countries 
We included patients with CHD to have a patient group more homogeneous than 
the group of CVD patients in general This did not completely prevent 
heterogeneity within our study population The CHD group comprised on the one 
hand patients who had a myocardial infarction or vascular surgery and have been 
treated in secondary care and on the other hand patients with stable angina 
pectoris who might have been treated in primary care exclusively 
/mp//ca//ons 
Despite room for improvement primary care can provide high quality preventive 
care for CHD patients Future research will have to focus on implementing 
improvement programs The variation between practices within each country is 
unwanted and proves potential for improvement Though one might argue that all 
scores should be 100%, this will be impossible But the variation with highly 
performing practices within each country proves that in each national context good 
CVRM is possible Differences found between countries and especially best 
practices can form lessons for all countries For instance the Quality and 
Outcomes Framework from the UK can be an example to other countries but focus 
may differ according to the national situation as the position of primary care within 
the larger context of the health care system 
In contrast to most previous research our analysis did not indicate significant 
influence of practice size on the quality indicator scores In various studies larger 
practices tend to perform better, supporting the development of practice 
collaboration with consequently larger groups of CHD patients to organize care 
This may enhance expertise and logistics We could not confirm this tendency 
Here, further research is needed 
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Abstract 
Background: 
Detection and registration of high risk for cardiovascular diseases (CVD) by 
assessing individual's absolute cardiovascular risk is recommended in clinical 
guidelines. Effective interventions to reduce cardiovascular risk are available, but 
not optimally implemented. The aim of this study was to assess the quality of 
cardiovascular risk-factor recording and lifestyle counseling in high-risk patients in 
European primary care and to identify factors related to these clinical processes. 
Methods: 
An international cross-sectional observational study was conducted in stratified 
samples of primary care practices in nine European countries. Patient records 
were audited, using a structured data-abstraction tool based on internationally 
developed quality indicators. To identify factors associated with the recording, 
additional data were collected in a patient survey. Descriptive and multilevel data 
analyses were conducted. 
Results: 
In 268 general practices across Europe, 3723 records of individuals at high risk for 
cardiovascular diseases were audited. We found important variations in the quality 
of documentation of risk factors and lifestyle interventions. 
Recording of risk factors was best for blood pressure (92.5% of audited records, 
95% CI 0.89-0.96). Lifestyle advice was recorded best for smoking cessation 
(65.6%, 95% CI 0.58-0.73) and worst for physical activity (38.8%, 95% CI 0 .31-
0.47). Of the study population, 50.6% (0.42-0.59) had elevated blood pressure 
levels, 59.8% (0.51-0.69) had total cholesterol >5 mmol/l, and 30.5% (0.22-0.39) 
were smokers. Multivariate analyses showed that recording of risk factors and 
counseling were related to specific patient characteristics more than to country 
effects. 
Conclusions: 
Analysis of different country results can be helpful for developing quality-
improvement strategies. 
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Background 
Cardiovascular disease (CVD) is the major cause of premature death in most 
European populations.1 CVD is an important source of disability and contributes to 
the expanding costs of health care.12 
Atherosclerosis, which is the underlying pathology of most CVD, develops 
insidiously over many years and is usually advanced by the time symptoms 
emerge.3 It is long known that the development of CVD strongly relates to 
modifiable lifestyle factors such as smoking, poor physical activity, and unhealthy 
diets, with overweight and obesity as consequences. Healthcare providers face 
the challenge to monitor and manage risk factors and life styles in large numbers 
of individuals with increased risk for developing CVD. Modification of risk factors 
has unequivocally been shown to reduce morbidity and mortality.4"6 
Cardiovascular preventive aims are to improve both quality of life and life 
expectancy for people at increased risk for developing CVD and those with 
established CVD.7 Mass screening for CVD in the general population is not cost-
effective,8 but opportunistic screening in the primary care setting is more 
promising.3,9 
The key to CVD risk management is comprehensive risk assessment. Clinical 
guidelines, such as the European Guideline on cardiovascular disease prevention, 
recommend the assessment of the individual's absolute global risk to get a 
cardiovascular event or to die from CVD within a specific timeframe as the basis 
for risk management,5,10"13 rather than to focus on individual risk factors 
separately. Consensus was reached on quality indicators for recording risk factors 
and lifestyle interventions in patients at high risk for CVD.14 In the past, large 
European studies such as EUROASPIRE, have focused on prevention of patients 
with established CVD,6,15 and stated a compelling need for more effective lifestyle 
management.16 However, data on prevention in patients at high risk for CVD in 
primary care were not available. We report here on a large European study which 
focused on cardiovascular risk management in primary care. The aim of this paper 
was to describe the registered cardiovascular risk assessment and lifestyle 
interventions in primary care patients at high risk for CVD in nine European 
countries. 
Methods 
This large European observational cross-sectional study (EPA Cardio) was 
conducted between 2008 and 2009. The participating countries were recruited 
from the TOPAS Europe Association, which is a collaboration of researchers of 
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quality improvement in health care founded in January 2005. Ethics committees in 
all countries approved the study. 
General practices were approached by the national research teams mostly out of a 
list provided by medical associations, intending to include 36 practices with 15 
patients per practice from each of the countries in order to achieve a predefined 
degree of statistical accuracy.17 The practices willing to cooperate were stratified 
by urbanization and practice size. 'Rural' was defined as practice in a town with 
fewer than 100,000 inhabitants. Size was 'small' with up to two GPs and 'large' 
with more than two GP full-time equivalents. Out of the resulting four stratification 
boxes, practices were randomly chosen according to the national distribution of 
general practices across the countries with the intention of achieving a 
representative country sample. 
In each practice, 30 patients at high risk for CVD were randomly sampled 
(assuming 50% response) and invited to participate. Inclusion and exclusion 
criteria for patients are listed in Table 1. 
Table 1. Inclusion and exclusion criteria. 
1 High-nsk patients defined by risk calculation with recommended tools according to national 
guidelines, e g 10% fatal CVD risk as calculated by the Dutch risk tables 
Inclusion
 o r 
criteria 
2 Proxy measure Patients with three out of the following four risk factors hypertension, 
hypercholesterolaemia, smoking, men over 60 years 
1 Patients with established CVD (including ischaemic heart disease, myocardial infarction, 
angina pectoris, coronary surgery or revascularisation procedures, ischaemic stroke, transient 
Exclusion ischaemic attack, claudication or peripheral vascular disease) 
cnteria 2 Patients with diabetes 
3 Terminal illness, cognitive disorders (e g dementia), psychiatric diseases (e g schizophrenia) 
and lack of language knowledge 
Practice staff, mostly nurses but also practice assistants or GPs, identified the 
target population out of the practice registry receiving detailed written instructions 
and support from the research team. In the UK, a researcher visited the practice 
and undertook the audit. Where applicable, the nurses' work was financially 
incentivized by the national research teams. Patients were asked to give written 
informed consent. 
Data on recorded risk factors and life style counseling, relating to the last 15 
months, were manually abstracted out of medical records, using paper-based 
abstraction forms. The audit was based on EPA Cardio quality indicators which 
had been developed in an earlier stage of the project.14 Completed abstraction 
forms were forwarded pseudo-anonymized to the national research teams. The 
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following cardiovascular risk factors were audited: blood pressure, cholesterol, 
blood glucose, smoking status, physical activity, and weight or body mass index 
(BMI). Records were also reviewed for recorded lifestyle advice on smoking, 
physical activity and diet. 
Participating patients were also asked to complete a patient questionnaire about 
sociodemographic factors. All instruments had been developed and piloted in the 
EPA Cardio project before being applied in the study. 
Descriptive data analysis was conducted using SPSS version 18.0 for Windows. 
Outcome measures were recorded blood pressure, cholesterol, blood glucose, 
smoking status and advice for smoker, physical activity status and advice, 
weight/BMI, and diet advice. For each of these binominal outcomes, numeric and 
interval-scaled explanatory variables were included in a two-level logistic 
regression, taking into account that patients were nested in countries (Table 2). 
This multilevel analysis was performed with PROC GENMOD version 9.2 (SAS). 
Results 
A total of 268 general practices took part in the study. The number of participating 
practices ranged between 17 and 36 per country. A total of 4479 eligible patients 
were identified as being at high risk for CVD, with a range of 166 to 863 per 
country. Data were extracted out of 3723 patient records and 3896 patients 
completed a questionnaire. The mean age of the patients included was 66 years 
and 29.5% were female. 
Risk factors 
This study found that 50.6% (CI 0.42-0.59) of the high-risk patients had elevated 
blood pressure >140/90 mmHg, 59.8% (CI 0.51-0.69) had total cholesterol 
>5mmo/l, 30.5% (CI 0.22-0.39) were smokers, 31.4% (CI 24.2-38.5) had a 
BMI>30 kg/m2, 76.5% (CI 0.71-0.82) had a BMI>25 kg/m2, and 14.6% (CI 0.06-
0.23) had fasting glucose levels over 6.1 mmol/l or random glucose levels over 10 
mmol/l (Table 3). 
Recording of risk factors and lifestyle counseling 
Blood pressure was documented in 92.5% of the audited records, cholesterol in 
83.9% and blood glucose in 78.4%. Lifestyle factors such as smoking status, 
weight/BMI, and physical activity status were documented in 77.3%, 66.4%, and 
45.1% respectively. The documentation of risk factors showed some variation 
across countries and items. In total, the recording of the three risk factors blood 
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pressure, cholesterol, and blood glucose was better than the recording of the 
lifestyle factors smoking, physical activity, and weight/BMI. Blood pressure was 
documented best, BMI worst. Assessment of risk factors was recorded most 
frequently in Belgium, Slovenia, and France, whereas recording of lifestyle factors 
was most frequent in Slovenia. 
Lifestyle advice was recorded best for smoking cessation and worst for physical 
activity. Advice to quit smoking was documented best in Slovenia and UK, 
whereas advice about diet and physical activity were recorded most frequently in 
Slovenia (Table 4). 
Table 2. Variables included in the multilevel analysis. 
No Variable/label Value/category Data source/explanation 
1 Age (numeric) 
2 Gender 
3 
4 Number of 
uncontrolled risk 
factors 
5 Duration of being 
patient in the practice 
6 
7 
8 
Numeric 
Female 
Male 
Numeric 
Frequency of practice 
attendance 
9 
10 
11 Health status 
12 
13 
14 ID countnes 
15 
16 
17 
18 
19 
20 
21 
22 
Up to 2 years 
3-7 years 
More than 7 years 
Up to 3 times /year 
4-7 times/year 
More than 7 
times/year 
Good 
Fair 
Poor 
Austria 
Belgium 
Finland 
France 
Germany 
Netherlands 
Slovenia 
Switzerland 
UK 
Patient chart patient age was divided by 5 to interpret 
beta coefficients by increasing age in 5-year steps 
Patient chart 
Patient chart- number out of five nsk factors (1 ) BMI>30 
kg/m2, (2) fasting blood glucose>110 mg/dl (6 1 mmol/l) 
or random blood glucose >180 mg/dl (10 mmol/l), (3) 
total cholesterol >5 mmol/l (200 mg/dl), (4) mean systolic 
>140mmHg or diastolic >90 mmHg, and (5) smoking 
Patient questionnaire 
Patient questionnaire 
Patient questionnaire 
Patient chart 
Table 3. Characteristics of the patient samples (n=3723). 
Country Practices Patients Female Mean age ± SD Raised blood Raised 
(n) (n) (%) pressure (%)' cholesterol (%)" 
Smoking Overweight/ Obesity (%) Raised blood 
(%) BMI>25kg/m2 BMI >30kg/mz g'"cose (%)c 
Austria 
Belgium 
Finland 
France 
Germany 
Netherlands 
Slovenia 
Switzerland 
UK 
Total/mean 
33 
25 
17 
34 
28 
36 
36 
23 
36 
268 
286 
267 
147 
378 
471 
468 
842 
329 
535 
3723 
37.5 
24.1 
44.0 
43.3 
55.1 
10.9 
35.3 
46 3 
1.1 
29.5 
65 ± 10.7 
67 ± 6.1 
61 ± 9.4 
65 ± 10 3 
6 7 ± 11.1 
71 ± 7.1 
62 ± 8 9 
67 ± 8 6 
67 ± 5.5 
66 ± 9.1 
53.6 
37 0 
58.4 
30 5 
59 0 
66.3 
54.0 
44.8 
51.5 
50.6 
64 4 
52.3 
60.3 
57 8 
75.1 
56.7 
70.5 
66 7 
34 8 
59.8 
27.4 
38.3 
41.9 
22.5 
11.7 
27.7 
26.1 
27 7 
51.1 
30.5 
77.3 
63.8 
81.4 
81 7 
80.6 
66.9 
82 4 
82 1 
73.2 
76.5 
28.5 
15.0 
47.5 
35 5 
32.8 
21.1 
35 4 
34 4 
32.5 
31.4 
188 
13.9 
12.1 
21.4 
9 6 
13.8 
14.9 
13.6 
2.9 
14.6 
a Defined as a mean of 1-3 blood pressure measurements, as documented in patients records, if mean systolic blood pressure values are over 
140 mmHg or diastolic over 90 mmHg. b. Defined as total cholesterol levels over 200 mg/dl or 5 mmol/l. c Defined as levels over 110 mg/dl or 6,1 mmol/l 
for fasting blood glucose, and 180 mg/dl or 10mmol/l for random blood glucose. BMI=body mass index 
Table 4. Recording of risk factors, lifestyle factors and lifestyle advice (n=3723). 
Country 
Austria 
Belgium 
Finland 
France 
Germany 
Netherlands 
Slovenia 
Switzerland 
UK 
Mean (95% CI) 
Blood 
pressure 
93 0 
95 8 
85 0 
96.6 
91.9 
86.9 
95.6 
96.4 
91.4 
92.5 
(0 89, 0 96) 
Cholesterol 
84.2 
90 9 
83 0 
92.3 
89.3 
68.7 
89.0 
83 9 
73 5 
83.9 
(0 78, 0 90) 
Blood 
glucose 
88.3 
95 8 
90 6 
90 3 
85 0 
73.2 
94.5 
76.8 
64 3 
75 5 
(0 58, 0 97) 
Smoking 
status 
100.0 
75 8 
63 3 
71.0 
81.1 
56 8 
84.0 
66.9 
96 6 
77 3 
(0 66, 0 89) 
W e i g h t / B M I 
66.0 
72.0 
48.3 
92 6 
62 9 
45.6 
75.9 
65 0 
69 3 
66 4 
(0 56, 0 77) 
Physical 
activity 
39.6 
41.5 
51.1 
47.7 
42.0 
41 9 
57.9 
44.0 
40 4 
45 1 
(0 40, 0 50) 
Smoking 
advice 
67.2 
63 5 
63.2 
60.7 
56.8 
55.1 
73.0 
63.9 
84.7 
65.6 
(0 58, 0 73) 
Diet advice 
50.5 
34.5 
41.1 
46.7 
44.7 
23.2 
71.9 
27.9 
45 9 
42 9 
(0 32, 0 54) 
Physical 
activity advice 
47.0 
34.0 
29.9 
45 9 
35 4 
26 1 
57.9 
45.6 
27.9 
38.8 
(0 31,0 47) 
Table 5. Factors associated with recording and counseling. 
Explanatory variable 
Age (increasing in 5 year steps) 
Gender 
female 
male 
Number of risk factors increasing 
Duration in practice 
Up to 2 years 
3-7 years 
More than 7 years 
Frequency of practice attendance 
Up to 3 times /year 
4-7 times/ year 
More than 7 times/year 
Health status 
Good 
Fair 
Poor 
Countries 
Austria 
Belgium 
Finland 
Outcome measures: Beta estimates (log odds ratios) and 95% confidence intervals and p-values 
Blood pressure 
0 19(0 10,0 28) 
p<0 0001 
0 39 (-0 02, 0 76) 
Reference 
1 32(1 10, 1 55) 
p<0 0001 
0 01 (-0 66, 0 68) 
-0 12 (-0 57, 0 33) 
Reference 
-0 82 (-1 35, -0 29) 
p=0 0024 
-0 17 (-0 68, 0 35) 
Reference 
0 45 (-0 31, 1 21) 
0 32 (-0 44, 1 07) 
Reference 
-0 85(-1 86,0 16) 
0 00(-1 10,1 10) 
-1 03 (-2 12, 0 07) 
Cholesterol 
0 06 (-0 01, 0 12) 
0 16 (-0 10, 0 43) 
1 11 (0 97, 1 26) 
p<0 0001 
-0 51 (-0 96, -0 06) 
p=0 0255 
-0 01 (-0 34, 0 32) 
-0 65 (-1 02, -0 28) 
p=0 0005 
-0 1845 (-0 54, 0 17) 
0 39 (-0 14, 0 92) 
0 1763 (-0 35, 0 71) 
0 14 (-0 51, 0 79) 
1 08(0 35,1 81) 
p<0 05 
0 55 (-0 29, 1 39) 
Blood glucose 
0 08(0 02,0 15) 
p=0 0139 
-0 07 (-0 34, 0 21) 
0 69 (0 56, 0 82) 
p<0 0001 
-0 42 (-0 87, 0 03) 
-0 10 (-0 42, 0 23) 
-0 36 (-1 35, -0 29) 
0 01 (-0 34, 0 35) 
-047 (-1 11,017) 
-0 48(-1 12,0 17) 
1 22 (0 50, 1 94) 
p=0 0009 
2 29 (1 37, 3 22) 
p<0 0001 
1 63 (0 60, 2 66) 
p=0 0019 
Smoking status/ 
advice where 
appropriate 
-0 00 (-0 05, 0 04) 
-0 02 (-0 18, 0 15) 
0 09(0 02,0 17) 
p=0 0183 
0 08 (-0 23, 0 39) 
0 09 (-0 20, 0 22) 
-0 39 (-0 64,-0 15) 
-0 20 (-0 43, 0 03) 
0 31 (-0 05, 0 66) 
0 25 (-0 10, 0 60) 
-0 49(-1 61,0 64) 
-1 82 (-2 77, -0 87) 
p=0 0002 
-2 02 (-3 08, -0 95) 
p=0 0002 
Physical activity 
status/ advice 
-0 01 (-0 05, 0 02) 
0 24(0 10,0 39) 
p=0 0011 
0 19(013,0 26) 
p<0 0001 
0 06 (-0 21, 0 34) 
-0 01 (-0 20,0 18) 
-0 47 (-0 67, -0 26) 
p<0 0001 
-0 08 (-0 27, 0 11) 
0 09 (-0 22, 0 39) 
0 07 (-0 23, 0 37) 
0 31 (-0 40, 1 03) 
0 06 (-0 66, 0 79) 
0 70 (-0 20, 1 60) 
Weight/BMI/ 
diet advice 
-0 05 (-0 10,-0 00) 
p=0 0420 
0 26 (0 07, 0 45) 
p=0 0083 
0 44 (0 35, 0 53) 
p<0 0001 
0 06 (-0 31, 0 43) 
0 11 (-0 14,0 36) 
-0 64 (-0 91,-0 36) 
p<0 0001 
-0 31 (-0 57, -0 05) 
0 04 (-0 37, 0 45) 
0 06 (-0 35, 0 47) 
0 05 (-0 65, 0 76) 
0 27 (-0 45, 0 99) 
-0 40 (-1 23, 0 43) 
Explanatory variable 
France 
Germany 
Netherlands 
Slovenia 
Switzerland 
UK 
Outcome measures: Beta estimates (log odds ratios) and 95% confidence intervals and p-values 
Blood pressure 
1 18 (-0 18, 2 55) 
-0 81 (-1 79,0 16) 
-144 (-2 31,-0 57) 
p=0 0003 
-0 36 (-1 29, 0 56) 
0 30 (-0 81, 1 42) 
Reference 
Cholesterol 
1 80 (1 05, 2 75) 
p<0 05 
0 84(0 16,1 52) 
p<0 05 
-0 56 (-1 09, -0 03) 
0 52 (-0 05, 1 09) 
0 42 (-0 22, 1 06) 
Blood glucose 
1 47(0 76,2 19) 
p<0 0001 
0 98 (0 32, 1 63) 
p=0 0034 
0 42 (-0 29, 0 77) 
1 90(1 22,2 57) 
p<0 0001 
-0 88 (-2 71, 0 36) 
Smoking status/ 
advice where 
appropriate 
-1 69 (-2 63, -0 75) 
p=0 0004 
-1 36 (-2 32, -0 40) 
p=0 0054 
-2 34 (-3 23, -1 45) 
p<0 0001 
-1 15 (-2 06,-0 23) 
p=0 0141 
-1 77 (-2 73, -0 82) 
p=0 0003 
Physical activity 
status/ advice 
0 61 (-0 09,1 31) 
-0 00 (-0 70, 0 70) 
-0 03 (-0 68, 0 62) 
0 76(0 12, 141) 
p=0 0202 
0 35 (-0 38, 1 08) 
Weight/BMI/ 
diet advice 
1 73 (0 78, 2 68) 
p=0 0003 
0 27 (-0 43, 0 97) 
-0 91 (-1 51,-0 31) 
p=0 0028 
0 43 (-0 20, 1 07) 
0 11 (-0 59, 0 80) 
BMI=body mass index 
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Factors associated with the outcomes 
Table 5 shows the results of the multivariate analysis. For the six outcome 
measures regression coefficients of the explaining variables, confidence intervals 
and significance levels with p<0.05 are indicated. 
On the patient level, blood pressure recording increased with increasing age of 5 
years. In contrast, weight/BMl/diet advice were recorded less often with increasing 
age. In comparison to men as reference category, female gender came along with 
greater recording rates of weight/BMI/diet advice as well as physical activity and 
advice. The more risk factors a patient had, the greater was the documentation 
rate of all outcomes. The duration of being patient in practice showed less 
significant influence. Compared with patients attending the practice more than 7 
times a year, the documentation rates, except for blood glucose, were smaller in 
patients, who attend the practice only up to 3 times a year. Self reported health 
status did not influence documentation rates significantly. 
Country origin affected the outcomes in different directions. Compared with the UK 
as reference country, recording rates of smoking status, and advice for smoker 
were smaller in all other countries, whereas recording rates of blood glucose were 
greater in almost all other countries. 
Discussion 
We measured in our study quality indicators relating to the recording of risk factors 
and counseling activities in the medical records of patients at high risk for CVD. 
The results showed that large proportions of these patients in Europe do not 
receive appropriate risk assessment and lifestyle advice as recommended in 
European guidelines.5·10·12 There is considerable variation between European 
countries. 
Recording of risk factors and lifestyle counseling 
The identification of individuals at high risk for cardiovascular disease in primary 
care for tailoring pharmaceutical treatment and lifestyle counseling is a major 
strategy in the prevention of CVD.3 Mostly cardiovascular quality-improvement 
programs focus on patients with established CVD.14 Modifiable risk factors for 
CVD, accounting for approximately 80% of the risk for an acute Ml,18 are easily to 
identify and to follow up in patients seen in the primary care setting. We found high 
percentages of individuals with elevated blood pressure and dyslipidaemia, 
suggesting that risk-factor treatment in this patient group is suboptimal. Similar 
rates were reported in the EUROASPIRE III survey, which reported data of high-
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risk patients out of general practices, although it is not mentioned how many 
practices per country were involved in this study.7 Similar studies showed 
considerable variation in recording rates of risk factors.19"21 Our results show that 
recording of lifestyle factors is improvable, especially recording of physical activity 
levels. Considering that the majority of our study population were overweight, it 
would be important to assess physical activity as a crucial part of weight reduction 
interventions. Reasons for this might be that it takes more time and effort to 
assess individual's lifestyle than to measure just blood pressure, as short lifestyle 
assessment tools are still not well implemented.22 Also, lifestyle factors are not 
needed to calculate cardiovascular risk and lifestyle advice can be provided 
without adequate recording. Low figures of lifestyle recording were also found in 
other studies within the primary healthcare setting.23 
Lifestyle modifications are an integral part of effective disease-management 
plans,24 and effective behavioral counseling strategies for the primary care setting 
are described.25-28 Behavior change counseling in general practices means 
continuous processes over a long time. Ideally, GPs should agree goals with 
patients stepwise during every consultation and follow up consequently: for 
example, without recording of goals or motivational stage, it is hardly possible to 
structure counseling steps as recommended. Therefore, in our opinion, GPs 
should assess risk factors and lifestyle, offer behavior-oriented counseling and 
record the findings simultaneously. In our study, rates for recorded lifestyle 
counseling were improvable. 
Factors related to recording of risk factors and lifestyle counseling 
Increasing age was correlated positively with the documentation of blood-pressure 
and blood glucose, in line with previous studies.21 Gender inequalities were also 
seen in other studies which reported greater recording rates for cholesterol levels 
or treatment in men.29,30 The number of risk factors had the most impact on 
recording and counseling. This is consistent with other studies, which have shown 
that documentation in patients with established diseases is greater than in patients 
at lower risk and may reflect GPs' attention on established diseases rather than on 
systematic risk-factor checking.21,30 
The differences between the countries may be associated with different healthcare 
systems and different availability and reimbursement of preventive services. The 
UK showed greatest rates for the recording of smoking status and advice, 
explainable by quality improvement strategies incentivizing recording of risk factors 
due to the Quality and Outcome Framework.31 Research has showed that 
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technical enhancement of the electronic medical record, such as the automatic 
calculation of CVD risk and feedback, could lead to an increase of risk-factor 
documentation and detection of CVD.32 
Strengths and limitations 
This is one of the largest international studies on management of high 
cardiovascular risk in patients without established CVD in European primary care. 
We used validated measures and carefully designed sampling procedures. 
Nevertheless, in some countries it was difficult to enrol 36 practices per country as 
intended in the study protocol. The additional workload of the audit and the 
difficulties in selecting the eligible patient groups out of the practice registry were 
the most important reasons for declining participation. Another limitation is that 
different sampling methods were used, e.g. based on ICPC codes in some 
countries but not in others, resulting in different samples. Women were 
underrepresented, which was to be expected as being 'male over 60 years' was 
one of the risk factors used for inclusion, explaining also the mean age of 66 years 
in the sample. However, in our logistic regression model we took the differences 
regarding demographic characteristics into account. 
Conclusion 
Completeness of risk-factor assessment is an important precondition for identifying 
patients at high risk for CVD and for modifying therapy accordingly. Although 
recording of risk factors such as blood pressure and cholesterol has improved over 
the years, the assessment of lifestyle factors and lifestyle counseling is 
consistently low. Disease-management strategies should consider addressing 
both sets of issues simultaneously to reduce the incidence of CVD. Analysis of 
different country results with different healthcare systems can be helpful for 
developing quality-improvement strategies in cardiovascular prevention. 
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Abstract 
Background: 
Many young adults have unhealthy lifestyles, which puts them at increased risk of 
poor health outcomes. Most individuals in this age group attend general 
practitioners (GPs) infrequently, limiting opportunities for opportunistic case finding 
and health promotion. We aim to describe health-related lifestyles associated with 
cardiovascular risk in adults aged 18-45 visiting a GP. 
Methods: 
A postal survey study was conducted in samples of adults (aged 18-45 years), 
recruited from samples of GPs in Austria, Belgium, England, Finland, France, 
Germany, Israel, the Netherlands, Slovenia and Switzerland. In a questionnaire we 
measured six risk factors: smoking status, body mass index, diet, physical activity, 
hypertension, and hypercholesterolemia. With the various risk factors and the 
number of risk factors as outcome we performed a logistic multilevel analysis with 
predictors including patient's age, gender, having a partner, being employed, level 
of education, and number of practice visits. 
Results: 
A total of 3892 adults provided valid data; 40% reported no risk factors, 35% one, 
19% two, and 6% three or more. Adults visiting their GP more than once per year 
had increased risk in more domains. The average number of risk factors raised 
from 1.41 in patients with up to 1 yearly practice visit to 1.71 with more than 3 
visits. 
Conclusion: 
A majority of adults had increased cardiovascular risk. These adults tended to visit 
their GPs more than once per year, offering opportunities for prevention. Further 
research should examine the effectiveness of preventive activities in this age 
group. 
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Introduction 
The prevalence of cardiovascular diseases (CVD) is high worldwide.1 The 
detection and management of cardiovascular risk, before CVD become manifest, 
is crucial to optimize patient health outcomes and health expenditures. Many 
studies have reported on a high prevalence of unhealthy life styles in various 
populations; the World Health Organization provides a data overview from national 
surveys.2 In all countries programs have been launched to improve the 
cardiovascular risk in patients and in the population as a whole.3 These include 
public health programs aiming at the public at large or at specific groups as well as 
programs in clinical settings targeting specific patient groups. Here, detection and 
counseling has the advantage that the approach can be tailored to individual 
needs. Primary care might provide good opportunities based on continuity of care,4 
because many individuals visit a general practitioner (GP) each year. However, it 
is unknown how often healthy adults with risk factors contact their GP, which 
would enable opportunistic case finding and health promotion. 
In this study we explored the need and possibilities for providing advice on health-
related life styles for people in primary care across Europe. Cardiovascular risk 
management and risk tables in many countries in Europe are based on the 
international practice guideline of the European Cardiology Society (ESC),5 taking 
into account combinations of individual risk factors such as age, smoking and 
blood pressure. Risk calculation is based on the Framingham risk calculator or 
Score instrument, the latter being used in the ESC practice guideline.6,7 As risk 
factors are highly correlated, a high risk patient is likely to be someone with 
several risk factors, generally related to lifestyle.8"12 To draw valid conclusions 
across countries data need to be gathered comparably in the various countries as 
used to be done in the Monica study. However, this data collection was stopped in 
the 1990's.13 In our project we provide actual international data using a uniform 
collection methodology. 
The aim of our study was to describe lifestyle and cardiovascular risk factors in 
adults identified in primary care and to determine whether adults with increased 
risk were more likely to attend a GP, as visits represent opportunities for 
preventive screening and counseling. 
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Methods 
Data for this study were collected as part of the EPA Cardio project, an 
international observational study in general practice conducted in 2008 and 
2009.14 Countries participating in this survey were Austria, Belgium, England, 
Finland, France, Germany, Israel, the Netherlands, Slovenia, and Switzerland. In 
each country we aimed to recruit a stratified sample of 36 general practices from a 
national or regional list based on urbanization and practice size; stratification 
mirrored the national situation. In every country ethical approval was obtained if 
necessary. 
Study population 
All participating general practices were instructed to draw a random sample of 
patients aged 18 to 45 years from their records or practice register, or - if not 
possible or feasible - to include those patients within the preset age limits 
consecutively visiting the practice. Within these age limits we aimed to include 
those adults with a low likelihood of established CVD. Patients with a diagnoses of 
diabetes and/or CVD were excluded because these patients should be receiving 
drug treatment and lifestyle counseling as part of secondary prevention. Further 
exclusion criteria were: terminal illness, cognitive impairment, psychiatric illness, 
and poor language skills. We aimed at 15 responding patients per practice. In 
order to achieve these numbers, and anticipating a response rates of less than 
50%, 40 patients per practice were sent questionnaires, and where necessary one 
reminder was sent. 
Questionnaire 
The questionnaire included questions on socio demographic characteristics, 
general practice visit frequency, cardiovascular risk factors, and aspects of 
patients' health-related lifestyle based on validated questionnaires recommended 
for use in primary care.15 The questionnaire was initially developed in English and 
then translated into the different languages using systematic forward and 
backward translation with help from a native speaker, and pilot tested.16 
For each respondent we assessed the presence of risk in various domains: 
Overweight or obesity. Respondents were asked about their weight and height; 
with these data we calculated the Body Mass Index (BMI, weight/height2 in kg/m2) 
to identify respondents who were overweight (BMI 25-30 kg/m2) or obese (BMI 
over 30 kg/m2). 
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Poor diet. Using the Rapid Eating and Activity Assessment for participants-
shortened version (REAP-S)17 we defined poor diet as: usually or often skipping 
both fruit and vegetables more than twice a week. We restricted the risk factor 
'poor diet' to fruit and vegetables consumption, because these questions were 
clearly defined and easy to interpret, independent from national and cultural 
variety. 
Poor physical activity. Based on the 'Rapid assessment of physical activity' 
(RAPA)18 results respondents were scored as underactive when they reported light 
physical activity every week or less. Recommended physical activity would mean: 
at least 5 days a week at least 30 minutes moderate physical activities or at least 3 
days a week at least 20 minutes a day vigorous physical activities. We excluded 
from 'underactive' those people who did do moderate or vigorous physical activity 
but did not meet the required frequency or time. 
Actual smoking behavior, hypertension, and hypercholesterolemia was directly 
asked for. For hypertension and hypercholesterolemia we accepted the presence 
of this risk factor if the respondent reported it as such, without further information 
of levels or treatment. 
Number of risk factors. We constructed the outcome 'number of risk factors' based 
on the risk factors actual smoking, obesity, poor diet, underactive, hypertension, 
and hypercholesterolemia with a score from 0 to 6. 
Analysis 
To explore the influence of demographic data on the presence of risk factors we 
constructed a logistic regression model with country, patient age, and gender as 
independent factors. In the next step we simultaneously added employment 
status, having a partner (married or living together), education, and number of 
yearly practice visits as factors along with lifestyle factors. We assessed the 
relation between smoking, poor diet and under activity on the one hand and 
overweight and obesity on the other hand, and between all these risk factors and 
hypertension and hypercholesterolemia. 
Results 
In total 4090 patients completed the questionnaire. We excluded 114 patients 
because these patients were not within the pre set age limits of 18-45. 
Furthermore, we excluded 84 patients because they reported a diagnosis of CVD 
or diabetes mellitus. Samples were selected from practice registers in the 
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Netherlands, Germany, the UK, and partly in Switzerland. In other countries 
patients were recruited from those who visited the practice. 
Table 1 shows information about the 3892 patients included in the study from 279 
general practices, which represented 93% of the target sample. Overall, the 
sample was homogeneous across countries and the majority of the patients had 
been either registered with or attending their general practice for more than 3 
years. 
Table 2 presents the patient reported cardiovascular risk factors. While high blood 
pressure and high cholesterol were self reported in less than 10% of the sample 
on average, high cholesterol reporting showed some variation from 2.8% in 
England up to 17.2% in Austria. Self-reported unhealthy life style behaviors and 
other risk factors showed some variation between countries with >40% of the 
overall sample being either overweighed or obese and 25% being sedentary or 
underactive. In addition, about 25% of the sample smoked and 25% consumed 
less fruit or fewer vegetables than recommended. 
Table 3 shows an overview of the number of risk factors. Roughly 40% of the 
patients self reported no risk, 35% increased risk in one domain, and 25% 
increased risk in two or more domains. 
Table 4 shows the results of the regression analyses and the influence of the 
included patient characteristics on the prevalence of unhealthy life styles and risk 
factors. The number of risk factors increased with age (B=0.010, 95% CI 0.0005-
0.014). Women reported fewer risks, except for poor physical activity (OR 1.32, 
95% CI 1.114-1.564). In general, being employed appeared to be beneficial, just 
as having a partner, except that individuals with a partner were likely to be 
overweighted (OR 1.307, 95% CI 1.094-1.562). Furthermore, poor physical 
activity was associated with overweight and obesity; overweight and obesity were 
both associated with hypertension and hypercholesterolemia. 
Adults with more than one visit per year to a GP reported increased risk in more 
domains (estimates varying from 0.120 to 0.306 in the various frequency groups) 
after controlling for a number of patient characteristics. In other words, in adults 
aged 18-45, a higher frequency of visits was associated with a higher number of 
cardiovascular risk factors and elevated risk. Patients visiting their GP up to once a 
year on average had 1.41 risk factors, while patients with 2 or 3 yearly visits had 
1.56 risk factors and those with more visits 1.71. 
Table 1. Patient characteristics. 
Austria 
Belgium 
Finland 
France 
Germany 
Israel 
Netherlands 
Slovenia 
Switzerland 
UK 
Total 
Number of Number of 
patients 
350 
215 
159 
408 
528 
135 
571 
890 
373 
263 
3892 
practice 
30 
22 
18 
33 
27 
21 
36 
36 
23 
33 
279 
% 
female 
64 
63 
75 
59 
66 
46 
57 
58 
63 
61 
61 
Mean 
age 
36.6 
34.8 
33.9 
33.6 
34.9 
31.3 
35 4 
35 5 
34.5 
35 1 
34.9 
SD 
7.3 
77 
7.5 
7.4 
8.5 
7.1 
7.7 
7.2 
8.0 
7.5 
7.7 
Education (years) 
<9 
28.2 
24 
76 
45 
8.6 
07 
1 8 
14.5 
28.2 
5.4 
11.3 
9-13 
48 7 
20 9 
36 1 
22.4 
75.6 
35.1 
15.9 
50.0 
47 2 
43.6 
42.1 
>13 
23 1 
76 8 
56.3 
73.1 
158 
64.2 
82.3 
35.5 
24.6 
51.0 
46 7 
(self) 
Employed 
(%) 
90.9 
83.7 
75.8 
87 7 
89.1 
88 7 
89 2 
86 9 
91.6 
79 8 
87 3 
Married / 
cohabiting 
76.9 
69.0 
70.3 
66 8 
74.0 
55.6 
72.3 
70 5 
71.0 
63.6 
70 4 
Attending this general 
practi 
<3 
9.8 
12.6 
25.3 
20.4 
16.4 
29 6 
129 
12.5 
136 
16.6 
15.2 
ce in years (%) 
3-7 
17.3 
22.0 
25.9 
38.1 
27.1 
20.0 
19.4 
25.0 
35 1 
15.8 
25.2 
>7 
72.8 
65.4 
48.7 
41.5 
56.5 
50.4 
67.8 
62.5 
51.2 
67.6 
59.6 
Mean yearly GP-vlsit 
0-1 
12.0 
20.1 
25.5 
8.6 
13.8 
18.5 
48.4 
23.6 
32.6 
39.8 
24.9 
frequency 
2-3 
42.1 
34.1 
53.5 
38.5 
42.1 
38.5 
34.4 
42.0 
34.2 
36.4 
39.3 
>3 
45.8 
45.8 
21.0 
52.9 
44.0 
43.0 
172 
34.4 
33.2 
23.8 
35.7 
Table 2. Prevalence of self reported risk factors (%). 
Austria 
Belgium 
Finland 
France 
Germany 
Israel 
Netherlands 
Slovenia 
Switzerland 
UK 
Total 
Currently 
smoking 
30.7 
27.0 
27.7 
28.1 
26 4 
14.6 
18.1 
26 0 
25 5 
20.2 
24.8 
Overweight 
(1) 
29.1 
31.3 
30 9 
23.3 
31 7 
26.3 
28.1 
35 3 
24 2 
32.8 
29.9 
Obesity 
(1) . 
12.3 
9.0 
19.7 
89 
11.7 
75 
96 
14.4 
13.1 
11 3 
11 9 
Unhealthy diet 
Fruit 
(3) 
25.0 
38.0 
16.3 
34.5 
30.0 
30.3 
25.3 
34.0 
25.5 
24.7 
29.4 
Vegetables 
(3) 
23.3 
27.1 
154 
32.2 
31 1 
28 5 
12.1 
30 9 
25 3 
197 
25 4 
Poor 
diet (4) 
11.9 
19.7 
76 
19.2 
19.4 
14 6 
52 
21.1 
14.6 
132 
155 
Physical 
Sedentary / 
under-active 
22.9 
35.0 
107 
40.9 
27.1 
27 4 
16.9 
25.6 
21.3 
18.3 
24.9 
activity (2) 
Under-active 
regular 
35 8 
29 9 
51.6 
31 0 
31 1 
38.5 
36.0 
32.9 
38.3 
36.6 
34.8 
High blood 
pressure 
8.1 
7.5 
103 
32 
9.4 
31 
78 
8.7 
7.5 
4.7 
7.4 
High cholesterol 
172 
4.8 
14.3 
5.0 
12.5 
11.5 
4.7 
8.8 
51 
2.8 
8.4 
1 BMI constructed on the basis of self reported length and weight Overweight means BMI between 25 and 30 kg/m2, obesity BMI >30 kg/m2. 
2 RAPA score 1-3 = sedentary / under active; score 4-5 = under active regular. 
3 In an average week eat less than 2 servings of fruit / vegetables a day9 Usually/often 
4 In an average week respondent usually/often eats less than 2 servings of fruit and vegetables a day 
Table 3. Prevalence of number of domains with Increased risk (In %). 
Austria 
Belgium 
Finland 
France 
Germany 
Israel 
Netherlands 
Slovenia 
Switzerland 
UK 
Total 
0 
36 7 
37 0 
43 4 
30 4 
34 6 
46 6 
55 5 
34 4 
44 4 
55 1 
40 3 
1 
33 8 
35 5 
33 6 
39 9 
35 2 
32 3 
30 7 
38 0 
32 1 
31 9 
34 9 
2 
22 1 
199 
15 1 
24 7 
22 7 
188 
107 
188 
187 
108 
186 
3 
57 
52 
59 
4 7 
55 
2 3 
27 
78 
36 
1 6 
51 
4 or more 
1 7 
23 
20 
02 
22 
00 
04 
1 0 
1 1 
05 
1 2 
Risk factors current smoker, obesity (BMI>30 kg/m2), poor diet, underactive, hypertension, hypercholesterolemia 
Table 4. Patient factors associated with increased cardiovascular risk. 
Age 
Gender 
Education1 
-middle 
-high 
Unemployment 
Partner 
Frequency practice visit 
2-3 
4-5 
6-7 
8-9 
10 or more 
Age 
Gender 
1— J ι 1 
Education 
-middle 
-high 
Unemployment 
Partner 
Frequency practice visit 
2-3 
4-5 
6-7 
8-9 
10 or more 
Currently smoking 
Under active 
Poor diet 
25<BMI<30 
BMI>30 
per year^ 
per year2 
Smoki 
Exp(B] 
0 983 
0 731 
0 784 
0 441 
1 187 
0 683 
1 150 
1 219 
1 226 
1 225 
1 622 
ng 
I 
(0 973-0 994)" 
(0 621-0 862)*" 
(0 613-1 008) 
(0 337-0 581)"* 
(0 942-1 503) 
(0 573-0 818)"* 
(0 931-1426) 
(0 950-1 572) 
(0 884-1 713) 
(0 796-1 901) 
(1 101-2 408)* 
Overweight 
Exp(B] 
1 054 
0411 
0 803 
0 633 
1 219 
1 307 
1 262 
1 340 
1 865 
1 158 
2 201 
1 059 
1 354 
1 121 
I 
(1 042-1 065)*** 
(0 351-0 481)*** 
(0 623-1 035) 
(0 484-0 829)" 
(0 967-1 537) 
(1 094-1 562)** 
(1 036-1 537)* 
(1 056-1 701)* 
(1 366-2 546)"* 
(0 754-1 777) 
(1 485-3 261)"* 
(0 887-1 263) 
(1 133-1 619)" 
(0 908-1 383) 
Poor diet 
Exp(B) 
1 005(0 991-1 018) 
1 324 (1 079-1 625)" 
0 619(0 462-0 830)" 
0 581 (0 424-0 797)** 
0 898(0 667-1 210) 
0 951 (0 762-1 187) 
0 770 (0 593-0 999)* 
0 830(0 613-1 124) 
1 233 (0 852-1 783) 
1 445(0 903-2 312) 
1 387(0 893-2 155) 
Adiposity 
Exp(B) 
1 036(1 019-1 053)*** 
0 748 (0 592-0 940)* 
1 393(0 953-2 021) 
1 015(0 671-1 522) 
1 002 (0 710-1 404) 
1 133(0 863-1 479) 
1 562(1 122-2 161)** 
2 195(1 512-3 162)*" 
3 036(1 952-4 681)*" 
2 616(1 464-4 622)" 
3 146 (1 837-5 329)*** 
0 903(0 692-1 173) 
1 747 (1 365-2 226)*" 
0 932 (0 681-1 269) 
Under activity 
Exp(B) 
0 994 (0 983-1 005) 
1 320(1 114-1 564)** 
0 758 (0 584-0 984)* 
0 589 (0 446-0 780)*" 
1 162(0 916-1473) 
1 051 (0 872-1 267) 
1 059 (0 850-1 320) 
1 334(1 038-1 713)* 
1 472 (1 068-2 029)* 
1 241 (0 803-1 919) 
1 246 (0 836-1 859) 
Hypertension 
Exp(B) 
1 079(1 056-1 104)*" 
0 511 (0 380-0 686)*** 
0 983 (0 630-1 535) 
1 077 (0 662-1 753) 
1 646 (1 095-2 474)* 
0 711 (0 513-0 985)* 
1 206 (0 809-1 797) 
2 340 (1 502-3 643)*** 
1 912 (1 088-3 360)* 
2 519(1 240-5 117)* 
1 867(0 938-3 717) 
1 336 (0 976-1 827) 
0 896(0 641-1 252) 
0 865 (0 577-1 296) 
2 089 (1 480-2 950)*** 
6 575 (4 576-9 446)*** 
Number of risk factors 
Β 
0 010 (0 005-0 014)*" 
-0 164 (-0 228-0 101)*" 
0 031 (-0 072-0 134) 
-0 147 (-0 256-0 039)** 
0 140 (0 047-0 234)** 
-0 068 (-0 139-0 003) 
0 120 
0 273 
0 233 
0 211 
0 306 
(0 041-0 199)" 
(0 178-0 368)*" 
(0 107-0 360)*** 
(0 042-0 381)* 
(0 146-0 467)*" 
Hypercholesterolemia 
Exp(B) 
1 106 
0 567 
1 453 
1460 
1 472 
0 827 
0 798 
1 341 
0 969 
1 111 
1 586 
1 287 
1 190 
0 904 
1 979 
2 576 
(1 082-1 130)*" 
(0 431-0 745)"* 
(0 951-2 221) 
(0 915-2 329) 
(0 988-2 193) 
(0 606-1 129) 
(0 559-1 139) 
(0 898-2 004) 
(0 561-1 672) 
(0 558-2 212) 
(0 882-2 852) 
(0 959-1 726) 
(0 880-1 609) 
(0 625-1 309) 
(1 467-2 670)*" 
(1 784-3 719)*** 
Legend Presented are estimated odds ratios for the results of the logistic regression analyses, assuming a binomial distribution, and the Β values for the 
linear regression analysis considering the absolute number of risk factors Countries were included in the analyses as factors (data not shown) 
' Middle and high education compared to low education 2 Number of practice visits compared to patients visiting the practice once annually or less 
* sign ρ <0 05, " sign ρ <0 01, * " sign p<0 001 
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Discussion 
About 60% of young adults (aged 18-45 years) in general practices reported a life 
style that is associated with increased risk for CVD and other health problems. 
Individuals in this group patients will develop a high risk for CVD over the years, if 
these risk factors remain unchanged. These unhealthy life styles were most 
prevalent in males and in individuals at higher age within the studied age range. 
Patients visiting their practice more than once a year also had more risk factors 
present compared to those with one or no practice visit, which implies that 
particularly visitors of GPs have increased cardiovascular risk. 
It is unknown whether risk factors can be reduced in this group of young adults by 
public health programs. In a systematic review community programs showed on 
average a 0.65% reduction in CVD risk, but in these programs people from older 
age groups were included.19 As opposed to public health activities, patients at high 
risk, defined by their cardiovascular mortality risk in ten years, receive 
individualized risk management. The evidence showing the effectiveness of 
preventive screening and counseling is not overwhelming. For instance, a study of 
motivational interviewing by trained nurses in primary care found little effects on 
life style behaviours or cardiovascular risk.20 
Young adults with multiple risk factor will, due to their age, still have an absolute 
low cardiovascular mortality risk. However, within their age group their risk is 
relatively elevated and in due time their absolute risk will increase and become 
intermediate and high if no risk factor reduction is achieved. Counseling can be 
based on the relative risk chart showing the relative contribution of the various risk 
factors.5 Use of this relative risk chart needs a personalised preventive contact 
with an integrative approach of multiple risk factors considering the relation 
between these various factors and an intensity related to the risk profile. 
In the UK the Health Department introduced a nationwide screening program for 
an older age group, namely all people aged 45-74 free from CVD and diabetes.21 
Pre-stratification of eligible people based on using routine data may be more cost 
effective without loss of clinical effectively.22 In the Netherlands a recently 
launched practice guideline advocates a stepwise approach starting with a patient 
questionnaire to identify and counsel people with elevated chance on high risk of 
CVD, diabetes, or chronic kidney disease.23 Research evidence supporting the 
effectiveness of this nationwide implemented approach is lacking. In a Finnish 
study among an age group of 45 to 70 a simple cardiovascular risk factor 
questionnaire combined with a home measurement of waist circumference proved 
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to be a cheap and practical tool as a first step for further risk stratification in 
general practice.24 
Besides issues of effectiveness, the feasibility of large scale preventive screening 
and counseling needs to be considered. The capacity of primary care to manage 
large numbers of individuals with poor life styles may be too limited, although 
larger practices seem to be able to provide more comprehensive preventive 
services.25 Finally, pro-active screening and counseling of healthy adults has 
ethical implications that need to be considered. 
Strength and weaknesses 
The study had some limitations. We did not conduct a population survey with risk 
factor assessment like blood pressure and cholesterol measurements taken and 
verified from patient medical records. We assessed lifestyle based on a patient 
self-reported but previously validated questionnaires. The reported frequencies of 
hypertension and hypercholesterolemia were based on the respondents' 
knowledge of themselves having or being diagnosed hypertension or 
hypercholesterolemia; probably many people did not know their values or maybe 
some perceived themselves not at risk because of drug treatment. 
We could not avoid some selection bias. In some countries patient were invited to 
participate during a practice visit, especially in countries and practices without 
registered patients, which made a random sampling approach impossible and 
excluded those patients who do not visit their practice. The patient sampling 
approach might have influenced some of the differences across countries although 
in general the key findings were clear and consistent throughout our countries' 
samples and differences between countries was not our primary focus. 
Conclusion 
The causes of CVD and diabetes are well documented and treatment includes 
advice related to poor lifestyle behaviours in relation to diet, smoking and 
exercise.5 Our study shows that over 60% of patients aged 18-45 have these risk 
factors and lifestyle behaviours predisposing them to be at high risk of developing 
CVD or diabetes. This will have implications for increased morbidity and earlier 
mortality as well as cost implications for health care systems. 
Public health programs address their interventions to the public in general as in for 
instance stop smoking campaigns. Small effects in large numbers of people may 
be the result. People within the age group 18-45 years with a clustering of risk 
factors will have a low absolute cardiovascular risk score, but within their age 
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group a relative high risk which may need a personalized approach. The general 
practice is ideally placed to deliver personalized primary prevention in this patient 
group and as patients with multiple risk factors visit their general practice more 
often even case finding might be a means to reach this patient group. However, 
further research should focus on the effectiveness of various strategies for 
preventive activities in this age group. 
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Abstract 
Introduction: 
Delphi procedures are frequently used to develop performance indicators, but little 
is known about the validity of this method. We aimed to examine the consistency 
of indicator selection across different procedures and across different panels. 
Methods: 
Analysis of three indicator set development procedures: the EPA Cardio project, 
which used international GP panels; the UniRap project, a Dutch GP indicator 
project; and the Vitale Vaten project, which used a national multidisciplinary health 
professional panel and a stakeholder panel. 
Results: 
With respect to clinical indicators, consistency between procedures varied 
according to the origin of the indicators. In Vitale Vaten the multidisciplinary panel 
of health professionals validated 63% from the international EPA Cardio indicators 
again. From the UniRap GP set only 13% was rated valid again. Considering 
organizational indicators, 27 indicators were rated in both EPA Cardio and Vitale 
Vaten. In the Vitale Vaten project 17 indicators (63%) were validated, including 
eight of the nine indicators validated in EPA Cardio. Consistency between panels 
was moderate, giving a decisive role to the health professional panel, being the 
most critical. 
Conclusion: 
The consistency of selected performance indicators varied across procedures and 
panels. Further research is needed to identify underlying determinants of this 
variation. 
Consistency of performance indicators for cardiovascular risk management 
Θ1 
Introduction 
Indicators for assessing quality and outcomes of healthcare delivery have been 
developed in many healthcare systems and countries. Indicators provide 
healthcare professionals formative feedback to enhance learning and 
improvement of clinical practice.1 They can also be used to create transparency on 
quality of care. Indicators should be valid and reliable, feasible, and effective with 
respect to their aims.2 This implies that indicators should be developed and 
evaluated systematically. Some methods for indicator development, such as the 
Delphi-procedure, have been adopted across the world.3 
Nevertheless, many questions remain concerning indicator quality and appropriate 
development methods. This paper addresses the consistency of panel evaluations 
of indicators, using data from three indicator development projects in 
cardiovascular risk management (CVRM). 
The importance of the quality of care for patients with cardiovascular diseases 
(CVD) and those at high risk remains undisputed: the incidence of CVD is high 
worldwide with high morbidity, mortality, and costs. Many countries have launched 
large programs to improve CVRM.4 In the Netherlands, a multidisciplinary clinical 
guideline for CVRM was published in 2006.5 In 2009 a platform of stakeholder 
organizations (Platform Vitale Vaten) issued a multidisciplinary guideline with 
recommendations on the organization, delivery and process of care ('care 
guideline'),6 largely based on Wagner's chronic care model.7 Simultaneously, a set 
of multidisciplinary quality indicators covering clinical and organizational aspects 
was developed, using a Delphi procedure with two panels: healthcare 
professionals and other stakeholders. 
Consistency and confirmability are criteria mentioned to add to the reliability of 
indicator development procedures.8 Though widely used in medical science, the 
Delphi procedure itself is still being studied and compared with other methods of 
indicator development.9"12 Previously published Delphi procedures with different 
panels show variable effects and amounts of agreement between panels, 
challenging consistency.13"16 It has been shown that healthcare providers 
especially have a decisive role in multidisciplinary procedures, depending on the 
influence of a single panel in a multipanel procedure. In a procedure with different 
panels, an indicator is usually validated when validated by all panels. This 
methodology leads to a core set of generally supported indicators but may be too 
rigid. 
We aimed to examine the consistency of indicator selection across different 
procedures. We assessed the results of consecutive validation ratings and 
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compared the results of two Delphi procedures with different panels. Furthermore, 
we examined consistency across health professional and a stakeholder panels. 
Method 
This paper is based on the analysis of the Vitale Vaten project, partly in relation to 
Epa Cardio and UniRap, projects in which performance indicators for CVRM were 
selected. The relationship between the projects and the comparisons made in this 
study is illustrated in the figure. Table 1 presents some project features. 
Figure. The EPA Cardio and Vitale Vaten procedures. 
Clinical indicators 
175 clinical 
indicators 
Organizational indicators 
27 organizational 
indicators 
52 organizational 
indicators: 
38 from guideline 
9 from DCGP vision 
5 additional 
Red arrows show 
comparisons for 
analysis of consistency 
between procedures; 
panel ratings in orange 
arrows are analyzed to 
assess consistency 
between panels. 
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Table 1. Characteristics of the EPA Cardio, Vitale Vaten and UniRap project. 
Procedure 
Number of panels 
and composition 
Setting 
EPA Cardio 
Two-round Delphi 
procedure 
9 GP panels 
9 countnes in Europe 
(Austria, Belgium, Finland, 
France, Germany, the 
Netherlands, Slovenia, UK, 
Switzerland) 
Vitale Vaten 
Clinical indicators: 
One-round scoring 
Organizational indicators: 
Two-round Delphi procedure 
A multidisciphnary health 
professional panel and a 
stakeholder panel 
The Netherlands 
UniRap 
Successive discussion rounds 
Experts, representatives of 
GP information technology 
user organizations, final 
approval by professional GP 
organizations 
The Netherlands 
EPA Cardio project 
The EPA Cardio project is described elsewhere.17 In summary, general practitioner 
(GP) panels from nine European countries (total n=101) rated 202 indicators for 
CVRM in primary care in two Delphi rounds. This resulted in a set of 35 clinical 
and nine organizational indicators, including primary prevention and risk 
management in patients with established CVD or diabetes. 
UniRap project 
A Dutch College of General Practitioners (DCGP) working group developed 
indicators for the Uniform Reporting Project (UniRap), as part of a project to create 
one national indicator set for GP care.18 The UniRap indicator set consisted of 17 
indicators on established CVD and six concept indicators on primary prevention of 
CVD. The goal of UniRap was to provide indicators that met the criteria of content 
validity based on the CVRM guideline, and were feasible: GPs should be able to 
deliver the data from their medical record system for internal and external use. A 
set of indicators was discussed in an expert group and, in order to make them 
feasible, with representatives of GP information technology user organizations. 
Consequently, these indicators had little room for nuances. Various stakeholder 
organizations provided comments on draft sets, leading to revisions and a final set 
that was approved by the Dutch professional GP organizations. 
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Vitale Vaten project 
In the Vitale Vaten project, indicators for CVRM were selected in a two-round 
Delphi procedure, involving multidisciplinary panels of health professionals and 
stakeholders from The Netherlands. Table 2 presents the panel's composition. As 
this project has not been published elsewhere, it will be described in more detail. 
Table 2. Panel composition in the Vitale Vaten procedure. 
Health care professional panel Stakeholder panel 
3 General practitioners 3 Members of patient organizations 
2 Internists 2 Representatives of health Insurance companies 
2 Cardiologists 2 Platform members 
1 Neurologist 1 Dutch Heart Foundation 
1 Vascular surgeon 1 Dutch diabetes federation 
1 Pharmacist 1 Health department 
1 Medical psychologist 1 Health inspectorate 
1 Nurse practitioner vascular care 1 DCGP, prevention specialist 
1 Dietician 1 Expertise centre on quality review in healthcare and welfare 
1 Manager primary care center 1 The Netherland Organization for Health Research and Development 
1 Physiotherapist 1 Director integrated Care department 
All participants were related to the Platform Vitale Vaten, an initiative of the Dutch 
Heart Association and many national stakeholders to improve CVRM. A major 
activity of the Platform was the development of a so-called 'care guideline', 
recommendations on the organization of CVRM, complementary to the 
multidisciplinary clinical guideline of which key elements were included in the care 
guideline. Simultaneously, performance indicators were developed. The board of 
the Platform recruited and motivated participants for the indicator selection 
procedure. All correspondence was via email. 
The initial list of 58 clinical indicators presented in this project comprised two 
previously developed sets: the 35 EPA Cardio clinical indicators, and the 23 
UniRap indicators. Clinical indicators were presented in the first Delphi round only. 
The 74 organizational indicators presented in the first round of the Vitale Vaten 
project came from three sources. The 27 indicators on organization presented in 
the original EPA Cardio list were all included. Furthermore, 38 indicators were 
formulated on the basis of the draft version of the care guideline and nine on the 
basis of the DCGP's vision on care. Finally, five additional indicators were 
formulated based on comments in the first Delphi round. 
Participants assessed the necessity of the clinical indicators, defined as 
'necessary to deliver and record in the patient's medical record'. Organizational 
indicators were assessed regarding clarity ('expressed in clear, precise and 
unambiguous language') and necessity in the first round. Here, panellists had 
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room to formulate comments and additional indicators. The panellists received 
feedback on the first-round necessity results and scored the organizational 
indicators in the second round regarding necessity and feasibility ('availability of 
data on a consistent, comparable and reliable basis'). Necessity, clarity and 
feasibility were defined exactly the same as in EPA Cardio. All scores were on a 
scale from 1 to 9. 
Table 3 shows the response rates of the panels. Because two out of five 
responding stakeholders did not score the clinical indicators, this selection was 
based on the results of the health professional panel only. Clinical indicators were 
validated when they had a median necessity score of 7, 8 or 9 with agreement, 
meaning that 80% of respondents scored 7 or higher. 
Organizational indicators were validated if the second-round necessity score in 
both panels met the criteria as described for clinical indicators. Furthermore, both 
panels should rate the indicators feasible without disagreement. Indicators were 
rated feasible when the median score was 7, 8 or 9; less than one-third of the 
scores had to be 1, 2 or 3 in order to conclude that there was no disagreement. 
There was no preset maximum number of indicators. 
Table 3. Response rates in the Vitale Vaten two-round Delphi procedure. 
Number of participants (%) 
Health care professionals n=15 Stakeholders n=15 
Round 1 10(67) 5(33) 
Round 2 11 (73) 9(60) 
Analysis 
To examine the consistency of indicator selection procedures we assessed the 
results on the clinical indicators from the Vitale Vaten project. As previously 
developed sets were the startingpoint, the percentages of indicators validated 
reflected agreement and were taken as a measure for consistency. 
In addition, we compared the validity rating results of the list of 27 organizational 
indicators rated in both EPA Cardio and Vitale Vaten. 
To examine consistency of indicator selection across panels, we compared the 
results from the health professional and stakeholder panels scoring the 
organizational indicators in Vitale Vaten. 
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Results 
Consistency across indicator selection procedures 
Table 4 focuses on the Vitale Vaten set of clinical indicators. The panel selected 
25 indicators, including three out of 23 from the UniRap indicators (13%) and 22 
out of 35 from the EPA Cardio set (63%). 
Table 4. Clinical indicators selected by a multidisciplinary panel of health professionals by origin of 
the indicators. 
Number Number (%) of indicators rated valid 
by multidisciplinary panel 
of health care professionals 
Uniform Reporting Project set, the Netherlands 23 
International EPA Cardio set 35 
Total 58 
3(13) 
22 (63) 
25 (43) 
Table 5 presents the clinical indicators selected in Vitale Vaten. 
Table 5. Vitale Vaten set of clinical indicators. 
Clinical indicators Origin 
1 Percentage of patients with established CVD with a record of smoking status. UniRap 
2 Percentage of patients with established CVD with anticoagulant or antiplatelet drugs UniRap 
prescnbed 
3 Percentage of patients with established CVD in the practice population at the end of the UniRap 
reporting period (denominator is the practice population) 
4 For patients with CVD (CHD, stroke, TIA, or PVD) there is a record of smoking status in the EPA Cardio 
past 15 months except those who never smoked 
5 For patients with diabetes there is a record of blood pressure at least once in the last 15 EPA Cardio 
months. 
6 For patients prescribed antihypertensive medication for diagnosed hypertension there is a EPA Cardio 
record of blood pressure at least once in the last 15 months 
7 For patients with established CVD (CHD, stroke, TIA, or PVD) there is a record of blood EPA Cardio 
pressure at least once in the last 15 months 
8 For patients with diabetes there is a record of their cholesterol (general/total, HDL and LDL) EPA Cardio 
at least once in the last 15 months 
9 For patients with CVD (CHD, stroke, TIA, or PVD), there is a record that anti-platelet EPA Cardio 
therapy (aspirin, Clopidogrel or equivalent) at least 75 mg daily has been offered unless 
contramdicated 
10 CVD risk assessment includes smoking status EPA Cardio 
11 CVD risk assessment includes blood pressure EPA Cardio 
12 CVD risk assessment includes personal history of diabetes EPA Cardio 
13 For patients with CVD Blood Plasma Glucose is tested at diagnosis EPA Cardio 
14 For patients with diabetes there is a record of smoking status in the past 15 months except EPA Cardio 
for those who have never smoked whose smoking status should be recorded at least once 
15 For patients with diabetes there is a record of their weight or Body Mass Index at least EPA Cardio 
once in the last 15 months 
16 For patients with CVD (CHD, stroke, TIA, or PVD) there is a record of their weight or Body EPA Cardio 
Mass Index at least once in the last 15 months 
17 For patients with diabetes there is a record that diet advice has been offered at least once EPA Cardio 
in the last 15 months 
18 For patients with CVD (CHD, stroke, TIA, or PVD) there is a record of their cholesterol EPA Cardio 
(general/total, HDL and LDL) at least once in the last 15 months 
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Clinical indicators Origin 
19 All patients with CVD (CHD, stroke, TIA, or PVD) should have their systolic blood pressure EPA Cardio 
controlled to < 140 
20 All patients with CVD (CHD, stroke, TIA, or PVD) are offered a statin. EPA Cardio 
21 For patients who have had an Myocardial Infarction there is a record that a beta blocker EPA Cardio 
has been offered (unless a contraindication or side-effects is recorded). 
22 CVD risk assessment includes age. EPA Cardio 
23 CVD risk assessment includes gender. EPA Cardio 
24 CVD risk assessment includes diabetes status. EPA Cardio 
25 For patients with diabetes there is a record that specific advice about lifestyle was offered EPA Cardio 
at least once in the last 5 years. 
CHD: coronary heart disease; CVD: cardiovascular disease; PVD: peripheral vascular disease; 
TIA: transient ischaemic attack. 
Table 6 focuses on the Vitale Vaten set of organizational indicators. In general, 46 
out of 79 indicators were selected. From the list of 27 indicators also presented in 
EPA Cardio, the Vitale Vaten panels validated 17 indicators (63%). In EPA Cardio, 
nine indicators from this list were selected; eight indicators were validated in both 
procedures. 
Table 6. Organizational indicators selected by panels of healthcare professionals and stakeholders 
by origin of the indicators. 
Indicators formulated on the basis 
of the care standard 
International EPA Cardio set 
Indicators formulated on the basis 
of the DCGP's vision on care 
Added after round 1 
Total 
Number 
38 
27 
9 
5 
79 
Number (%) of 
Health care 
professional panel 
22 (58) 
17(63) 
5(56) 
2(40) 
46 (58) 
indicators rated valid 
Stakeholder 
panel 
32(84) 
18(67) 
7(78) 
2(40) 
59 (75) 
Both 
panels 
22 (58) 
17(63) 
5(56) 
2(40) 
46 (58) 
Table 7 shows these indicators with the results from EPA Cardio and Vitale Vaten. 
On the web, we present all organizational indicators validated in Vitale Vaten, 
ordered by origin. 
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Table 7. Results of EPA Cardio and Vitale Vaten considering the list of 27 organizational indicators 
presented in both procedures. 
EPA 
set 
Infrastructure 
The practice should have a system for offering all patients with chronic illness (e g 
established CVD CHD, stroke, TIA, or PVD - see glossary), a check-up/review at least 
once in the last 15 months 
Patients who smoke and are recorded as being motivated to stop should be offered at 
least one follow-up consultation within 3 months 
For all patients who are obese (Body Mass Index >30kg/m'!) there should be a record that 
they have been offered at least one follow-up consultation within the last 15 months 
All practices should use an electronic disease classification system that can be used to 
create registers of patients with established CVD (CHD, stroke, TIA or PVD) e g 
International classification of Primary Care, READ Codes 
All practices should use an electronic disease classification system that can be used to 
create registers of patients at risk of CVD (hypertensives, etc ) e g International 
Classification of Pnmary Care, READ Codes 
All patients at high risk (e g chronic respiratory disease, established CVD (CHD, stroke, 
TIA, or PVD), chronic heart disease, chronic renal failure, diabetes, immunosuppression of 
any cause, residents of nursing homes etc, anyone aged >65) should be offered flu 
vaccination in the preceding flu season (e g 1 September to 31 March or 1 September to 
31 December) 
People 
All GPs should attend at least one training/continuing medical education event on CVD 
within the last 5 years 
At least one GP per practice should attend > one training/continuing medical education 
event on CVD within the last 15 months 
All nurses should attend at least one training/continuing medical education event on CVD 
within the last 5 years 
At least one nurse per practice should attend at least one training/continuing medical 
education event on CVD within the last 15 months 
GPs should take part in education about CVD nsk factors (e g diet, exercise, smoking) in 
schools 
Nurses should take part in education about CVD risk factors (e g diet, exercise, smoking) 
in schools 
GPs should take part in local/community campaigns or actions on CVD risk prevention 
(e g stop smoking campaigns, fun-runs etc ) 
Nurses should take part in local/community campaigns or actions on CVD risk prevention 
(e g stop smoking campaigns, fun runs etc) 
Information 
The medical record should contain a summary list of major medical problems 
The medical record should contain details of current actual prescribed medication 
The medical record should contain information about intolerances and contraindications to 
medication 
Information leaflets about CVD (e g CHD, stroke, hypertension, stopping smoking etc) 
should be available at the practice for patients to take home or read in the practice 
Advice to patients about CVD risk factors/lifestyle should be based on using validated 
assessment tools (e g food frequency questionnaire, international physical activity 
questionnaire, etc) 
A CVD risk assessment tool should be integrated with the patient medical record system 
(e g so that the CVD event risk score is entered directly in to the patient's medical record) 
CVD risk advice (e g about modifiable risk factors such as diet and exercise) should be 
integrated with the patient medical record system 
Smoking status should be clearly identifiable on the paper and/or electronic record 
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9 The diagnosis of hypertension should be clearly identifiable on the paper and/or electronic 
record 
10 The diagnosis of diabetes should be clearly identifiable on the paper and/or electronic 
record 
11 The diagnosis of CVD should be clearly identifiable on the paper and/or electronic record 
12 The practice has an up-to-date directory of prevention activities/organizations available 
locally (e.g. gyms, walking group, weight-watchers etc) 
Quality and safety 
1 The practice should have a team meeting about quality improvement relating to CVD at 
least once in the last 15 months 
EPA 
set 
V 
V 
V 
Vitale 
Vaten 
set 
V 
V 
V 
V 
CVD: coronary heat disease; CVD: cardiovascular disease; PVD: peripheral vascular disease; 
TIA: transient ischaemic attack V = rated valid. 
Consistency across health professionals and stakeholders 
Table 6 also shows the results of the two Vitale Vaten panels separately. The 
stakeholder panel selected 59 out of the 79 indicators (75%), while the health 
professional panel selected 46 indicators (58%), all included in the stakeholder 
set. 
Discussion 
Main findings 
This study showed, first, that clinical and organizational indicators for CVRM, 
selected by international panels of GPs (EPA Cardio), were reasonably well 
validated by a multidisciplinary panel of health professionals in one country (Vitale 
Vaten). Conversely, indicators previously selected by a national GP working group 
(UniRap) were not validated. 
Second, the study showed high consistency between health professionals and 
stakeholders (Vitale Vaten) regarding organizational indicators. Health 
professionals were most critical in their selection. 
Interpretation 
Several studies compared different consensus procedures showing consistency;19" 
22
 other studies focused on quantifying the results of Delphi rounds, for instance 
assessing the result of each round.23"25 Research on Delphi procedures with 
different panels shows variable results depending on the validation criteria. Hardy 
et al accepted indicators when validated by at least one panel.13 In EPA Cardio, 
nine national GP panels validated 30-61% of the indicators.17 In a procedure with 
11 different stakeholders panels rating indicators on primary mental healthcare 
services, agreement within panels was very high but low between panels.14 
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Indicators had to be validated by all panels, effectively giving physicians most 
influence. Comparing the results of healthcare managers and family physicians 
rating indicators of quality of primary care in the UK managers gave significantly 
higher ratings.16 In summary, the inclusion criteria in a multipanel Delphi procedure 
determine the final set, often giving a decisive role to the most critical panel. 
We can only speculate on the factors underlying the variable consistency of Delphi 
procedures regarding clinical indicators. Considering the EPA Cardio indicators, 
low consistency might be expected, due to the international perspective on general 
practice only. On the other hand, EPA Cardio was rigorous, because the 
procedure ensured that indicators were excluded if not assessed highly necessary 
in all countries. The reasonable consistency between EPA Cardio and Vitale Vaten 
may also reflect the fact that CVRM mostly is a primary care activity, so the 
perspectives of health professionals from other backgrounds may not have 
changed much, compared with GPs only. 
UniRap indicators were not very successful in Vitale Vaten, showing little 
consistency between procedures. Explanations may be that they were specifically 
for general practice or that development was very much driven by the possibility of 
registering the indicators in GP information systems with computerized extraction. 
Additionally, EPA Cardio indicators were formulated with nuances in contrast to 
the UniRap indicators, formulated in terms of measurability in electronic patient 
records. Furthermore, new insights in the prevailing guideline, reflected in the 
UniRap clinical indicators, may not been well known or accepted yet. Finally, 
UniRap indicators focus more on (proxy) outcome, a choice that is always 
debatable. 
Regarding the organizational indicators rated in EPA Cardio and Vitale Vaten, 
consistency between procedures was high. Eight out of 17 indicators validated in 
Vitale Vaten were in the EPA Cardio set of nine indicators. As expected, the two-
panel procedure was more liberal: it is of course more difficult to have 
understanding in nine country panels. Surprisingly, the one indicator from the EPA 
Cardio set not validated in Vitale Vaten was about offering flu vaccination to high-
risk patients, a long-existing practice. The health professional panel did not agree 
on necessity. 
The high consistency between health professionals and stakeholders regarding 
their selection of organizational indicators may reflect active involvement of all 
participants in the Platform Vitale Vaten. Consistency varied noticeably with the 
origin of the indicators. Many indicators validated by stakeholders, but not by 
health professionals, were derived directly from the care standard text. These 
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indicators considered innovations such as an individual treatment dossier, and an 
explicitly appointed central care giver. The stakeholders validated all these seven 
indicators about the dossier. This gave the health professionals a decisive role, in 
agreement with previous studies.14,16 Probably, results would have changed with a 
central question about concordance between indicators and recommendations 
instead of necessity. 
There are several explanations for the results concerning innovative issues. We 
assume that the presence of supportive evidence may be an important motivation 
for the necessity rating. As opposed to the enormous amount of clinical evidence 
in CVRM, evidence on organizational aspects is sparse, and new concepts 
obviously lack evidence, as developments and opinions precede research 
evidence. This may be a reason for panellists to reject these indicators. On the 
other hand, similar concepts used in diabetes care are evaluated positively.26,27 
Our results show that healthcare professionals are yet not willing to accept 
indicators on important elements of the chronic care model as the basis for patient 
empowerment, supporting self management and clarifying central care givers' 
tasks in CVRM. Competition between indicators cannot explain the results: all 
indicators were rated separately without a maximum. Anyhow, results suggest that 
a Delphi procedure with health professionals is less suitable to select indicators 
concerning innovative organizational concepts. Other methods may be more 
appropriate, like expert meetings. On the other hand, as the Vitale Vaten projects 
show, stakeholders seem less suitable to rate clinical indicators. 
Strengths and weaknesses 
Clinical indicators presented in Vitale Vaten were the result of former selection 
procedures (EPA Cardio and UniRap), and a list of organization indicators was 
presented identically formulated in identical procedures (Vitale Vaten and EPA 
Cardio). These are the strengths of this study. Nevertheless, the study should be 
regarded explorative and further research into underlying factors for consistency of 
Delphi procedures is needed. A limitation was that the response rates were not 
maximal, in particular of the stakeholders. 
The stakeholders were selected because they represented different organizations. 
However, some panellists were also healthcare professionals. This 'cross over' 
may have increased consistency between panels. 
92 Chapter 6 
Conclusion 
The consistency of Delphi procedures to select indicators was mixed. Several 
factors related to the procedures and the panel's composition could influence this. 
Regarding CVRM, a large number of international indicators (EPA Cardio) were 
validated again. This finding supports the view that rigorous international indicator 
selection procedures are valuable. A limitation, however, seems to be that these 
tend to exclude indicators reflecting healthcare delivery innovations. Another 
challenge is to involve stakeholders meaningfully, as we found that they did not 
assess clinical indicators and that their assessments of organizational indicators 
largely reflected those of health professionals. 
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Abstract 
Background: 
The number of patients with chronic diseases is increasing which poses a 
challenge to healthcare organizations. A proactive, structured, and population-
orientated approach is needed: the chronic care model (CCM) provides such a 
framework. 
Aim: 
To assess organizational conditions for providing structured chronic care 
according to the CCM across different healthcare systems. 
Design of study: 
International observational study. 
Setting: 
A stratified sample of 315 primary care practices in 10 European countries and 
Israel in 2008 and 2009. 
Method: 
Practice questionnaires and interviews. Outcome measures were mean practice 
scores on CCM domains per country, as a percentage of the maximum score, and 
the influence of practice size and urbanization on these scores. 
Results: 
Practice size showed large differences with the largest practices in Spain, 
England, Finland, and Israel. These countries, with a strong primary care 
orientation, had most physicians and staff involved per practice. The CCM 
domains 'clinical information systems' and 'decision support' had total practice 
means of 90%; other domains scored about 50%. Spain and England scored 
above average on almost all domains. Practice size and urbanization had little 
impact. 
Conclusion: 
Characteristics for chronic care delivery differed for most CCM domains. The most 
common characteristics related to computerization, providing a good starting point 
and high potential everywhere. All countries showed room for improvement. 
Further research should focus on relations between practice characteristics, 
organizational features, including health system and primary care orientation, and 
outcomes. Primary care seems suited for chronic care delivery; however, a 
stronger primary care was associated with better scores. 
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Introduction 
Ageing populations, effective health technologies, and poor lifestyle have 
contributed to the increasing number of patients with chronic diseases. 
Comprehensive and coordinated management of chronic disease is a major 
challenge for healthcare systems, covering the full range of health care from 
prevention and early diagnosis to treatment of established disease. A proactive, 
structured and population-orientated approach is needed, with important 
implications for the organization of health care. Two widely accepted frameworks 
on the organization of chronic care and prevention are the chronic care model 
(CCM),1 and the patient-centered medical home (PCMH).2 In the CCM, outcomes 
of disease management are seen as the result of interaction between a proactive 
practice team and an active patient. The CCM seeks to coordinate activities within 
primary care by fostering more productive interactions between trained proactive 
care teams and well-informed, motivated patients.3 The six key elements of the 
CCM are 'community resources and policies', 'healthcare organization', 'self-
management support', 'delivery system design', 'decision support', and 'clinical 
information systems'; for further explanation see Box 1. The key concepts of the 
CCM are also used for preventive programs (the expanded CCM).4 From studies 
conducted in the US and in other, European, healthcare systems, there is 
evidence that the CCM improves process and health outcomes for patients with 
chronic illnesses.5-7 The medical home is an organizational framework that 
evolved into the patient-centered medical home (PCMH),8 also adopted by 
professional organizations such as the American Academy of Family Physicians. 
While lacking a shared vocabulary,9 the PCMH model combines traditional primary 
care core values such as continuity, coordination, and comprehensiveness, and is 
predicated on patients having enhanced access to a personal physician.8 
Implementation of models such as CCM and PCMH in routine healthcare delivery 
provides substantial challenges. 
Depending on the healthcare system, various healthcare providers can deliver 
chronic care according to the CCM, including public health organizations, primary 
care groups, and hospital specialists. The role of primary care varies across 
countries and there are differences between the primary care quality of the 
healthcare organization in Europe and worldwide.10,11 Some countries, like the UK 
and Spain, have a strong primary care organization with, for instance, all patients 
registered with a general practice as gatekeeper to specialist care. In other 
countries like Germany and France, patients are not registered and can directly 
visit ambulatory specialists. Primary care practices vary considerably with respect 
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to their organizational capacity to provide structured chronic care. Examples of 
variation are the presence of nurses and other non-physicians in the practice 
team,12 and practice size.13 So, characteristics of the healthcare system such as 
strength of primary care and practice characteristics determine the primary care 
capacity to provide comprehensive structured chronic care. Many countries have 
nationwide programs to strengthen primary care for chronic conditions, such as the 
Quality and Outcomes Framework in the UK, and disease-management 
programmes in Germany.14 The aim of this study was to document the 
organizational characteristics of primary care practices in 10 countries in Europe 
and in Israel, to assess the organizational conditions for providing structured 
chronic care according to the six key elements of the CCM across different 
healthcare systems. 
Box 1. Features of the chronic care model 
Community resources and policies 
• Provider organizations are linked to community-based resources, for example, exercise programs, 
senior centers, and self-help groups 
Healthcare organization 
• Chronic care is seen as a priority, otherwise innovation will not take place 
• Reimbursement of the healthcare organization has a major impact on chronic care improvements, 
increasing revenues or reducing expenses will support a reimbursement system 
• Chronic care quality needs to be rewarded by purchasers and insurers to sustain improvements 
Self-management support 
• Patients themselves become the principal caregivers 
• Most patients can learn to manage their illnesses, and substantial segments ofthat management -
diet, exercise, self measurement, and medication use - are under the direct control of the patient 
• Self-management support involves collaboratively helping patients and their families acquire the skills 
and confidence to manage their chronic illness providing self-management tools, and routinely 
assessing problems and accomplishments 
Delivery system design 
• Planned management of chronic conditions is separated from acute care 
• Non-physicians support patient self-management, arrange for routine periodic tasks, and ensure 
appropriate follow-up 
• Planned visits are an important feature of practice redesign 
Decision support 
• Evidence-based clinical practice guidelines provide standards for optimal chronic care and should be 
integrated into daily practice through reminders 
• Specialist expertise is available and does not always require full specialty referral 
• Guidelines are reinforced by educational sessions for practice teams 
Clinical information systems 
• Registries, a central feature of the chronic care model, are lists of all patients with a particular chronic 
condition on an organization's or physician's panel 
• Reminder systems help primary care teams comply with practice guidelines 
• Feedback to physicians shows how each is performing on chronic illness measures 
» Registries are used to plan individual patient care and conduct population-based care 
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Method 
The European Practice Assessment Cardiovascular project (EPA Cardio) was an 
international observational study in primary care in 2008 and 2009.15 In this 
project, indicators for cardiovascular risk management were developed, 
instruments for the study were developed and piloted, and a large observational 
study was performed (Ludt et al., 2011, unpublished data).16,17 Countries included 
were Austria, Belgium, England, Finland, France, Germany, Israel, the 
Netherlands, Slovenia, Spain, and Switzerland. 
In each country, the aim was to include stratified random samples of 36 practices, 
representing the national situation using two stratification factors: practice size and 
urbanization. Practice size was defined as 'small' with up to two full-time equivalent 
GPs and 'large' with more than two full-time equivalent GPs; urbanization was 
defined as 'rural' for towns with < 100,000 inhabitants and 'urban' for cities with 
>100,000 inhabitants. Country project partners were instructed to develop 
additional stratification criteria for practice size and urbanization, particularly if 
some cells in the national stratification table were empty. Practices were to be 
recruited from national or regional lists, with stratification being taken into account. 
This article focuses on the organizational characteristics of the practices, collected 
by written questionnaires and telephone interviews with the participating GP per 
practice. Questions on practice organization were derived from the previously 
validated EPA instrument.18 The questions in the domain 'community resources 
and policies' were derived from the original EPA Cardio indicator list.16 All 
questions were answered by ticking a box with 'yes', 'no', or 'not applicable'. The 
specific questions have been listed in Box 2. 
In this study, the items were categorized post hoc into the CCM domains.3 The key 
domains are 'community resources and policies', 'healthcare organization', 'self-
management support', 'delivery system design', 'decision support', and 'clinical 
information systems'. In the domain 'delivery system design', four subdomains 
were formed: 'practice-led contact for patient groups', 'practice-led contact for 
prevention', 'attendance rates for preventive activities', and 'preventive 
procedures'. The mean practice scores on each domain per country were 
determined as a percentage of the maximum score on that domain, with the 
standard deviation as a measure of the variation within the countries. All questions 
were formulated positively, with 'yes' indicating the presence of a characteristic. All 
questions were scored dichotomously, answered as either 'yes', or 'no' -
consisting of: 'no', 'missing value', and 'not applicable'. 
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Box 2. Questions in questionnaire and interview ordered by CCM domains. 
Community resources and policies: Community participation 
1 Does the practice participate in public healthcare programmes on life style (physical exercise, stop 
smoking)9 
2 Did nurses take part in education about cardiovascular disease risk factors (for example, diet, exercise, 
smoking) in schools9 
3 Did GPs take part in local/community campaigns or actions on cardiovascular disease nsk prevention 
(for example, stop smoking campaigns and fun-runs)9 
4 Did nurses take part in local/community campaigns or actions on cardiovascular disease risk prevention 
(for example, stop smoking campaigns and fun-runs)9 
Health system - organisation of health care 
1 Does the practice have a procedure for the management of patient information in relation to detailed 
examination results and the documentation of measures that were taken (for example, blood 
examinations)9 
2 Does the practice have a procedure for the management of patient information in relation to the review 
of detailed examination results by the doctor (in terms of outgoing needs)9 
3 Does the practice use a system for reviewing medication prescribed to individual patients on a regular 
basis9 
4 Does the practice produce an annual report9 
5 Does the practice produce a quality report9 
6 Has the practice undertaken at least one clinical audit in the last 12 months9 
7 Does the practice have a critical incident register9 
Self-management support 
1 Are there information leaflets about cardiovascular disease (for example, coronary heart disease [CHD], 
stroke, hypertension, and stop smoking) available at the practice for patients to take home or read in the 
practice9 
2 Does the practice have an up-to-date directory of prevention activities/organisations available locally (for 
example, gyms, walking group, and weight-watchers)9 
3 Do you offer regularly written information on lifestyle9 
4 Do you regularly offer advice about websites for education on health risks or healthy lifestyle9 
Delivery system design 
Practice-led contact for patient groups 
1 Does the practice use a system for recalling patients with cardiovascular diseases9 
2 Does the practice use a system for recalling patients with diabetes9 
3 Does the practice use a system for recalling patients with asthma/chronic obstructive pulmonary 
disease9 
4 Does the practice use a system for recalling patients with hypertension9 
Practice-led contact for prevention 
1 Does the practice use a system for recalling populations at risk for preventive care regarding 
cardiovascular diseases9 
3 Does the practice use a system for recalling populations at risk for preventive care regarding influenza9 
3 Does the practice use a system for recalling populations at risk for preventive care regarding cervical 
screening9 
4 Does the practice use a system for recalling populations at risk for preventive care regarding breast 
cancer screening9 
Attendance rates for preventive activities 
1 Does the practice have the attendance rate for cervical screening9 
2 Does the practice have the attendance rate for influenza vaccination9 
3 Does the practice have the attendance rate for breast cancer screening9 
Preventive procedures 
1 Does the practice have a procedure for prevention of pressure sores9 
2 Does the practice have a procedure for prevention of osteoporosis9 
3 Does the practice have a procedure for using folic acid by women who are pregnant or want to get 
pregnant9 
4 Does the practice have a procedure for smoking cessation (for example with the minimal intervention 
strategy)9 
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Decision support 
1 Do the GPs have direct access to medical guidelines (either on paper or electronic) in their treatment 
rooms? 
2 Do the GPs have direct access to (peer-reviewed) medical journals (either on paper or electronic)7 
3 Do the GPs have direct access to literature data banks such as Medlme/Pubmed or Cochrane? 
Clinical information systems 
1 Do you have internet access? 
2 Do you have e-mail access in the practice9 
3 Are the computers with internet access outfitted with anti-vims software? 
4 Is the access to the practice computers protected, in that a user name and password have to be 
entered9 
5 Does the practice use a computer-supported patient file system? 
6 Is the computer used for creating medication prescriptions9 
In the questionnaire, respondents were asked about the numbers of patients in 
their practice. In countries without patients listed or registered within a practice, the 
number of different patients attending the practice each year was taken as practice 
population size. Furthermore, questions about the practice staff were included. 
Data analysis mainly consisted of descriptive statistics. In addition, the influence of 
practice size and urbanization of practice area on the presence of CCM features 
was explored using random coefficient regression modeling, with practices being 
nested in countries, using SPSS (version 16). The model included practice size 
(with full-time equivalent GPs as a continuous variable), urbanization, and their 
interaction as independent factors. 
Results 
Table 1 shows the practice numbers included per country according to the preset 
stratification. A total of 315 practices were included (80% of the target sample). All 
countries worked with a sample from a list of practices and considered the 
stratification, with the exception of Austria and Switzerland where a personal 
approach was used to recruit practices. In Belgium, additionally to practice 
recruitment from the list, four practices contacted personally were included. In 
France the list consisted of 1270 GPs from a network; in Spain the list consisted of 
all practices in the Catalonian Health Organization. All other countries used a 
regional or national list. Four countries made extra strata to fit their sample more 
closely to the national situation; these data are not in Table 2. In England most 
practices are 'large' considering the study definition, so this group was split up into 
more or less than four full-time equivalent GPs. In the Netherlands, on the other 
hand, a majority of practices is 'small'. This stratum was differentiated into single-
handed practices and up to two full-time equivalent GPs. In Germany and 
Slovenia, the urbanization had a stratum for practices in towns with <30,000 
inhabitants. 
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Table 1. Number of primary care practices 
Austria 
Belgium 
England 
Finland 
France 
Germany 
Israel 
Netherlands 
Slovenia 
Spain 
Switzerland 
Totals 
'Rural' (including towns 
< 100,000 inhabitants) 
'Small' 'Large' 
<2 Fte GPs >2 Fte GPs 
20 
13 
1 
1 
16 
13 
7 
21 
18 
0 
17 
128 
0 
7 
7 
3 
5 
1 
9 
1 
7 
21 
0 
60 
as stratified per country 
'Urban' 
> 100,00c 
'Small' 
(cities with 
I inhabitants) 
'Large' 
<2 Fte GPs >2 Fte GPs 
11 
2 
10 
0 
4 
4 
7 
9 
5 
0 
0 
52 
0 
1 
16 
3 
4 
0 
8 
4 
1 
15 
0 
52 
and totals. 
Data on practice 
size or urbanization 
missing 
0 
1 
2 
2 
2 
3 
4 
0 
5 
0 
4 
23 
Total 
number of 
practices 
31 
24 
36 
9 
31 
21 
35 
35 
36 
36 
21 
315 
Fte = full-time equivalent 
Table 2 gives information on the practices included. There were large differences 
in patient numbers per practice, with the largest practices by far in Spain and 
Finland with a mean of over 23,000 patients, followed by England and Israel with 
5,000 to 7,000 patients. Austria, Belgium, France, Germany, the Netherlands, and 
Switzerland all reported a mean practice size of about 3,000 to 3,500 patients. 
Finally, Slovenia reported the smallest practice sizes with approximately 2,000 
patients. Practice size varied widely within each of the countries, as reflected by 
the estimates of standard deviations. Spain, Finland, England, and Israel had most 
GPs involved per practice and most staff. Most managers were found in countries 
with large number of GPs per practice, including Spain, Finland, England, and 
Israel. Spain in particular reported many 'other staff - for instance, social workers, 
paediatricians, and physiotherapists are included in the primary care practice staff. 
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Table 2. Mean practice population size and staff composition per country and totals. 
ID Country 
Austna 
Mean 
η 
SD 
Belgium 
Mean 
η 
SD 
England 
Mean 
η 
SD 
Finland 
Mean 
η 
SD 
France 
Mean 
η 
SD 
Germany 
Mean 
η 
SD 
Israel 
Mean 
π 
SD 
Netherlands 
Mean 
η 
SD 
Slovenia 
Mean 
η 
SD 
Spam 
Mean 
η 
SD 
Switzerland 
Mean 
η 
SD 
Total 
Mean 
η 
SD 
Practice 
population 
size 
29431 
29 
1307 
2884 
24 
2192 
6573 
32 
3655 
23750 
2 
18031 
3096 
15 
2734 
35871 
17 
2129 
5263 
35 
4515 
3169 
35 
1200 
2059 
36 
792 
23761 
36 
11619 
33301 
18 
2513 
6467 
279 
8550 
Fte GPs 
1,00 
31 
0,00 
2,43 
23 
1,75 
3,78 
36 
2,28 
11,71 
7 
11,51 
2,34 
29 
1,88 
1,31 
19 
0,57 
3,43 
35 
3,03 
1,45 
35 
0,75 
2,32 
31 
2,06 
13,81 
36 
7,32 
1,14 
17 
0,32 
3,85 
299 
5,30 
Fte Nurse 
1,83 
31 
0,50 
0,09 
22 
0,29 
2,08 
36 
1,26 
9,29 
7 
8,77 
0,05 
20 
0,22 
2,28 
19 
1,13 
2,62 
28 
1,73 
0,42 
32 
0,45 
2,97 
30 
2,66 
16,81 
34 
7,88 
1,55 
17 
0,70 
3,68 
276 
6,10 
Fte practice 
assistants 
with clinical 
tasks 
0,00 
31 
0,00 
0,45 
22 
0,80 
0,93 
36 
1,29 
4,71 
7 
5,74 
0,05 
20 
0,22 
0,03 
19 
0,11 
0,04 
35 
0,19 
1,12 
32 
0,55 
0,09 
32 
0,30 
2,13 
35 
1,23 
0,02 
17 
0,05 
0,68 
286 
1,45 
Fte practice 
assistants 
without clinical 
tasks 
0,00 
31 
0,00 
0,46 
22 
0,63 
5,33 
25 
2,40 
4,00 
7 
4,36 
0,78 
20 
1,08 
0,00 
19 
0,00 
1,47 
35 
1,41 
0,34 
32 
0,63 
0,13 
32 
0,42 
11,72 
36 
5,40 
0,00 
17 
0,00 
2,45 
276 
4,51 
Fte 
practice 
manager 
0,00 
31 
0,00 
0,14 
22 
0,35 
1,10 
36 
0,43 
1,86 
7 
4,49 
0,15 
20 
0,37 
0,03 
19 
0,11 
0,81 
35 
0,38 
0,07 
32 
0,22 
0,37 
35 
0,49 
1,86 
36 
0,39 
0,04 
17 
0,15 
0,59 
290 
0,97 
Fte 
other 
staff 
0,00 
31 
0,00 
0,59 
22 
1,03 
0,26 
36 
0,70 
1,14 
7 
1,86 
0,29 
20 
0,72 
0,09 
19 
0,19 
4,12 
35 
4,11 
0,12 
32 
0,38 
0,44 
32 
1,19 
9,40 
29 
4,07 
0,16 
17 
0,30 
1,70 
280 
3,56 
Fte = Full-time equivalent 
1
 Data do not refer to patients listed or registered but to the yearly attending population of different patients 
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Table 3 shows the overall figures regarding domains of the CCM. Again, 
substantial variation was observed across and within countries. 
Table 3. Scores on Chronic Care Model domains: number of items, mean practice scores of 
possible maximum (%) per country, standard deviation (SD), and total. 
Country (n) 
Austria (31) 
Mean 
SD 
Belgium (24) 
Mean 
SD 
England (36) 
Mean 
SD 
Finland (9) 
Mean 
SD 
France (31) 
Mean 
SD 
Germany (21) 
Mean 
SD 
Israel (35) 
Mean 
SD 
Netherlands (35) 
Mean 
SD 
Slovenia (36) 
Mean 
SD 
Spam (36) 
Mean 
SD 
Switzerland (21) 
Mean 
SD 
Total (315) 
Mean 
SD 
Health 
system -
organi-
zation of 
healthcare 
7 
57 
15 
52 
28 
95 
8 
56 
11 
39 
24 
56 
22 
75 
26 
51 
21 
42 
26 
77 
13 
30 
20 
59 
28 
I 
Contact 
patients 
4 
45 
37 
9 
23 
100 
0 
8 
13 
17 
35 
74 
26 
64 
32 
66 
28 
26 
31 
100 
0 
8 
24 
53 
42 
Delivery system design 
Contact 
preven-
tion 
4 
6 
11 
44 
35 
73 
19 
50 
22 
21 
37 
25 
31 
56 
24 
56 
16 
44 
26 
75 
0 
6 
22 
44 
33 
Atten-
dance 
rates 
3 
1 
6 
49 
41 
75 
22 
89 
24 
27 
38 
35 
20 
28 
29 
61 
21 
48 
28 
67 
0 
25 
21 
45 
34 
I 
Preven-
tive 
proce-
dures 
4 
30 
40 
54 
33 
74 
24 
50 
35 
43 
29 
38 
34 
64 
33 
51 
25 
40 
27 
82 
16 
23 
27 
52 
34 
Self 
manage-
ment 
Support 
4 
66 
27 
64 
26 
91 
12 
35 
14 
50 
23 
61 
22 
21 
18 
69 
26 
56 
25 
66 
18 
45 
25 
59 
29 
Decision 
support 
3 
96 
14 
89 
23 
100 
0 
96 
11 
84 
21 
79 
20 
100 
0 
93 
16 
69 
36 
100 
0 
76 
28 
90 
22 
Clinical 
information 
system 
6 
67 
30 
95 
10 
100 
0 
100 
0 
91 
16 
79 
26 
100 
0 
97 
9 
78 
18 
100 
0 
67 
24 
89 
20 
Community 
resources 
and policies 
4 
35 
18 
20 
21 
32 
22 
83 
33 
27 
24 
54 
29 
46 
33 
21 
24 
76 
33 
85 
19 
33 
23 
45 
34 
Domains with relatively high scores across Europe were 'clinical information 
systems' and 'decision support', with respective total practice means of 89% and 
90%. In all other domains, mean scores across Europe ranged between 44% and 
59%. Spain had scores above average on all domains, ranging from 66% to 100%. 
England had similar scores, with the exception of a below-average score on 
'community resources and policies'. The best scores on this domain were found in 
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Spain again (85%), Finland (83%), and Slovenia (76%). The lowest scores (<10%) 
were found for contacting defined patient populations (Belgium, Finland, and 
Switzerland), preventive activities (Austria and Switzerland), and attendance rates 
for preventive activities (Austria). 
Table 4 shows that practice size and urbanization did not have any impact on most 
aspects of practice organization. In cities with >100,000 inhabitants, practice 
scores were 0.43 higher in the seven-issue domain Organization of health care' 
^=0.023), 0.35 higher on the four-issue subdomain 'preventive procedures' 
(p=0.024), and 0.30 lower on the domain 'community resources and policies' 
(p=0.024). No other effects were found. 
Table 4. Significant results of regression analyses. The model assessed the influence of practice 
size (based on full-time equivalent GPs as a continuous measure), urbanization 
(dichotomous), and their interaction term on the (sub)domains. 
Effect size 
(sub) domain variable (number of items) significance 
Organisation of health care urbanization 0.43 (7) 0.023 
Preventive procedures urbanization 0.35 (4) 0.024 
Community resources and policies urbanization - 0.30 (4) 0.024 
Discussion 
Summary of main findings 
This observational study provided a mixed picture regarding organizational 
conditions for providing structured chronic care. Regarding implementation of the 
CCM, the domains 'clinical information systems' and 'decision support' had high 
scores across countries, reflecting high levels of information technology in the 
practices included. In the other domains, mean scores were about 50%, with great 
variation between and within countries. Practices varied substantially with respect 
to the number of registered or attending patients, and with respect to team size, 
numbers, and types of other staff. 
Strengths and limitations of the study 
The strength of this study is the sampling strategy of primary care practices to 
ensure good representation. As the best alternative for a completely random 
sample, practices were stratified and samples were taken from lists in all but two 
countries, although the participation rate in some countries was low. To the 
authors' knowledge, the sample is unique with data from practices from 11 
countries across Europe and up to 36 practices per country, in total over 300 
practices, allowing for robust results and conclusions with data on practice staff 
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and characteristics. There is no reason to think the findings are explained by 
sampling issues. 
Another issue is that all data were self-reported. Data are presented as the 
percentage of 'yes' from the total number of practices, ignoring missing values or 
answers of 'not applicable'. As such, the results may be conservative; the actual 
situation may be slightly better. The 'not applicable' option was especially used in, 
for instance, Germany, where GPs are not always allowed to recall patients for 
preventive activities. It might be argued that practice characteristics were not 
scored here, but healthcare organization characteristics, but it was decided to 
simply score the presence of the features. In addition, variation in results between 
countries showed that the instrument was discriminative. 
Comparison with existing literature 
Previous research found that primary care practices with an organization of care in 
accordance to the CCM in general or studying separate domains had better 
outcomes.5"7,19-24 Additionally, CCM-implementation programs have also been 
evaluated as positive.25,26 Another approach in healthcare organization research is 
considering strength and integration of primary care within the healthcare system, 
assessing features as 'first contact', longitudinality, comprehensiveness, 
coordination, community orientation, access, location, and family centeredness.11 
Differences of the healthcare organizations across countries were not studied as 
such; instead, the study aimed to assess the presence of CCM features in primary 
care in different healthcare settings. However, in general, a stronger primary care 
orientation is associated with higher scores. 
All items in the domain 'delivery system design' in this study were related to 
organization of preventive actions and to processes and outcomes. Offering 
preventive services is one of the characteristics for the comprehensiveness of the 
care system. Both primary and secondary prevention require a clear view of the 
targeted patient population.27 This proactive approach is much favored by a 
system where patients are registered - a requirement for longitudinality. Austria, 
Germany, and Switzerland did not report on patients listed or registered but on 
patients attending each year, reflected in rather low scores in this domain. In some 
countries GPs were - at least to some extent - not allowed to contact patient 
populations. 
'Self management support' showed considerable variation. It is one of the pillars of 
the CCM, as it is the factor that should empower patients to take an active role in 
the management of their disease. In England only, the score is high; in all other 
Primary care characteristics and population-orientated health care across Europe 109 
countries scores vary from 20% to 70%. Patient empowerment and self-
management support very much involve the roles of both parties in the medical 
contact, the patient and the doctor or the medical team, and sharing 
responsibilities. There is much to be gained by better implementation of this aspect 
oftheCCM. 
Primary care practices use information technology extensively, reflected in high 
scores on 'clinical information systems' and 'decision support', opening possibilities 
to enhance other domains. Data management provides opportunities to enhance 
patient selection for preventive activities or regular checks, but also for self-
management support.23-28 So, information technology and electronic patient 
records form a solid basis for the other domains. 
The domain 'community resources and policies' in this study focused on outreach 
participation in programs or education by the practice team members. In most 
countries, only a minority of GPs and practice nurses actively participate in public-
health-oriented programs. Strength and manpower in public health organizations 
may be of importance, as well as role experience of primary care practices. 
Lifestyle-related programs are often public health based, but primary care practice 
participation in public health programs offers an opportunity to actually provide the 
whole spectrum of care, starting with primary prevention for healthy subjects. 
In several national studies, the influence of practice size on care processes and 
outcome indicators showed a tendency to more or better services in larger 
practices.7,13,29"31 However, the results of the present study did not support this 
effect of larger practice size. The practice sample size per country of up to 36, and 
controlling for country, made it difficult to reach significance. The presence of 
supportive staff members with the possibility of task delegation plays a role, 
too.22,32,33 Across countries, large differences were found in the numbers of staff 
members. Supportive staff are helpful, if not necessary, to deliver comprehensive 
preventive care for large groups. In most countries, GPs are outnumbered by staff 
members, especially in the countries with the largest practices: Finland, Israel, 
Spain, and England. So, in these countries, with a strong primary care, practices 
are on average the largest and have relatively the largest staff, enhancing features 
like comprehensiveness, including prevention. 
Implications for future research and clinical practice 
In summary, the study data show that across countries, features for chronic care 
delivery within general practice settings are apparent but differ regarding most 
domains of the CCM. Further research will have to focus on the relation between 
110 Chapter 7 
practice characteristics, organizational features, including the national health 
system organization and strength of primary care, and outcomes. Primary care is 
not ready to provide population-oriented health care throughout Europe, but at 
present there is at least a good starting point everywhere for implementation, as 
information technology in particular is widely used, offering possibilities to reach 
improvement in other domains, such as self-management support. 
This study shows that on all CCM domains high scores are possible, proving that 
primary care is suited for care delivery according to the CCM in both stronger and 
weaker primary-care-orientated healthcare systems. However, a stronger primary 
care orientation seems associated with higher CCM scores. Policy makers may 
empower primary care, providing circumstances for better implementation of the 
CCM, as most research shows positive effects of implementing the CCM or its 
components. This will be the case particularly in countries with a weak primary 
care orientation, with patients not listed or registered within a practice. Having a 
well-defined patient group is necessary for personalized preventive activities. 
Offering preventive services requires staff to organize and manage all these 
patient contacts. Practice staff shows large variation between countries. In some 
countries staff enlargement and diversification could be very helpful to enhance 
structured preventive care. 
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Abstract 
Background: 
Policies in many countries are aimed at strengthening primary care so that it 
provides reliably recommended treatments to patients with chronic diseases. This 
international study examined the associations between primary care organization 
and cardiovascular risk management (CVRM) provided to coronary heart disease 
(CHD) patients in Europe. 
Methods: 
In 2008-2009 we performed a chart audit in randomly sampled patients from 
primary care practices in Austria, Belgium, England, Finland, France, Germany, 
the Netherlands, Slovenia, Switzerland, and Spain. CVRM was measured using 
validated indicators: risk factor recording, anti platelet therapy, influenza 
vaccination, blood pressure levels (systolic <140, diastolic <90 mmHg), and LDL 
cholesterol <2.5 mmol/l. Structured questionnaires were used to document 
practice organization. In multilevel regression analyses we examined the effects of 
practice organization on CVRM. 
Results: 
Data on 4563 CHD patients from 273 primary care practices in 10 countries were 
available. Better organization of the primary care practice was associated with 
better scores on three indicators: risk factor registration (B=0.0307, p<0.0001), 
antiplatelet therapy (B=0.0519, p=0.0245), and influenza vaccination (B=0.1174, 
p<0.0001 ). Practice organization accounted for 21 to 27% of the variation on these 
indicators, while country characteristics accounted for another 10 to 20%. No 
associations between practice organization and recorded blood pressure or 
cholesterol levels were found. Self-management support and use of clinical 
information systems were the organizational dimensions most consistently linked 
to performance indicators. 
Discussion: 
Across different healthcare systems, better organization of primary care practices 
was associated with better CVRM in CHD patients. This finding supports 
investments in chronic care organization. 
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Introduction 
Providing high-quality healthcare for patients with chronic diseases poses major 
challenges for health care systems. In many countries policy makers aim to 
strengthen the ability of primary care to provide chronic illness care, so that large 
patient populations can be supported reliably over a long period of time. The 
Chronic Care Model (CCM) proposed that six organizational components are 
crucial to achieve this: 'health care organization', 'delivery system design', 
'decision support', 'clinical information systems', 'self-management support', and 
'community resources and policies'.1,2 Other organizational models, such as the 
Patient-Centered Medical Home,3 specified similar components. Though these 
models are based on some research,4-10 their positive impact on clinical and 
preventive performance needs further research as implementing best practices for 
chronic illness management shows little success.11 While it has been claimed that 
all organizational components are important, it would be informative to get better 
insight into the relative value of different domains. For instance, a study on 
diabetes care in 17 centers found that 'delivery system design' was positively 
correlated to outcomes, 'clinical information systems' and 'self-management 
support' were not significantly associated.6 
This paper focuses on preventive treatment of patients with coronary heart 
diseases (CHD) in primary care across Europe. CHD is a condition with high 
morbidity and mortality worldwide.12 Practice guidelines with recommendations for 
effective secondary preventive therapy are widely available.13,14 Although the 
effects of antiplatelet therapy and of control of blood pressure and serum 
cholesterol levels are beyond discussion, research showed that preventive 
treatment is suboptimal, both in Europe and in the US.15,16 Preventive treatments 
for patients with established CHD is mostly delivered in primary care, especially in 
countries with a strong primary care oriented health care system. The aim of our 
study was to examine the associations between organization of primary care 
practices and quality of cardiovascular risk management provided to CHD patients 
across different health care systems in Europe. 
Methods 
This study was part of the EPA Cardio project, an international observational study 
on cardiovascular risk management in 10 European countries.17 In stratified 
samples of primary care practices in each of these countries randomly sampled 
medical records were reviewed to provide data on cardiovascular risk 
management and structured questionnaires for general practitioners were used to 
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provide data on practice organization. The participating countries comprised a 
convenience sample: Austria, Belgium, England, Finland, France, Germany, the 
Netherlands, Slovenia, Switzerland, and Spain. Data collection took place in 2008-
2009. 
Indicators for cardiovascular risk management 
Data from medical records were linked to internationally validated indicators on 
cardiovascular risk management, which were developed in a structured Delphi 
procedure.18 Primary care physician panels from nine countries initially evaluated 
650 indicators for cardiovascular risk management. This resulted in a core set of 
44 indicators, which were then operationalized in specific measures and tested in 
a pilot study.19 This study is based on performance indicators related to preventive 
treatments in CHD patients. The first indicator was an aggregate score which 
indicated the number of risk factors recorded per patient. Risk factors considered 
were: smoking behavior, body mass index, physical activity, blood pressure, and 
cholesterol levels (range 0-5). Five other indicators, all dichotomous, were: 
antiplatelet therapy unless contraindicated, influenza vaccination offered, systolic 
blood pressure (SBP) <140 mmHg, diastolic blood pressure (DBF) <90 mmHg, 
and LDL cholesterol <2.5 mmol/l. 
Organization of primary practice 
A large set of questions on practice organization was included in structured 
questionnaires, which were partly administered in written form and partly in 
interviews with general practitioners in the participating practices. These questions 
comprised mainly items from the European Practice Assessment (EPA) 
instrument. This EPA instrument was previously validated in an international 
project.20 We constructed post hoc measures by linking items to one of the six 
domains of the Chronic Care Model as published before.21 The aggregated scores 
of the following five CCM domains were positively correlated: 'health care 
organization' (seven items), 'delivery system design' (15 items), 'decision support' 
(three items), 'clinical information systems' (six items), and 'self-management 
support' (four items). These correlations were highly significant with Spearman's 
rho values varying from 0.2 to over 0.6. In addition, an overall measure of 
structured chronic care was defined, with equal weight for each CCM domain. This 
had a Cronbach's alpha of 0.74. One CCM domain, 'community resources and 
policies' (four items), was left out of the overall score due to lower correlation with 
other domains. 
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Data analysis 
In order to examine the associations between practice organization and 
performance indicators we applied multilevel regression analyses, using indicators 
for cardiovascular risk management as outcomes. Age and gender were included 
as explanatory variables (covariates) at the patient level. The second level was the 
practice level at which the organizational measures were specified. In this level, 
we entered two factors: the domain 'community resources and policies' was a 
predictor in all analyses; furthermore we entered either one of the five other 
domains or the overall aggregated score. The third level was the country level (as 
fixed factor). The analyses were performed for each of the six outcomes 
separately. Furthermore, we assessed the intraclass coefficients for the variation 
in outcomes to assess the contribution of countries and practices using Snijders' 
and Bosker's methodology for the dichotomous outcomes.22 The risk factor 
recording was analyzed in a linear regression model, while the dichotomous 
outcomes, antiplatelet therapy, influenza vaccination, blood pressure and 
cholesterol levels, were handled in binomial logistic regression models. We 
considered p-values of 0.05 or less to indicate statistical significance. For the 
descriptive data presentation we used SPSS 16; the regression analyses were 
conducted using SAS 9. 
Results 
From the 284 practices in the EPA Cardio study 11 practices were excluded due to 
low numbers of patients. We included 273 primary care practices with data on 
4563 patients (Table 1). The number of practices varied from 12 in Finland to 36 in 
England and Spain. Overall, one third of the patients was female; in Switzerland 
and Belgium less than 25%; in Finland and England about 38%. On average 
patients were over 69 years of age. Patients in Spain were on average the eldest: 
over 73 years of age. 
Table 1. Countries, practices and patients included. 
Country Number of practices Number of patients % female Mean age 
Austria 
Belgium 
England 
Finland 
France 
Germany 
Netherlands 
Slovenia 
Spam 
Switzerland 
23 
23 
36 
12 
25 
26 
35 
35 
36 
22 
307 
269 
540 
245 
346 
463 
507 
822 
722 
342 
36 1 
23.6 
38.0 
38.4 
27 9 
36.9 
29.1 
35.8 
37 0 
22.4 
71.5 
66.8 
67.9 
72 1 
68.5 
69 0 
69.4 
68 2 
73 3 
67 8 
Total 273 4563 33.4 69 5 
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Table 2 presents figures on performance indicators. Overall performance varied 
from 46% of the maximum score for LDL treatment target and 60% for systolic 
treatment target up to 87% for antiplatelet therapy and diastolic treatment target. 
Table 2. Indicators for cardiovascular risk management. Percentage of maximum score in risk 
factor recording (with standard deviation) and percentage of the patients with positive 
scores for the binary outcomes is shown (n=4563 patients with CHD). 
Austria 
Belgium 
England 
Finland 
France 
Germany 
Netherlands 
Slovenia 
Spam 
Switzerland 
Total 
Risk factor 
recording (SD) 
80.6(18.6) 
80.8(21.2) 
87 5(16.6) 
70 1 (24.4) 
81.4(16.5) 
80.4(19.2) 
59.8(31.7) 
77 4 (24.8) 
58.1 (32.9) 
76.8 (24.2) 
74.0 (26.8) 
Antiplatelet 
therapy 
86.4 
90.7 
92.0 
93.2 
90.4 
67.5 
85.2 
93.9 
80.2 
95.3 
87.0 
Influenza 
vaccination 
52.8 
89 2 
86.7 
72.5 
59.1 
71.5 
96.4 
31 8 
67 5 
55.2 
66.1 
SBP 
<140 mmHg 
61.4 
55.9 
69.7 
50.2 
58.9 
58.0 
43.6 
56.8 
72.8 
65.4 
60.1 
DBP 
<90 mmHg 
85 9 
85.2 
95.9 
84.4 
89.5 
81.3 
85 7 
79.8 
96.1 
87.2 
87.1 
LDL 
< 2.5 mn 
56.1 
44.8 
65.5 
65.8 
38 2 
30 4 
45.1 
38.2 
45.9 
46.3 
46.3 
Table 3 presents the results of the regression analyses. Overall better practice 
organization was associated with more reliable risk factor registration (B=0.0307, 
pO.0001), antiplatelet prescribing (B=0.0519, p=0.0245), and influenza 
vaccination (B=0.1174, pO.0001). The same associations were found for the 
component 'clinical information systems'. The component 'self-management 
support' was associated with better risk factor registration (B=0.1676, p<0.0001), 
influenza vaccination (B=0.4368, p^.0004), and LDL treatment target (B=0.1371, 
p=0.0252). The component 'delivery system design' was associated with better 
risk factor registration (B=0.0352, p=0.0002) and vaccination (B=0.1259, 
p=0.0036). The domains 'health care organization' and 'decision support' were 
associated with influenza vaccination only. The domain 'community resources and 
policies' was found to be associated with DBP. 
Table 3a. Results of regression analyses (B values) with p<0.05 as significance level, a three level model.1 
Age 
Gender 
1 = female 
2 = male 
CCMS^ (score from 0 to 5) 
Community resources and policies (n=4) 
Linear regression 
Sum score risk 
factor registration 
Β 
-0 0042 
0 0200 
0.0307 
0.0084 
Ρ 
0 0207 
N.S. 
<.0001 
N.S. 
Logistic regression 
Antiplatelet 
therapy 
Β 
0 0040 
0.5707 
0.0519 
-0.0999 
Ρ 
N.S 
<0001 
0.0245 
N.S. 
Influenza 
vaccination 
Β 
0 0665 
0 0601 
0.1174 
-0.1610 
Ρ 
<0001 
NS. 
<.0001 
NS 
SBD<140 mmHg 
Β 
0 0227 
-0.0407 
0.0028 
0v0078 
Ρ 
<0001 
NS 
N.S. 
NS. 
DBDOO mmHg 
Β 
-0.0143 
-0 0046 
0 0091 
0.1446 
Ρ 
0.0036 
N.S. 
N.S 
0.0283 
LDL<2.5 mmol/l 
Β 
-0.0115 
-0.3296 
0.0037 
0.0985 
Ρ 
0.0035 
0.0001 
NS. 
N.S. 
Table 3b. Results of regression analyses (Β values) with p<0.05 as significance level, a three level model.1 
Health care organization (n=7) 
Clinical information systems (n=6) 
Self-management support (n=4) 
Decision support (n=3) 
Delivery system design (n=15) 
Linear regression 
Sum score risk 
factor registration 
Β 
0.0280 
0.0498 
0.1676 
0.0685 
0.0352 
Ρ 
N.S. 
0.0236 
<.0001 
N.S 
0.0002 
Logistic regression 
Antiplatelet 
therapy 
Β 
0.0364 
0.2770 
0.0525 
0 1785 
0.0580 
Ρ 
N.S. 
0.0016 
N.S. 
NS. 
NS. 
Influenza 
vaccination 
Β 
0.1763 
0.3899 
0.4368 
0 3603 
0.1259 
Ρ 
0.0243 
0.0002 
0.0004 
0.0411 
0.0036 
SBD<140 mmHg 
Β 
-0.0062 
0.0559 
-0.0320 
0.0739 
0.0022 
Ρ 
N.S. 
N.S. 
N.S. 
Ν S. 
NS. 
DBDOO mmHg 
Β 
-0.0195 
0.0543 
J 
0.0643 
-0.0240 
Ρ 
N.S. 
N.S. 
N.S. 
NS. 
LDL<2.5 mmol/l 
Β 
-0.0200 
-0.0380 
0.1371 
0.1102 
0.0033 
Ρ 
N.S. 
N.S. 
0.0252 
N.S. 
N.S 
The results presented are the estimates from the multilevel analysis For instance a positive estimate for the effect of 'self-management support' on LDL 
raises the chance for a certain person (with a certain age and gender in a certain country) to have a LDL <2.5 mmol/l when his practice has a better score 
in the domain self-management support 
More specific, an estimate of B=0.1371 signifies that one point extra on the 'self-management support' score would raise a 50% chance on LDL <2.5 
mmol/l to a 53% chance. The estimate of 0.1174 as found for influenza vaccination signifies that one point extra on the CCM5 score raises the average 
66% chance to 69%. 
1
 Three level model outcomes on patient level with age and gender as covariates; practice characteristics was the next level and country the third level. 
Country proved to be a significant factor in all analyses (p<0 0001, data not shown) 
3a practice level with two variables 1 community resources and policies; and 2. the Chronic Care Model sum score of the other five domains (CCM5, 
comprising health care organization, clinical information systems, self-management support, decision support, and delivery system design) 
3b practice level with two variables. 1 community resources and policies, and 2 one of the other five domains: health care organization, clinical 
information systems, self-management support, decision support, or delivery system design Only the estimates of these last domains are displayed in 
table 3b. 
2
 CCM5 is the sum score of five domain scores: health care organization, clinical information systems, self-management support, decision support, and 
delivery system design 
3
 Analysis found no estimate. 
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Table 4 shows the estimated intra class coefficients (ICC), indicating the relative 
contribution of country and practice to the total variation in performance across 
patients. About half of the variation in the influenza vaccination rate was explained 
for: 27% at the practice level and 24% at country level. Risk factor registration and 
antiplatelet prescription was over 20% accounted for by practices and about 10% 
by country; these percentages for blood pressure and cholesterol levels varied 
from 3 to 9%. 
Table 4. Estimates of intra class coefficients (ICC), signifying the portion of variance explained by 
country, by practice, or unexplained. 
Sum score risk Antiplatelet Influenza SBD DBD LDL 
factor registration therapy vaccination <140 mmHg <90 mmHg <2.5 mmol/l 
ICC countries 0.10433 0.08961 0.23663 0.03026 0.08882 0.05618 
ICC practices 0.25582 0.21132 0.26614 0.06560 0.07269 0.07400 
unexplained 0.63986 0.69908 0.49723 0.90414 0.83849 0.86982 
Discussion 
Main results 
Better practice organization was associated with better risk factor registration, 
antiplatelet prescription and influenza vaccination in CHD patients. Especially the 
organization of 'self-management support' and 'clinical information systems' 
showed consistent associations, followed by 'delivery system design'. A substantial 
proportion of the variation in risk factor registration, antiplatelet prescribing, and 
influenza vaccination was accounted for at the practice level. To a lesser extent, 
this was also the case in the blood pressure and cholesterol levels. In general, 
differences between primary care practices were larger than differences between 
countries. These findings suggests that practice organization had indeed impact 
on quality of cardiovascular risk management in CHD patients in primary care. 
Related research 
While the impact of practice organization mainly concerned aspects of preventive 
performance rather than risk factors, it should be noted that antiplatelet therapy 
has a well-assessed effect on cardiovascular events and mortality.23 Likewise, the 
benefits of influenza vaccination in preventing complications are well-documented 
and guidelines recommend vaccination to patients with cardiovascular 
diseases.13·14·24 This implies that better organization of primary care was 
associated with improved survival and fewer cardiovascular events in patient with 
CHD. 
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Previous research showed that various domains of practice organization had 
impact on indicators of clinical performance,4"10,25,26 When testing the various 
domains, we found that not all had equal effects on performance. The components 
'self-management support' and 'clinical information system' proved to be most 
consistently related to cardiovascular risk management. We cannot rule out the 
possibility that our measures of these domains may have been more accurate than 
those of other domains or that the participating primary care practices had specific 
characteristics explaining the findings. On the other hand, the importance of self-
management support is emphasized in models of chronic illness care. In these 
models, outcomes are considered the result of the interaction between a pro active 
health care organization team and a well informed and active patient.1 Self-
management support is therefore one of the mainstays of structured chronic care. 
It was striking that differences between primary care practices were larger than 
those between countries, even though several practice organization characteristics 
are related to health systems. For instance approaching patients for preventive 
activities, on the basis of registration of these patients on a list, is highly 
dependent on the national organization of the health care system. In a high-
performing health system primary care is at the centre.27,28 Examples of countries 
with a strong primary care organization are the United Kingdom and Spain. 
Irrespective of the strength of primary care improvement programs considering 
cardiovascular diseases have been launched in all countries.29 
Our results were in line with previous studies. O'Connor et al. studied diabetes 
care and explained less than 20% of the variation at the level of the practice and 
the physician together.30 However, they assumed an underestimation of the 
physician's contribution, as for instance physician's characteristics could improve 
patient's characteristics such as medication adherence. Kontopantelis et al. 
explained about 20-30% of the variation at patient and practice level together, with 
practice size as a dominant feature.31 In patient surveys, over 90% of the variation 
in outcomes such as general satisfaction was found to be patient related.32,33 In 
another study, about 40% of the total variation was accounted for.34 Of this 
explained variation the physician level explained 40%, practice site, medical group 
and service area accounted for the rest. 
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Strengths and weaknesses 
The EPA Cardio study was based on random sampling of patients using well 
developed measures of cardiovascular risk management and practice 
organization. The primary care practice samples from a convenience sample of 
countries may not reflect the national situation, despite stratification by size and 
urbanization level. Though we included a convenience practice sample in several 
countries, a strong point remains that we in general included practices from 
national or regional lists. This provides us with results from everyday life and not 
from academic settings or selected practices. The international design had the 
advantage that external influences linked to health systems were controlled for to 
some extent. 
We did not use inclusion criteria such as CHD diagnosed in specialist care. The 
group patients with myocardial infarction in their history will be evaluated and 
treated by cardiologists in a vast majority as all patients with coronary 
interventions. This might not account for all patients with stable angina, possibly 
resulting in some inclusion errors. In our sample female patients may be slightly 
underrepresented. In various national databases male CHD prevalence is 1.5 to 2 
times the female prevalence.35"37 A limitation is that the measures of the CCM 
were post-hoc constructed. The findings may not be generalizable to developing 
countries, although chronic diseases pose an increasing challenge for developing 
countries as well. 
Conclusion 
Our observational study provided data from a real life situation in contrast to 
academic settings or trial results with controlled interventions. High scores appear 
to be possible on all outcomes, but still improvements in primary care for CHD 
patients are possible throughout our country sample. Working according to CCM 
principles is positively related to better quality of care on most outcomes. This 
accounts especially for the domains 'clinical information systems' and 'self-
management support'. 'Self-management support' is the mainstay of the CCM, 
making the patient a real partner in patient practice collaboration. As the use of 
computerization is involved in all other domains the domain 'clinical information 
systems' is essential as well. Its effects proved to be significant in this study, which 
involved ten countries with different health care organizations, adding to the 
importance of these domains and robustness of the findings. This study reinforces 
the importance of strengthening the organization of primary care practices for 
improving their clinical performance. 
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Abstract 
Background: 
Information exchange networks for chronic illness care may influence the uptake of 
innovations in patient care. Valid and feasible methods are needed to document 
and analyze information exchange networks in healthcare settings. This 
observational study aimed to examine the usefulness of methods to study 
information exchange networks in primary care practices, related to chronic heart 
failure, diabetes and chronic obstructive pulmonary disease. 
Methods: 
The study was linked to a quality improvement project in the Netherlands. All 
health professionals in the practices were asked to complete a short questionnaire 
that documented their information exchange relations. 
Feasibility was determined in terms of response rates and reliability in terms of 
reciprocity of reports of receiving and providing information. For each practice, a 
number of network characteristics was derived for each of the chronic conditions. 
Results: 
Ten of the 21 practices in the quality improvement project agreed to participate in 
this network study. The response rates were high in all but one of the participating 
practices. For the analysis, we used data from 67 health professionals from eight 
practices. The agreement between receiving and providing information was, on 
average, 65.6%. The values for density, centralization, hierarchy, and overlap of 
the information exchange networks showed substantial variation between the 
practices as well as between the chronic conditions. The most central individual in 
the information exchange network could be a nurse or a physician. 
Conclusions: 
Further research is needed to refine the measure of information networks and to 
test the impact of network characteristics on the uptake of innovations. 
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Background 
Providing healthcare to patients with a chronic illness is an important challenge for 
health systems, and has major implications for health professionals' tasks, the 
organization of healthcare delivery, and the societal costs of healthcare.1 Many 
patients with chronic illness receive healthcare in primary care settings. Large 
variations have been reported in the organization and delivery of chronic illness 
care in primary care practices.2 Understanding of the social factors that influence 
the uptake of clinical or organizational recommendations is, as yet, limited. For 
example, evidence that perceived team climate and organizational culture are 
associated with professional performance or health outcomes in primary care is 
inconsistent.3,4 In this paper, we consider the structure of the information exchange 
networks in a primary care practice as a potential determinant of the uptake of 
recommendations for patient care. 
Theory on diffusion of innovations predicts that specific characteristics of social 
networks are associated with the uptake of practices.5 For example, connections 
of network members to relevant individuals outside the network help to signal the 
existence of specific recommendations for patient care. More particularly, the 
presence of individuals in a network who are also members of other networks 
('boundary spanners') is expected to increase the likelihood that a 
recommendation becomes known to members of the network. It has been 
suggested that the presence of weak ties in a network is associated with uptake of 
recommendations, because individuals with weak ties are more likely to be 
connected to other networks.6 Other research suggests, however, that having a 
centralized network position is associated with better transfer of knowledge.7,8 
Awareness of the existence of (new) knowledge, such as revised clinical 
recommendations or new organizational models for chronic illness care, is a 
necessary first step for the taking up of an innovation. But the innovation will only 
be implemented when this awareness is translated into (change of) individual 
behaviors. Networks that are dense and non-hierarchical in terms of information 
exchange may be better for the uptake of complex innovations, because they may 
provide credibility and legitimacy to the new practice.9 The information exchange 
and associated interaction in dense, nonhierarchical networks could speed up 
collective behavior change through mechanisms such as social comparison and 
role modeling, although obviously the quality of the connections plays a role as 
well. 
It is unclear whether these and other hypotheses on the uptake of innovations 
apply to healthcare. Social networks have mainly been studied outside the 
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healthcare domain, with only a few studies focused on healthcare professionals. 
For example, a study in England found that clinical directors were embedded in 
relatively small densely connected networks (cliques), while nursing directors had 
a central position in a more hierarchical network.10 Therefore nursing directors 
may be more adapted to gathering and disseminating information. A study of 
primary care partnerships in Australia found that independent staff played a crucial 
role in holding partnerships together.11 A study in the United States showed that 
primary care physicians obtained information from colleagues with greater 
expertise and experience as well as colleagues who were accessible based on 
location and schedule.12 
With few previous applications, greater understanding is required of appropriate 
methodologies for collecting and analyzing social network data in primary care 
settings. In particular, efficient and effective ways for collecting reliable primary 
data about the relationships between the members of the network are required. A 
pilot study used data from ethnographic field notes to construct matrices that 
indicated how practitioners interacted.11 Network characteristics, such as density 
and centralization, were determined for the two practices in the study. The study 
illustrated the approach very well, but the methods used were resource intensive 
and time consuming. 
In the study presented here, we developed and tested a short, structured 
questionnaire to collect data on information exchange networks in primary care 
practice. We focused on chronic heart failure (CHF), chronic obstructive pulmonary 
disease (COPD), and diabetes. These conditions were chosen because primary 
care has an important role in delivering care for these conditions in the 
Netherlands, while previous research showed that clinical and organizational 
recommendations were not optimally implemented.13 We had the following 
objectives. The first was to test the feasibility of the data collection method in 
primary care practices. This had two aspects: to establish that adequate response 
rates could be achieved, and to test the reliability of the data obtained about 
information exchange. The second objective was to examine whether the networks 
differed systematically between the three chronic diseases and between the 
practices in terms of a number of key network parameters. In the Netherlands, 
many quality improvement initiatives have focused on diabetes and COPD, and 
relatively few on CHF, hence some differences may be expected. Finally, we 
looked for variation in network parameters between practices for each of the three 
chronic conditions; the measurement of network parameters is only useful if 
practices can be shown to differ in these characteristics. 
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Methods 
Study design and study population 
We performed an observational study using a convenience sample of primary care 
practices. Our study was linked to an evaluation of a quality improvement project, 
focused on CHF, in Southern and Eastern parts of the Netherlands. The quality 
improvement project comprised of outreach visits to 21 general practices, 
provision of structured case registration forms for CHF patients, and telephone 
follow-up by the outreach visitor. The practices were invited separately to 
participate in this study on networking, and 13 practices agreed. Finally, ten 
practices participated. The ethical committee Arnhem-Nijmegen waived approval 
for the quality improvement study, in which this study was embedded. The 
practices were seen as separate cases, each with their own information networks. 
All general practitioners (GPs), practice nurses, and practice assistants in the 
participating practices were invited to complete a structured questionnaire. 
Measures 
We asked all health professionals in the practices about giving and receiving 
information around three chronic diseases: CHF, COPD, and diabetes. A written 
one-page questionnaire was developed (Additional File 1). This questionnaire 
listed the health professionals in a practice by name (GPs, practice nurses, 
practice assistants), and a number of types of health professionals outside the 
practice (designated by discipline only: other GPs, other practice nurses, 
cardiologists, internists, physiotherapists, and a category Others'). We asked each 
health professional to report on information exchange with each listed person, for 
each of the three chronic conditions separately, and for giving and receiving 
information separately. A simple tick box response format to indicate 'yes' was 
used. The information being exchanged might concern individual patients, practice 
management, or treatment in general. 
Dafa-ana/ys/s 
Response rates per practice were determined and descriptions of the information 
networks were made for each practice in terms of connections for receiving 
information within the practice and from healthcare providers outside the practice. 
We used UCINET 6 for the network analyses and SPSS15 for other analyses. 
Reliability was determined by examining to what degree connections defined by 
receiving information were confirmed by those defined by providing information 
(simple matching).14 A 'match' of receiving and providing information between two 
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professionals was based on the mutual agreement of either presence or absence 
of such connection. We did not expect complete agreement, as individuals may 
have different perceptions on the same communication process, but we expected 
a reasonable degree of similarity between receiving and providing information. 
Next, we computed a number of key parameters of the networks of the practices, 
which we theorized could be predictive of the uptake and sustainable adoption of 
new practices. We based these calculations on the network of receiving 
information links, because we assumed that these were most crucial for the uptake 
of innovations. A non-technical description of the network parameters is provided: 
Density. The density in a practice is the proportion of all possible connections in a 
network that are actually present. In a practice with a dense network, (new) 
information can flow directly between most individuals so that both the information 
is quickly shared as well as processes of interpretation and legitimization of the 
information are shared. This will result in a (often implicit) shared decision on how 
to act on the information. 
Centralization. This is a measure for the degree that a network is organized 
around a single person. If one person gives information to all the other individuals 
in the network, the outdegree of centralization of the network is high. A high 
indegree of centralization indicates that information from many practice members 
flow to one person. In a practice network with high centralization, it is important to 
get the central individual involved in efforts to implement knowledge in routine 
healthcare delivery. This individual may be recognized as a local opinion leader. 
Hierarchy. This is a measure for the direction in which information flows (note that 
it is not necessarily related to power). In a network without reciprocity, all 
information goes in one direction and the hierarchy will be strong. If the flow of 
information has two directions, there is a possibility for feedback and the hierarchy 
is lower. When the hierarchy of a network is low, more individuals in the practice 
can give information to other practice members. In a low hierarchy information 
exchange network, it is important to involve all members of the network in efforts to 
implement knowledge instead of targeting just specific individuals. 
Overlap. The total overlap indicates the proportion of present and absent ties in an 
index network (of all that could exist) that also exist in another network. A high 
number of absent connections can result in high total overlap, therefore a second 
measure of overlap is the overlap in connected individuals. This measure is the 
total number of connections in two (or more) networks divided by the total number 
of individuals who are connected (not including individuals in a network which are 
not connected). It is the mean number of connections held by any individual in the 
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networks, who has at least one connection. Overlapping information exchange 
networks in a practice, for example, regarding different chronic diseases, will 
enhance the speed of information exchange and likelihood of uptake in 
professional performance. 
We substituted missing values in the information receiving networks by imputation 
from the information providing network, when available. If the response of an 
individual on receiving information was missing, it was substituted by the 
responses of the individuals who indicated they had provided information to this 
individual. This method is commonly used in social network analysis15, although 
little is known about its appropriateness in the specific context of implementation 
research. We filled in a zero for no contact if both individuals did not provide 
information on their connection. Therefore, for further analysis a 'zero' in the data 
files referred to absence of a connection, or absence of data on presence of a 
connection. 
We computed parameters thought to be associated with either learning about an 
innovation or the uptake of an innovation. Practice network parameters that may 
be related to learning about an innovation are: total number of external 
connections, number of external connections as a fraction of all connections, and 
proportion of external connections to the most central individual in the practice. 
Network characteristics that are potentially associated with actual uptake of the 
innovation are: density, centralization, hierarchy, and overlap between the three 
disease information exchange networks. Regarding centrality, we also determined 
the professional discipline (physician, nurse, assistant) of the individuals with the 
highest centralization scores. 
Results 
Ten of the 21 practices in the quality improvement project agreed to participate in 
our study on information exchange networks. Two of these ten participating 
practices consisted of one GP and one practice assistant; these practices were 
excluded from the analysis in this paper. Table 1 provides descriptive information 
on the information networks in the eight participating practices. Compared to the 
21 practices in the quality improvement project, the participants in this networks 
study were less likely to be single-handed practices and practices without practice 
nurse. At the largest practice, ten out of the 20 practice staff (mostly practice 
assistants) did not complete the questionnaire. The number of connections for 
information exchange per condition varied between two and 47 within the practice 
(Table 1). On average, 65.6% of the receiving information connections (either 
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presence or absence) were confirmed by the reported providing information 
connections. The agreement was lowest for the diabetes information networks in 
all but one practice. 
Table 1. Descriptive information on the practice networks (n=8 practices with n=67 health 
professionals). 
Practice number 1 
Number of GPs 6 
Number of assistants 7 
Number of nurses 2 
Total number of providers in the 15 
practice * 
Total number of non-responders 0 
Receiving information within the pracl 
Reported CHF connections 6 
Reported COPD connections 41 
Reported Diabetes connections 47 
Theoretical maximum number of 210 
present connections (n * (n-1)) 
2 
2 
3 
1 
6 
0 
tice 
11 
12 
18 
30 
3 
2 
4 
1 
7 
0 
5 
6 
7 
42 
4 
1 
2 
1 
4 
1(GP) 
7 
7 
8 
12 
5 
2 
2 
1 
5 
2 (GP,A; 
2 
4 
3 
20 
Proportion agreement between receiving and providing information 
CHF 0 948 
COPD 0.919 
Diabetes 0.862 
0 567 
0.733 
0.667 
0.810 
0.667 
0.619 
0.667 
0.667 
0.500 
1.00 
1.00 
0.833 
6 
7 
9 
4 
20 
) 10(GP,9A) 
12 
31 
44 
380 
0 864 
0.833 
0.689 
7 
1 
2 
1 
4 
0 
6 
8 
7 
12 
8 
2 
3 
1 
6 
0 
9 
12 
12 
30 
Total 
23 
32 
12 
67 
13 
Mean 
0 833 0.767 0.807 
0.667 0.867 0 794 
0.417 0.867 0 682 
* GP=general practitioner, N=nurse, A=assistant 
Table 2 shows the values for density, centralization, and hierarchy of the 
information exchange networks (after imputation of missing values, where 
possible). Substantial variation existed between the practices as well between the 
chronic conditions. Density tended to be highest for diabetes and lowest for CHF, 
although two practices did not fit in this trend. Hierarchy of information exchange 
tended to have an opposite pattern to density, being lowest for diabetes and 
highest for CHF; three practices did not fit in this trend. Centralization (out degree 
and in degree) also showed high variation, but no clear pattern of differences 
emerged between the three conditions. 
The professional discipline of the most central person(s) in a practice varied both 
across practices and between chronic conditions within practices. Within practice 
one, for example, care for COPD patients was centered around two nurses, to 
whom the practice assistants worked almost exclusively; whereas care for diabetic 
patients centered on a GP and one of these nurses, with the practice assistants 
again working almost entirely to these two individuals (Figures 1, 2, and 3). The 
role of practice assistants differed across the practices, reflecting the variation of 
clinical roles that these individuals have in general practices. 
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Table 2. Information receiving network characteristics. 
Practice 
Density 
CHF 
COPD 
Diabetes 
Hierarchy 
CHF 
COPD 
Diabetes 
Centralization 
CHF 
COPD 
Diabetes 
Outdegree % 
Indegree % 
Outdegree % 
Indegree % 
Outdegree % 
Indegree % 
Professional discipline of individuals 
with highest outdegree centrality * 
CHF 
COPD 
Diabetes 
1 
(n=15) 
0.03 
0 20 
0.22 
1.00 
0.70 
0.70 
12 
28 
71 
33 
83 
68 
Ν 
Ν 
GP 
2 
(n=6) 
0.37 
0.40 
0.60 
0.92 
0.92 
0.00 
76 
28 
72 
48 
48 
48 
GP 
GP 
GP 
3 
(n=7) 
0.12 
0.14 
0.17 
0.83 
0.70 
0.70 
25 
25 
22 
22 
39 
39 
GP 
GP;N 
Ν 
4 
(n=4) 
0.58 
0.58 
0.67 
0.00 
0.00 
0.00 
56 
56 
56 
56 
44 
44 
GP 
GP 
GP;N 
5 
(n=5) 
0.10 
0.20 
0.15 
1 00 
1.00 
1.00 
19 
19 
28 
6 
13 
13 
GP,N 
Ν 
G P ; N 
6 
(n=20) 
0.03 
0.08 
0 12 
0.68 
0.56 
0.55 
24 
13 
63 
30 
54 
27 
GP 
GP 
GP 
7 
(n-4) 
0.50 
0.67 
0.58 
0 00 
0.00 
0.50 
67 
67 
44 
44 
56 
56 
GP 
G P ; N 
Ν 
8 
(n=6) 
0 30 
0.40 
0.40 
1.00 
0.92 
0.92 
84 
12 
72 
24 
72 
12 
GP 
GP 
GP 
GP=general practitioner, N=nurse, A=assistant 
Figure 1. Receiving information networks in practice 1 for chronic heart failure. 
:
 Practice assistant A = Practice nurse = GP 
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Figure 2. Receiving information networks in practice 1 for diabetes. 
Β = Practice assistant A = Practice nurse Φ = GP 
Figure 3. Receiving information networks in practice 1 for COPD. 
• = Practice assistant A = Practice nurse 9 = GP 
The overlap of information exchange connections across health conditions (CHF 
and COPD, CHF and diabetes, COPD and diabetes) is presented in Table 3. The 
overlap of (present or absent) connections was 80% or higher in all but one 
practice. This overlap was due to similarities in the absence of connections. 
Focusing on the similarities in presence of connections only, the mean number of 
connections amongst individuals with at least one connection varied substantially 
across practices and chronic diseases. 
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Table 3. Overlap between disease-specific information networks. 
Total Connected individuals 
Practice 1 
Practice 2 
Practice 3 
Practice 4 
Practice 5 
Practice 6 
Practice 7 
Practice 8 
CHF-COPD 
CHF-Diabetes 
COPD-Diabetes 
CHF-COPD-Diabetes 
CHF-COPD 
CHF-Diabetes 
COPD-Diabetes 
CHF-COPD-Diabetes 
CHF-COPD 
CHF-Diabetes 
COPD-Diabetes 
CHF-COPD-Diabetes 
CHF-COPD 
CHF-Diabetes 
COPD-Diabetes 
CHF-COPD-Diabetes 
CHF-COPD 
CHF-Diabetes 
COPD-Diabetes 
CHF-COPD-Diabetes 
CHF-COPD 
CHF-Diabetes 
COPD-Diabetes 
CHF-COPD 
CHF-Diabetes 
COPD-Diabetes 
CHF-COPD-Diabetes 
CHF-COPD 
CHF-Diabetes 
COPD-Diabetes 
CHF-COPD-Diabetes 
0.833 
0.805 
0 790 
0.967 
0.767 
0.800 
0 929 
0.905 
0.976 
1.000 
0.917 
0.917 
0.900 
0.950 
0 950 
0.918 
0 889 
0.887 
0.833 
0.417 
0.583 
0 90 
0.90 
1.00 
1.146 
1.128 
1.333 
1.529 
1 917 
1.611 
1.667 
2.071 
1 571 
1.500 
1.857 
2.250 
1 000 
1.875 
1.875 
2.750 
1.500 
1.667 
1 750 
2 250 
1.188 
1 200 
1.192 
1.370 
1.750 
1 300 
1.500 
2 100 
1 818 
1.818 
2.000 
2.818 
The number of connections to healthcare providers outside the practice varied 
from two to 15 per chronic condition (Table 4). The most central individual in the 
network (as defined by internal information exchange network in the practice) often 
had less than one-half of the connections to individuals outside the practice, 
indicating that the majority of the information receiving connections to external 
professionals were distributed among individuals less central in the internal 
information exchange networks. 
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Table 4. Connections outside the practice. 
Practice 
Receiving information from outside the practice 
Reported CHF connections 
Reported COPD connections 
Reported Diabetes connections 
Percentage of outside connections of all 
connections for the disease 
CHF 
COPD 
Diabetes 
Number of outside connections hold by the 
most central individual out of all outside 
connections 
CHF 
COPD 
Diabetes 
1 2 3 4 
(n=15) (n=6) (n=7) (n=4) 
! 
3 
11 
14 
33 
21 
23 
0/3 
4/11 
2/14 
7 
5 
6 
39 
29 
25 
1/7 
1/5 
1/6 
3 
3 
5 
25 
16 
19 
1/3 
1/3 
0/5 
4 
5 
4 
44 
50 
44 
0/4 
4/5 
2/4 
5 
(n=5) 
2 
4 
6 
50 
57 
75 
2/2 
2/4 
2/6 
6 7 8 
(n=20) (n=4) (n=6) 
2 2 
5 2 
15 2 
18 25 
17 20 
32 22 
0/2 2/2 
1/5 2/2 
3/15 0/2 
5 
5 
6 
46 
36 
40 
3/5 
2/5 
2/6 
Discussion 
This study showed that connections for exchange of information around specific 
chronic diseases could be measured with a simple structured questionnaire. About 
one-half the practices in a quality improvement project were willing to participate in 
this study of information exchange networks. The reliability of the data, in terms of 
receiving information confirmed by providing information, was reasonably high 
overall, but could be low in specific networks. Substantial variation across 
practices and chronic conditions was found regarding various network parameters. 
These results support undertaking further research to refine the measure and to 
examine associations between network characteristics and uptake of innovations 
in primary care practices. 
Our study was done in a convenience sample of practices, focusing on providing 
'proof of principle'. The results should not be translated to other settings, because 
the sample of practices was not representative of any larger group. We had a 
broad focus on information exchange that encompassed both information on 
individual patients and information on practice development. A more specific focus 
might change the study results. For example, another study in one large primary 
care practice used just one question, focused on women's health issues.12 Our 
focus was on receiving information relationships, because we considered this most 
relevant for the uptake of innovations, but an alternative approach would be to 
focus on relationships with confirmed ties (both receiving and providing 
information). Further validation of the measure used could focus on confirmation of 
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the reported connections by other measures, such as analysis of patient records 
or direct observation in the practice. Another area for development is more 
detailed identification and analysis of links to health professionals outside the 
practice, which was only of secondary interest in this study. 
Previous network studies in healthcare have not fully reported on participation and 
response rates.11,12 In our study, about one-half of the practices we approached 
participated in the networks study. This may suggest problems with the feasibility 
of network studies in healthcare settings. It should be noted that the practices 
were already participating in a quality improvement project, which may have 
affected recruitment to this study. Recruitment for network studies is an area for 
further research. The handling of missing values is a particularly difficult aspect of 
network analysis.15 Simulation studies have suggested that response rates of 70% 
to 80% are required to derive reliable estimates of many network parameters.15 
Our study achieved reasonably high response rates, except in one large practice. 
This practice reported problems with the interpretation of the form. Most practices 
in this study did not have many staff, and it is possible that larger practices will not 
provide such high response rates, particularly as the network data collection form 
increases in length with the size of the practice. 
Patterns in the practice scores on the network characteristics support the face 
validity of the method. For example, the dense information networks for diabetes 
and COPD may reflect the fact that in the Netherlands many practice nurses and 
supportive staff have a recognized role in providing patient care for these 
conditions, as opposed to CHF. It may also reflect the stronger focus on diabetes 
and COPD, compared to CHF, in nationwide programs for quality improvement in 
the Netherlands. The lower density of the CHF network in the practices may 
provide a challenge for the uptake of new clinical recommendations and models 
for structured chronic care. Such innovations may not be reinforced by the social 
influence mechanisms that are associated with dense networks, and therefore less 
likely to be implemented quickly. However, it is important to mention that social 
networks may function in counterintuitive ways that may reduce the relevance of 
perceived face validity. Furthermore, network characteristics that were not studied, 
such as 'trust' and 'tie strength', have been found to enhance the uptake of 
innovations in non-healthcare settings.7 Empirical and analytical research is 
needed to identify the social network processes that facilitate knowledge transfer 
and uptake of innovations. 
Information from people outside the practice can come through various individuals 
into the practice. These connections, through which innovations may be 
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introduced into a practice, were clustered to some extent in the most central 
individuals in the internal information exchange networks. This might enhance the 
uptake of innovations, because a centralized position in a network has been found 
to be associated with knowledge transfer.7 But even so, the majority of external 
connections were shared among less central individuals. Thus, while we found 
that the core individuals within the practice networks also tended to be the most 
prolific boundary spanners, information was also received through other channels. 
This may be important, because the adoption of an innovation is associated with 
the availability of multiple sources of information.9 Further research is required to 
explore the role of various individuals in the information exchange in a practice 
with individuals outside the practice. 
As many patients with chronic illness have several chronic conditions (multi-
morbidity), it was relevant to observe that the information exchange networks 
within practices for the three chronic conditions showed overlap. Overlap suggests 
that patients with multi-morbidity receive care for each of their chronic conditions 
from very much the same set of individuals. We can conjecture that this will be 
associated with better integration of care, higher efficiency of service delivery, and 
more patient-centered care. Conversely, low overlap suggests that care for each 
condition is provided by quite different practice teams, with medical notes 
providing the main, or only, means of communication and coordination between 
teams. 
The central individual in the information exchange networks could be a nurse or a 
physician, and in some practices this differed across the chronic conditions. This 
might reflect differences in the functioning of practices, which may be related to 
practice policies on how care is organized for particular conditions or to the 
presence of staff with particular skills or interests. We used formal network 
analysis to identify the central members of the network, but simple inspection of 
the network maps themselves can identify other particular types of individuals, 
such as those who are isolated from the network (i.e., lack links to others), and 
'brokers' who control the flow of information from one part of the network to 
another.5 
What does this study contribute to implementation science? While social network 
studies can be used to examine a wide variety of consequences and determinants 
of network configurations, our study concerned the potential impact of networks on 
uptake of (new) knowledge in clinical practice. We applied concepts and methods 
from 'diffusion of innovations' research and 'evidence-based medicine' research, 
two research traditions that have historically developed independently from each 
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other.16 Our study fits with calls to use theory-based approaches in research on 
the uptake of research findings.17 It remains to be seen if social networks can be 
changed in ways that encourage the implementation of new knowledge is indeed 
enhanced. However, currently available implementation interventions targeted at 
individual health professionals (focused on their motivation and competence) have 
mixed, and on average moderate impact.18 Therefore, there is a need for 
complementary methods that increase the impact of implementation interventions. 
Using network analysis to promote the uptake of research knowledge is not an 
entirely new approach in evidence-based medicine. Previous studies used 
sociometrie methods to identify local opinion leaders and involve them in the 
promoting of the uptake of interventions. For example, a study in Scotland showed 
that the feasibility of this approach was variable across different professional 
groups and settings.19 In combination with professional education, the approach 
had mixed effects on professional performance.20 Involving opinion leaders is just 
one intervention based on network analysis. Other network-based implementation 
interventions could be related to patient care teams, such as changes in the range 
of professional competencies included and their coordination structures.21 Yet 
another set of interventions could be linked to health professionals' communities of 
practice, although the exact meaning and implications of these remain topic of 
debate.22 Social networks analysis can provide the concepts and methods to 
operationalize such approaches, but more research is needed on the validity and 
feasibility of the method for this purpose. 
Summary 
Further research is required to refine the measure of information networks and to 
look for possible effects of specific network characteristics and knowledge 
utilization in primary care practices. Insight into information networks in healthcare 
organizations adds to the body of literature on social networks and diffusion of 
innovations, which has focused on innovation in larger organizations.23 If future 
research on information exchange networks in healthcare is fruitful, the method 
might inform the tailoring of interventions to a specific network to facilitate more 
effective and efficient knowledge utilization. Also, network data may be used 
directly to provide feedback to practices and stimulate reflection on working 
patterns in a practice in order to encourage organizational development. 
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Additional File 1: Questionnaire on information exchange 
Name 
Profession 
Practice ID 
Please tick those who gave you information and whom you gave information on 
chronic heart failure, COPD and depression in the previous 12 months. This 
information may concern individual patients, practice management, or treatment in 
general. 
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Staff in your practice 
GP1 
GP2 
GP3 
GP4 
Practice assistant 1 
Practice assistant 2 
Practice assistant 3 
Nurse 1 
Nurse 2 
Nurse 3 
Names 
People outside your practice 
Other GPs 
Other practice assistants 
Other nurses 
Dietician 
Physiotherapist 
Psychologist 
Medical specialist: Cardiologist 
Medical specialist: Pulmonologist 
Medical specialist: Internist 
Others, specify 
Chronic heart 
failure 
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Abstract 
Objective: 
Primary care plays a central role in the prevention and management of 
cardiovascular disease. We expected that countries with strong primary care 
systems would have programs to improve management of disease, but wondered 
how they dealt with lifestyle interventions delivered in primary care. 
Study Design: 
Observational comparative study. 
Methods: 
Using country coordinators and key informants, we collected information on 42 
programs to improve cardiovascular risk management in 11 countries (Austria, 
Belgium, Finland, France, Germany, Israel, the Netherlands, Spain, Slovenia, 
Switzerland, the United Kingdom). 
Results: 
Most (95%) of the improvement programs were targeted at health professionals; 
86% of these provided education. Evaluation was part of all programs. In countries 
with a strong primary care system, 63% of the programs focused exclusively on 
disease management, 29% on lifestyle interventions, and 8% on both. In countries 
with a weak primary care system, 22% of the programs focused on disease 
management and 78% on lifestyle improvement. 
Conclusions: 
Our findings suggest that a strong primary care system is likely to make efforts to 
improve disease management, but not necessarily efforts to improve delivery of 
lifestyle interventions. This may be a missed opportunity, given the potential of 
primary care to influence lifestyle. 
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Introduction 
A growing body of evidence on prevention and treatment of cardiovascular 
disease (CVD) has resulted in large numbers of recommendations for 
cardiovascular risk management (e.g., guidelines developed by the American 
Heart Association and the European Society of Cardiology). Despite these 
recommendations, CVD remains an important cause of mortality and morbidity in 
industrialized countries.1 The risk factors for CVD are the same all over the world.2 
The age-standardized CVD mortality rate per 100,000 population in the United 
States is 188.3 In Europe the mortality rate is 354 per 100,000 population, with 
marked differences between countries. In Eastern European countries rates are 
higher (e.g., 688 in the Russian Federation), whereas rates in Western European 
countries are comparable to those in the United States (e.g., United Kingdom, 182; 
Germany, 211; and France with a very low mortality rate of 118). 
Mortality rates remain high partly because of unfavorable lifestyles and partly 
because not all patients receive effective and recommended treatment.4"11 
All developed countries have large-scale programs to improve prevention and 
management of CVD, but the content and focus of these programs vary 
substantially. For instance, some programs focus on improving the management of 
chronic care for patients with established CVD, including lifestyle change and 
pharmaceutical treatment. These programs generally are called disease 
management programs. Other programs focus on lifestyle improvement for 
patients or the public in general, irrespective of the presence of CVD or risk factors 
as hypertension. Primary care plays a crucial role in both the prevention and 
management of CVD. Primary care presents opportunities for disease prevention 
and health promotion as well as early detection of problems; it is a bridge between 
personal healthcare and patients' families and communities.12 However, different 
countries' healthcare systems vary with respect to the strength and integration of 
their primary care systems.13 In some systems (e.g., the United Kingdom, the 
Netherlands), a general practitioner (GP) is the first point of contact for health 
problems for patients who register with a practice, and this physician coordinates 
access to other care providers through gate keeping. Conversely, in other systems 
(e.g., Germany, the United States) the GP is not a gatekeeper and patients are not 
listed in a practice (see Box 1 ). 
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Box 1 . Orientation on primary care (strong versus relatively weak). 
Countries with a strong primary care orientation (e.g. the Netherlands, Spain, the UK) 
• Patients register with a specific practice or practitioner as the first point of contact 
• GP acts as a gatekeeper to other services and coordinates care 
• Patients can be recalled for chronic care management 
• GPs keep good patient records 
• GPs monitor cardiovascular risk factors 
• Centrally led insurance system 
• Pay at least in part per capita 
Countries with a relatively weak primary care orientation (e.g. France, Germany, Switzerland) 
• No patient registration 
• No GP gatekeeper or coordinating role for other services 
• No physician/practice initiated access to services 
• No systematic recording of cardiovascular risk factors 
• Pay for service 
Previous studies on quality improvement of CVD management did not consider the 
organization and strength of primary care.14"19 However, evidence on chronic care 
management suggests that healthcare systems with a strong primary care 
orientation provide more comprehensive chronic care services than systems with a 
weaker primary care orientation.20 Moreover, high-income countries with stronger 
primary care systems generally achieve better health outcomes.21 Although the 
'primary care-ness' model of Starfield et al. looks at associations between primary 
care-ness and outcomes, it does not take into account wider health outcome 
determinants (e.g., quality of services), nor does it attribute better outcomes to 
specific elements of the system rather than the system as a whole.13 
Though primary care focuses on patients (in contrast to disease-focused 
secondary care), health system features in countries with a strong primary care 
orientation especially favor efforts to improve disease management. So we 
hypothesized that in these countries, efforts to improve cardiovascular care would 
predominantly focus on disease management, aligned to activities already being 
done. In addition, we wondered what efforts were being made to improve lifestyle 
interventions for patients without CVD in countries with either a strong or a weak 
primary care orientation. 
This article describes and compares large-scale programs to improve 
cardiovascular risk management in primary care in 11 countries across Europe 
and Israel. The characteristics of healthcare systems with a strong or weak 
primary care orientation are shown in Box 1. Such differences across Europe and 
the United States provide an opportunity to learn from the experiences of different 
countries. 
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Our intention was to identify commonly shared features of successful programs for 
improving cardiovascular risk management and prevention, and to assess 
differences in these programs' content and focus. In addition, we considered 
whether the focus of these programs was related to the strength of primary care. 
Methods 
Design and sample 
The EPA-Cardiovascular project was conducted as part of the TOPAS-EUROPE 
Association, founded in January 2005, in collaboration with and funded by the 
Bertelsmann Foundation.22,23 The aim of this international project is to help 
improve cardiovascular risk management and prevention in primary care, for 
instance, by identifying successful programs to improve CVD prevention and 
management in the participating countries. These countries were Austria, Belgium, 
Finland, France, Germany, Israel, the Netherlands, Slovenia, Spain (especially 
Catalonia), Switzerland, and the United Kingdom. 
This is a descriptive observational study of existing programs. We asked project 
partners from each participating country to identify and describe all large-scale 
cardiovascular risk management improvement programs in their country with the 
help of national key persons from different disciplines (health policy, research, and 
primary care) who had expertise on improvement programs. Each country's 
representative also was asked to provide information on additional regional or 
local projects. A maximum of 5 programs per country were included. As the goal 
was to learn from best practice, all programs had to have a positive evaluation, at 
least by preliminary results. 
Measures 
The project partners used a standardized form to provide information on program 
features (Box 2). A preliminary report with program information was discussed with 
all country coordinators and adapted where needed. They checked and approved 
the final results regarding completeness and accuracy. 
We dichotomized the countries into those with a strong or weak primary care 
system. We used the classification published by Macinko et al. for the countries 
analyzed in this article.13 For the other countries we used information on the 
organization of care in general practice that was relevant for delivery of preventive 
services. The countries were scored on 4 items (patients on practice list, 
physician-led patient recall allowed, systematic monitoring of risk factors, primary 
148 Chapter 10 
care involved in preventive activities) and judged strong scoring to be 3-4 and 
weak scoring to be 0-2. Country coordinators provided the necessary information. 
Box 2. Features of programs to improve cardiovascular risk management. 
• Target population' community and patients, aimed at professionals, or both 
• Goals: education and motivation, organizational changes (e.g. introduction of supportive staff, 
specialized staff), or both 
• Inclusion of financial incentives (e.g. Is there reimbursement for participating practices?) 
• Inclusion of regulations (Do regulations make part of the program'') 
• Professional involvement (medical organization or group of participants as stakeholder, rather than 
just individual involvement) 
• Primary focus on lifestyle improvement in patients/public, disease management (including 
pharmaceutical risk factor management and lifestyle advice for patients with established 
cardiovascular disease and diabetes), or both 
• Guidance: top down, bottom up, or mixed (Is there clear hierarchical top-down guidance, or is there 
autonomy at the practice level? Is the program tailored to local preferences?) 
• Focus: exclusively on cardiovascular diseases or on cardiovascular disease as a part of a wider set of 
topics 
• Scope nationwide or smaller scale 
• Evaluation: Are monitoring and evaluation part of the program or not? 
Dafa analysis 
Two researchers (JvL, MW) independently assessed the program features shown 
in Box 2. When there was disagreement, consensus was reached by discussion 
after repeated inspection of the program descriptions. Researchers were not 
blinded to the program name or country because of knowledge of many of the 
programs. 
Programs incorporating both disease management and lifestyle improvement were 
classified as either lifestyle improvement or disease management when a clear 
major focus was apparent. When both aspects were of great importance, this 
feature was scored as 'both lifestyle interventions and disease management'. 
Data analysis was descriptive, as the low numbers did not allow for statistical 
analysis. Features shared by more than 80% of the programs were considered to 
be commonly shared. The comparative analysis focused on the strength of primary 
care (weak vs strong). We used SPSS 14 (SPSS Ine, Chicago, IL) for cross-
tabulation to identify potential associations between program features and strength 
of primary care, considering that a 20% difference indicated potential relevance. 
Results 
A total of 47 programs from 11 countries were identified. We included 42 
programs; they are listed in the Appendix Table. Excluded programs were small 
scale or missed an intervention. Countries with a strong primary care focus were 
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Finland, Israel, the Netherlands, Slovenia, Spain, and the United Kingdom. 
Countries with a weak primary care focus were Austria, Belgium, France, 
Germany, and Switzerland. 
Table 1 provides descriptive program information. Features shared by the 
programs included interventions targeted at professionals (95%), interventions 
aimed at education and motivation (86%), and inclusion of an evaluation (100%). 
A small majority of projects (62%) were targeted at the public and patients as well 
as at healthcare professionals. 
Table 1. Features of the Improvement Programs (n=42). 
Features 
Target population 
Community 
Professionals 
Both the community and professionals 
Goal 
Eeducation/motivation 
Organizational changes 
Both education/motivation and organizational 
changes 
Inclusion of financial incentives 
Inclusion of regulations 
Professional involvement 
Yes 
No 
Nationwide 
Yes 
No 
Exclusive focus on CVD 
Yes 
No 
Focus 
Lifestyle interventions 
Disease management 
Both lifestyle interventions and disease 
management 
Evaluation performed or planned 
Yes 
No 
Guidance 
Top-down 
Mixed 
Bottom up 
Total 
Number 
(%) 
2(5) 
14 (33) 
26 (62) 
26 (62) 
6(14) 
10(24) 
8(19) 
4(10) 
30(71) 
12(29) 
18(43) 
24 (57) 
25 (60) 
17(40) 
21(50) 
19(45) 
2(5) 
42 (100) 
0(0) 
30(71) 
8(19) 
4(10) 
Number (%) 
Weak primary care 
system (n=18) 
1(6) 
4(22) 
13(72) 
12 (67) 
1(6) 
5(28) 
3(17) 
1(6) 
12(67) 
6(33) 
5(28) 
13(72) 
8(44) 
10 (56) 
14 (78) 
4(22) 
0(0) 
18(100) 
0(0) 
13(72) 
2(11) 
3(17) 
Strong primary 
care system (n=24) 
1(4) 
10(42) 
13(54) 
14 (58) 
5(21) 
5(21) 
5(21) 
3(13) 
18(75) 
6(25) 
13(54) 
11(46) 
17(71) 
7(29) 
7(29) 
15(63) 
2(8) 
24(100) 
0(0) 
17(71) 
6(25) 
1(4) 
CVD indicates cardiovascular disease 
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Strength of primary care 
Differences between programs in countries with a strong versus a weak position of 
primary care are shown in the Table also. Most programs (63%) in countries with a 
strong primary care system were exclusively focused on improving the 
management of CVD or risk. Additionally, another 2 programs had a disease 
management character that also had a clear goal of preventing the target disease 
(diabetes, coronary heart disease); this goal was being pursued through 
implementation of lifestyle improvement for the general public. 
In contrast, in countries with a weak primary care system most programs (78%) 
were focused on lifestyle interventions. Of the 4 disease management programs in 
countries with weak primary care orientations, 3 were diabetes programs. 
In countries with a strong primary care system, the 7 improvement programs with 
an exclusive focus on lifestyle were all more or less initiated by public health 
organizations outside primary care practices. In countries with a weak primary care 
system, however, 8 of the 14 programs on lifestyle improvement were oriented to 
general practice, whereas only 6 programs were initiated by public health 
organizations. 
An example of a program that focuses on lifestyle improvement in a country with a 
weak primary care system is the Checkup 35—Health Examination 
(Gesundheitsuntersuchung) in Germany (Box 3). 
Box 3. Example of a program with emphasis on lifestyle interventions. 
Check up 35-Health Examination (Gesundheitsuntersuchung), Germany 
In this program (begun in 1989), people age 35 years and older in statutory sickness funds are offered a 
cardiovascular disease (CVD), diabetes and kidney diseases risk check every 2 years GPs perform this 
check-up examination, which includes medical history, physical examination, blood pressure test, 
laboratory tests (cholesterol, glucose and urine-tests) and counseling. 
One of the aims of the program with respect to CVD is to improve the cardiovascular risk and lifestyle of 
patients. Patients receive education by counseling methods 
There are no evaluation data for the screening program in general. Smaller studies showed that health-
conscious people at low risk are especially likely to attend to get the screening examination, whereas 
people at high risk do not receive appropriate therapy (e g , statins) 
Box 4 presents the primary care disease management aspects of the National 
Service Framework on Coronary Heart Disease as an example of a program run in 
the United Kingdom, which has a strong position on primary care. Lifestyle 
improvement also is a focus in this program, including primary preventive activities 
for the public. Disease management aspects in primary and secondary care were 
important in the first years of the program and have been evaluated positively. 
Primary care strength linked to prevention programs for cardiovascular disease 151 
Box 4. Disease management characteristics of the UK National Service Framework on Coronary 
Heart Disease. 
National Service Framework on Coronary Heart Disease, UK 
The Department of Health leads the National Service Framework on Coronary Heart Disease (NSF CHD), 
a nationwide, ongoing program. It started in 2000 The focus of this program is entirely on CHD, but there 
also are frameworks for other diseases (e.g. chronic obstructive pulmonary disease, mental health, etc.). 
The overall aim of NSF CHD is to lessen the burden of CHD. For primary care, there are 2 steps: 
1. The first and most important step is identifying, advising and treating people who have clinical evidence 
of CHD (e.g. history of heart attack, angina, or coronary revascularization), or who have other clinical 
manifestations of occlusive arterial disease (e.g., peripheral vascular disease, transient ischemic attack, 
or ischemic stroke). 
2. The second step is identifying, advising, and treating people without clinical evidence of CHD or other 
occlusive arterial disease but whose risk of a cardiac event is greater than 30% over 10 years 
In the NSF both primary care and secondary care are involved; lifestyle improvement in patients and in the 
public is part of the program. Healthcare professionals and their organizations have to meet minimum 
standards for the delivery of health services in England. The Healthcare Commission, a national health 
regulator, is responsible for evaluating the implementation of NSF guidance. 
Compared with programs in countries that have a weak primary care system, 
programs in countries that have a strong primary care system were more 
frequently focused on CVD exclusively (71% vs 44%) and were more likely to be 
nationwide (54% vs 28%). In countries with a weak primary care system, programs 
were targeted at the community more often (78% vs 58%). There were no 
differences between programs in financial incentives, regulations, professional 
involvement, guidance, and aim at organizational changes. 
Discussion 
In countries with stronger primary care-orientated systems, successful 
improvement programs were focused more frequently on patients with established 
CVD, while in the other countries most programs focused on improving the 
delivery of lifestyle interventions to the general population. Stronger primary care 
was associated with initiatives designed to improve disease management, but less 
with the improvement of lifestyle interventions irrespective of CVD or risk factors. 
Cardiovascular prevention ideally consists of both lifestyle improvement and 
disease management. Considering the importance of primary care in CVD 
prevention, countries with a strong primary care system should make extra effort to 
implement lifestyle improvement programs. In healthcare systems with a weak 
primary care orientation (Germany, France, and the United States for most 
patients), primary care should be strengthened to provide greater opportunities for 
disease management improvement programs. Of course, the relationship between 
the organization of the healthcare system and cardiovascular mortality is complex. 
152 Chapter 10 
Strength of primary care is just one factor, which is shown by the low 
cardiovascular mortality rate in France, which has a weak primary care system. 
The included programs all are targeted at professionals, emphasize an 
educational/motivational approach, and have a formal process of evaluation 
integrated in the program. We included only successful programs and therefore 
cannot determine whether these features also can be components of unsuccessful 
programs. Successful programs do generally have these features. Only a few 
programs included financial incentives or regulations, without distinction between 
the countries with strong or weak primary care systems. Therefore, we cannot 
conclude from our findings that financial incentives are important facilitators in 
improvement programs. 
Strengths and limitations 
To dichotomize countries according to their primary care focus, we used published 
classification results from Macinko et al.13 For countries not in that analysis 
(Austria, Israel, and Slovenia), we used information from our country coordinators. 
These criteria applied to the countries in the article by Macinko et al. gave the 
same classification, indicating appropriateness. 
The international sample of programs to improve cardiovascular risk management 
brought together in this study is unique. We used systematic methods to 
guarantee data integrity (e.g., inclusion of several informants per country with 
repeated checking of their information). Analysis was not blinded because of 
familiarity with many of the programs, but 2 authors assessed features 
independently. Nevertheless, the study may suffer from inclusion bias and 
incompleteness. We purposefully sampled successful programs, although actual 
outcome data were not always available or mixed. Lifestyle improvement programs 
may especially suffer from this bias, as it may be harder to find positive 
evaluations. But disease management programs with positive evaluations did not 
prevent lifestyle programs from being included, as most countries did not supply 
information on the maximum of 5 programs. 
Another type of selection bias in our sample was that all included countries have 
relatively low cardiovascular mortality, below the European average. In 
consequence, the findings may not generalize to areas or patient groups with a 
higher mortality rate. However, the countries included and the United States have 
mortality rates in the same range. 
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There is no bias associated with country size: both the strong and weak primary 
care groups contain large and small countries. Furthermore, both groups contain 
about even numbers of countries and programs. 
Interpretation 
What can be learned by national health policy makers? Previous research showed 
that strong primary care is associated with better chronic care management.20 Our 
findings regarding CVD management are consistent with this trend. There are 
several potential explanations for the lower frequency of programs to improve 
lifestyle interventions in countries with strong primary care systems. Primary care 
physicians may feel that lifestyle improvement in healthy individuals is not their 
responsibility or priority, that it is not effective or cost-effective, or that it is 
unfeasible as large population groups need to be addressed.24 Disease 
management may be perceived as more relevant, evidence based, and aligned to 
priorities. These priorities may relate to the workload within primary care 
associated with registered patients and to the society burden of established 
disease. Disease management also may relate to the definition and values of 
primary care and to how well primary care is integrated within the wider healthcare 
system. For example, countries with a strong primary care orientation may 
simultaneously have a strong public health system. 
We found that all lifestyle improvement programs in countries with a strong primary 
care system were launched by public health organizations outside primary care. 
This fits both with the explanation that primary care is taking care of disease 
management instead of lifestyle improvement and with the explanation that public 
health is strongly organized. The implication, paradoxically, is that the full potential 
of primary care for delivering preventive services is not used in strong primary care 
systems. This is a missed chance, especially considering trends toward larger 
practices and more supportive staff in several countries, because these 
developments increase the ability of primary care to deliver the full spectrum of 
cardiovascular preventive services and by doing so, to deliver coherent, 
continuous care. Supported adequately, primary care could deliver lifestyle advice 
to healthy patients; the advantage over public health interventions would be that 
these interventions would be tailor-made to individuals, because of familiarity with 
listed patients. 
In countries with a weaker primary care system, implementation of disease 
management programs requires extra efforts to enhance the delivery of preventive 
services. Interesting disease management initiatives are being undertaken in 
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Germany and France, with regulations that reinforce the role of the family 
practitioner in delivering preventive services. In several US programs for improving 
disease management in primary care, baseline data collection showed marked 
room for improvement.25"27 There is little information on large programs in primary 
care that have been evaluated as successful, although small programs show clear 
results.28 The American Heart Association and the American Stroke Association 
have a 'Get With the Guidelines' program on implementation, but this is based on 
hospital care. 
What can be learned by program developers? We analyzed the content and focus 
of improvement programs in 10 European countries and Israel. Because the 
sample included countries from all over Europe, except Eastern Europe, trends 
were robust for variations across health systems and cultures. However, the 
effectiveness of a specific improvement program may not be generalizable to other 
countries. Implementing a successful program in another country needs a 
systematic approach, taking the national context into consideration.30 Assessing 
generalizability to another country needs groups of experts focusing on the 
professionals, the target population, and the healthcare system. When an 
intervention is considered effective, the next step is to examine whether the 
intervention can be implemented, again considering professionals, population, and 
system. This is acknowledged in both European and US guidelines. In the 
European guidelines on CVD prevention in clinical practice, only general remarks 
are made on implementation; national colleges are expected to organize 
implementation in accordance with local needs.31 The American Heart Association 
and the American Association of Cardiovascular and Pulmonary Rehabilitation 
defined core elements of implementation programs.32 It is considered essential to 
the success of any program that each intervention is performed in concert with the 
patient's primary care provider and/or cardiologist, who will supervise and refine 
interventions. Interventions are adapted and tailored at the patient level, not at the 
level of the implementation program. The American Heart Association Guide for 
Improving Cardiovascular Health at the Community Level presents 
recommendations to achieve their goals.33 The guide provides assistance with 
cardiovascular prevention on a community level without making recommendations 
regarding implementation. The American Heart Association Guidelines for Primary 
Prevention of Cardiovascular Disease and Stroke also make general remarks 
about implementation for individual patients.34 These guidelines state that 
implementation needs acceptance and a physician-patient partnership. They 
provide tools for risk assessment and communication, and for general information. 
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Optimal prevention and treatment programs require knowledge about both CVD 
and successful implementation.35 To reduce the burden of CVD, both lifestyle 
improvement in the general public and disease management improvement for 
patients with established CVD are mandated. A balanced approach is needed to 
create comprehensive programs across the risk spectrum.36 
Conclusions 
We found that in countries with weaker primary care systems successful 
cardiovascular preventive programs are more often lifestyle oriented rather than 
focused on patients with established disease. As such, the infrastructure and 
culture for successful disease management programs may be missing. The key 
message may be that before the start of a disease management program, the 
position of primary care should be strengthened. Several countries with weak 
primary care systems have been making interesting strides in this direction. 
A strong primary healthcare system seems beneficial for improving chronic care 
management of patients with established CVD but, paradoxically, not for 
deliverance of lifestyle interventions to the wider population. Such a system 
(Box 1) offers opportunities for the delivery of lifestyle counseling to relevant target 
groups. Nevertheless, lifestyle improvement programs are underrepresented, even 
though research evidence suggests they have a high impact on mortality and 
morbidity in the population.3739 Developments in primary care organization 
(increasing practice size, involvement of supportive staff) increase the feasibility of 
delivering large-scale lifestyle interventions. Policy makers should consider how to 
create the necessary conditions for these interventions to happen. 
Our survey sample was restricted to improvement programs for CVD. Further 
research might address the relation between the strength of primary care and 
implementation programs concerning other conditions such as chronic obstructive 
pulmonary disease, osteoarthritis, and malignancies. 
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Appendix Table. Disease management and prevention programs in various countries. 
Country 
Austria 
Belgium 
Finland 
France 
Programs (with some special features) 
Disease Management Program on Diabetes Mellitus type 2 
After pilot-phase nationwide program, to be followed by DMPs on other diseases An 
evaluation program with benchmarking by a web application involves healthcare organizations 
A Heart for Vienna 
With a focus exclusively on CVDs, public events for information form an important part of this 
ongoing program 
Vorarlberg Program 
CVD was one of several items in the program An important aim concerning CVDs was to 
improve cardiovascular risk and lifestyle by education 
National Preventive Health Check-up 
An ongoing program in which CVD is just one of several items Education of patients is 
achieved by using an invitation system to promote participation 
Herz.Leben project (Heart.Life project) 
The program gives education to patients and a Tram the Trainer program for health 
professionals with an exclusive focus on CVD 
Cardiovascular Risk Screening in General Practice 
In this ongoing program, all activities and interventions are targeted at education of healthcare 
professionals GPs are taught the use of 2 tools an algorithm as a decision aid for global risk 
management and a patient-communication guide 
PreCardio 
Patients are invited for a risk assessment and tailored advice is available on a website An 
electronic nsk calculator was developed and is linked to the GP's electronic medical file, 
generating goals depending on the risk profile 
Diabetes Project Leuven 
The objects of this program are (1 ) implementation of an evidence-based treatment protocol for 
diabetes type 2 patients in general practice through a multifaceted Quality Improvement 
Program and (2) scientific evaluation of the results Interventions on 5 of the 6 axes of the 
Chronic Care Model can be distinguished The program is meant to give a framework for 
diabetes care throughout the country 
North Karelia Project 
The aims of the program were to improve cardiovascular risk and lifestyle Activities and 
interventions consisted of education of both the public and health professionals Furthermore, 
activities were undertaken to facilitate cooperating with health organizations and with other 
institutions as schools and the food industry 
Diabetes Program 2000-10 (DEHKO) 
Activities and interventions in this nationwide program are targeted at several persons and 
organizations Activities consist of education of the public and support of self-care, group 
counseling, and support of local groups Activities targeted at health professionals consist of 
special information and education Local authorities are influenced for social support 
Helsinki Prevention Project (HPP) 
In this program, CVD was one of several items The aims were to improve quality of care, to 
implement guidelines, to share the tasks among doctors and nurses appropriately, avoiding 
double work, and to analyze the effect of facilitation One aim of the project is cost containment 
and efficiency improvement The mam activity in the program was education Education was 
targeted at patients, health visitor nurses, and GPs 
Private Team Health Action (ASALEE) 
This project is about sharing tasks between GPs and nurses Practices employ nurses, this is a 
new phenomenon in France CVD is one of several items in the program 
Escape 
The focus of the program is exclusively on CVD, aiming at improvement of cardiovascular risk, 
lifestyle, quality of care, and clinical performance GPs receive detailed guidelines and a 1-day 
educational session about targets, therapeutic strategies, and how to manage specific 
preventive clinics Patients receive education Five cardiovascular preventive clinics for 6 
patients per GP during 2 years are budgeted 
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Country 
Germany 
Israel 
Programs (with some special features) 
ANCRED 
The focus of this ongoing program is on diabetes only for most networks Some networks also 
focus on cardiovascular prevention Project activities are education of patients about healthy 
diet, physical activity, and foot care, and education of health professionals about diabetes and 
lifestyle changes Five cardiovascular preventive clinics for 6 patients per GP during 2 years 
are budgeted 
Rendez-Vous Prévention 
In this program, led by a National Health Insurance health project leader, CVD is one of several 
items Activities are mainly targeted at education Each patient is offered the chance to 
participate in 3 workshops (3 hours each) to better understand his/her health problems, to 
identify risk factors, to know what foods are to be favored or avoided, to learn to plan adapted 
physical activity, to identify the first signs of cardiovascular complications, and to manage 
drugs 
The Dinan project 
Men from age 60-64 years and women from age 50-54 years are offered cardiovascular risk 
assessment by their GP According to their risk, further activities are proposed by the GP GPs 
and nurses receive education on CVD management and patient education Physicians will be 
paid if they meet certain targets 
Disease Management Program 
The DMPs fit in a government strategy to strengthen the role of primary care in Germany 
DMPs focus on CHD and other chronic conditions such as diabetes Regulations and financial 
incentives both for GPs and patients are part of the DMPs 
Check up 35 - Health Examination 
People age 35 years and older in statutory sickness funds are offered a CVD, diabetes, and 
kidney disease risk check every 2 years Activities targeted at patients consist of education by 
counseling methods 
Three-Level Strategy 
In this program CVD is one of several items Cardiovascular risk is improved by health 
education on 3 levels a GP consultation (lifestyle counseling and "prescription" of lifestyle-
changing measures such as educational courses), educational group work in the practice, and 
educational group work at the community level (interdisciplinary cooperation) 
Vita Longa 
Nurses implemented the program for secondary prevention of cardiovascular events among 
patients after hospitalization for a cardiovascular event A special nurse invites patients to 
participate m a rehabilitation program and checks for use of preventive medications and for 
control of hypercholesterolemia, hypertension, and diabetes When there is a need for a 
physician's intervention, the nurse contacts the GP 
Diabetes Program 
The program is exclusively targeted to diabetes and the accompanying diseases of 
hypertension, hypercholesterolemia and nephropathy Patients receive education in the 
program Health professionals in the Clalit program receive computerized reminders, audit, and 
indicators of care Furthermore, the infrastructure for better organization of care was improved 
Computerized Community Cardiovascular Control (4C) 
The use of a computerized clinical decision support system will improve the performance of 
health professionals Special software is attached to the medical record When a patient's 
information is incorporated, the physician will receive alerts concerning the quality of care and 
suggestion to improve it A computerized case finding system was developed to identify 
patients at high risk for CVD 
Heart Failure Program 
In this program patients are referred to a heart failure clinic Education of patients by 
specialized nurses and quick and easy access are important features of the program There 
are professional consultations (by phone, e-mail, or fax) for physicians who are taking care of 
heart failure patients 
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Country Programs (with some special features) 
The Tailored Made Prevention 
Netherlands All interventions were targeted at general practices A national prevention team developed 
manuals for protocols, task delegation, health education matenals, and information technology 
District prevention teams organized informative and educational meetings An important aspect 
was the contribution of prevention consultants visiting general practices and giving advice by 
telephone There were financial incentives for participating GPs 
Familial Hypercholesterolemia 
The Foundation for Tracing Hereditary Hypercholesterolemia started a program with 
involvement of the Dutch College of GPs and the regional support structures The aim is to 
have identified nationwide all patients with familial hypercholesterolemia by 2010 Several 
organizational changes were implemented Regional support structures offer support to the 
general practices, a genetic fieldworker contacts identified patients and after their approval, all 
first-degree relatives are contacted and offered a test for diagnosis of familial 
hypercholesterolemia 
Heart Beat Limburg 
The program focused exclusively on CVDs Part of Heart Beat Limburg was a High Risk 
Project Cardiologists, GPs and patients were involved in this module The most important part 
of the program was the community project, with four low socioeconomic status areas selected 
as 'special attention areas' About hundred interventions targeted at nutrition, exercise, 
smoking and lifestyle in general in the community project 
Vascular Risk Management 
The funding Netherlands Heart Foundation supported the development of the multidisciplmary 
practice guideline on cardiovascular risk management Because one of the mam activities was 
education of patients and the public, a patient version of the practice guideline for 
cardiovascular nsk management was published A standard of care teaches patients what to 
expect from their healthcare provider and what is expected from the patients themselves 
Diabetes Program 
The importance of this new approach followed by the Diabetes Support Service is the 
combination of an organization taking care of logistic aspects and patient care still being 
provided by the patient's own GP The service gives information about the importance of the 
control system and the investigations done Group education for patients and their family 
members is arranged The service calls patients for laboratory testing and other investigations 
The service has a quality control system for glucose testing devices in general practice and 
gives advice about these devices General practices can receive help from a diabetes 
consultant GPs receive feedback both on practice level and on patient level, and they can get 
treatment advice 
Slovenia Risk Factors for Noncommunicable Diseases in Adults 
In the program CVD was one of several items The aims of the program with respect to CVD 
were to improve people's lifestyle and cardiovascular risk and to increase the accessibility and 
volume of healthcare 
Activities targeted at patients and the public consisted of education Healthcare professionals 
were offered basic education about health and the prevalence and importance of risk factors 
An information system enabled centralized data collection 
Heart Foundation Prevention Program & Study 
With a focus exclusively on CVD, the aims were to improve the lifestyle of both patients and 
the public and to improve cardiovascular nsk There was a CVD prevention program all over 
the country for the general public, including several publications, resuscitation courses, 
recreational sports events, a consulting service by phone and web, several consulting offices, 
food labeling (trade mark "Protects Health"), and measuring people's risk factors at various 
[public events, shopping centers, schools, and several companies 
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Country 
Spam 
Switzerland 
The United 
Kingdom 
Programs (with some special features) 
Nationwide Program on Primary Prevention 
All GPs' offices are involved and obliged to perform this ongoing nationwide program 
Healthcare professionals are offered education about health promotion and prevention 
Patients are sent a screening questionnaire for basic risk assessment, followed by an invitation 
for a nsk assessment for those with higher scores According to the results, patients receive 
education about healthy lifestyles and can join workshops to modify risk factors An information 
system for centralized data collection was developed and a central database of people at high 
nsk for CVDs was built 
Intervention on CVD 
The health department created a new directorate for management and prevention of circulatory 
diseases including CVD in primary care with a permanent structure Interventions in this part of 
the program are targeted at the diagnosis, treatment, and control of hypertension and 
hypercholesterolemia 
Intervention on Diabetes Mellitus 
Interventions target the diagnosis, treatment, and control of diabetes by primary care, as well 
as promotion of diabetes prevention Education and diet advice are supplied for patients and 
primary care professionals Furthermore, interventions target to increase use of consensus 
agreements for patients who have gestational diabetes 
Intervention on Lifestyle 
Interventions target the promotion of healthy lifestyle in school and at work, especially for 
young people Primary care professionals are encouraged to give their patients educational 
advice about how to lead a healthy life Global strategies for health promotion (eg, use of mass 
media, neighborhood activities) are used The Health Department develops guidelines and 
actions 
Disease Management Program 
This program is a coordinated system of interventions related to health and communication 
with patients who have congestive heart failure It includes a patient identification process, 
application of evidence-based clinical practice guidelines, collaboration models between 
different care providers, education for patient self-management, process and outcomes 
evaluation, and feedback of the information generated by the program Initially applied to 
congestive heart failure, it will be extended to other conditions where patient self-care is 
crucial 
Health Risk Assessment & Lifestyle Changes 
CVD is one of several items in the program The aims are improvement of (1 ) lifestyle, (2) 
patient experiences, and (3) cardiovascular risk There has been a public campaign to 
sensitize the public to the topic Education of patients is part of the program Healthcare 
organizations promote lifestyle changes GPs are taught communicative skills and counseling 
Counseling for Behavioral Change 
In the program CVD was one of several items The activities were targeted at health 
professionals The program consisted of education of physicians Through education of 
physicians, education of patients was achieved 
Quality and Outcome Framework 
The program is aimed at improving quality of care and health outcomes for a number of 
conditions, including CVD Prevention is predominantly secondary and tertiary rather than 
primary Practices receive a financial 'reward' for achieving high scores on quality indicators 
The program formally provides incentives in specific areas of prevention and disease 
management, including coronary heart disease, hypertension, diabetes, stroke, and transient 
ischemic attack Recalling patients is a central feature of the United Kingdom general practice 
preventive care and is now mcentivized in the Quality and Outcome Framework 
National Service Framework on Coronary Heart Disease 
Education about a healthier lifestyle is targeted at the public for pnmary prevention and at 
patients with established coronary heart disease for secondary prevention Healthcare 
professionals and their organizations have to meet minimum standards for the delivery of 
health services in England The Healthcare Commission, which is a national health regulator, is 
responsible for evaluating the implementation of National Service Framework guidance 
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Country Programs (with some special features) 
Primary Care Trusts 'Healthy Living Programs' 
The programs, which were started in 2005 and 2006, are ongoing and nationwide The 
Department of Health runs initiatives to help people quit smoking, eat better, and exercise 
more, as well as health screening projects and training and skills programs Each Primary Care 
Trust has its own healthy living schemes 
Heart Failure Nurse 
In this nationwide, ongoing program multidisciplmary heart failure teams were formed by 
primary care trusts There were specialist trainings for cardiac nurses They gave education to 
patients as well as family members on the disease process and management and control of 
symptoms Support also was provided after the diagnosis of chronic heart failure 
Improvement Foundation 
The Improvement Foundation, involving Strategic Health Authorities and Primary Care Trusts, 
works nationwide with potential access for all clinicians and healthcare professionals Several 
activities are targeted at the education of patients and the public, with emphasis on widening 
access to a healthy diet with focus on low-income groups There also are activities targeted at 
education of health professionals (eg, workshops on coronary heart disease and diabetes, but 
also on mental health and long-term conditions) 
Section III 
Improving primary care for patients with chronic heart failure 

Chapter 11 
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Abstract 
Background: 
Many patients with chronic heart failure (CHF) receive treatment in primary care, 
but data have shown that the quality of care for these patients needs to be 
improved. We aimed to evaluate the impact and feasibility of a program for 
improving primary care for patients with CHF. 
Methods: 
An observational study was performed in 19 general practices in the south-eastern 
part of the Netherlands, evaluation involving 15 general practitioners (GPs) and 77 
CHF patients. The program for improvement comprised educational and 
organizational components and was delivered by a trained practice visitor to the 
practices. The evaluation was based on case registration forms completed by 
health professionals and telephone interviews. 
Results: 
Management relating to diet and physical exercise seemed to have improved as 
eight patients were referred to dieticians and five to physiotherapists. The 
seasonal influenza vaccination rate increased from 94% to 97% (75/77). No 
impact on smoking was observed. Pharmaceutical treatment was adjusted 
according to guideline recommendations in 12% of the patients (9/77); 7 patients 
started recommended medication and 2 patients received dosage adjustments. 
GPs perceived the program to be feasible. Clinical task delegation to nurses and 
assistants increased in some practices, but collaboration with other healthcare 
providers remained limited. 
Conclusions: 
The improvement program proved to have moderate impact on patient care. Its 
effectiveness should be tested in a larger rigorous evaluation study using 
modifications based on the pilot experiences. 
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Background 
Heart failure is a chronic disease, which has high prevalence, high burden for 
patients, high mortality, and high costs of healthcare. The prevalence of chronic 
heart failure (CHF) in the western world is 1-2% in the general population and 10% 
or higher in the age group of 85 years and older.1,2 Hospitalization with CHF as 
main diagnosis occurred in 2004 in 1.5 per 1.000 men and women, and mortality 
rates in heart failure patients are - with about 50% in 5 years - markedly higher 
compared to their age group without heart failure.2,3 
International clinical guidelines for the management of CHF provide comparable 
recommendations on diagnosis, treatment and lifestyle advice.4,5 The 
recommended pharmaceutical treatment is complex and studies have reported 
suboptimal adherence to recommended drug treatment.6"11 Providing education 
and counseling on lifestyle issues is recommended, despite variable results. Many 
patients with CHF receive treatment in outpatient hospital clinics settings and 
various programs have been developed to improve the treatment in these 
settings.12 However, in countries with a strong primary care system, a large group 
of patients with CHF receives treatment in primary care. This poses specific 
challenges, as general practitioners (GPs) often work in office-based practices, 
which may be less equipped to provide structured care for CHF than specialized 
hospital departments. Therefore, we developed a program to improve primary care 
for CHF, comprising educational and organizational components. The program 
included educational materials for physicians to instruct them on the recently 
updated recommendations on treatment, an algorithm which summarized the 
recommendations, and educational materials for patients. The organizational 
components comprised advice on organizational development of the practice, 
particularly focused on delegation of clinical tasks to practice assistants and 
nurses, which was delivered by a trained practice visitor. The underlying 
expectation was that this multifaceted program would effectively improve patient 
care.13 The aim of our study was to examine the impact on patient care and the 
feasibility of the program. 
Methods 
Design 
The study had a prospective observational design, with a six-month follow up 
period. A mixed methods approach was used, including both qualitative and 
quantitative data-collection. Quantitative data included changes in lifestyle advice 
and medication during the study period. 
TOO t-jiapier ι ι 
Participants 
The study population consisted of GPs recruited in two regions in the southeastern 
part of the Netherlands. GPs were randomly selected from a national list and then 
approached for this study. Participating GPs were asked to include patients with 
CHF from their practice of whom the GPs considered themselves to be the 
physician taking care of the treatment of this condition in the patient. On average, 
a GP in the Netherlands has 25 patients listed with heart failure and about half of 
them receive their CHF treatment in primary care.1 4 , 1 5 
Improvement program 
The program comprised educational and organizational components, targeted at 
physicians, nurses and assistants, and patients. The educational component 
included a written summary of the non-pharmaceutical and pharmaceutical 
treatment recommendations. The information on non-pharmaceutical treatment 
concerned physical exercise, diet, smoking cessation, influenza vaccination, and 
materials to support advice to patients. The information on pharmaceutical 
treatment concerned the different drug groups advised: diuretics, ACE inhibitors or 
ARBs, beta blocking agents, aldosteron blocking agent, and digoxin. The contents 
were based on the prevailing Dutch College of General Practitioners' (DCGP) 
practice guideline on heart failure, revised and issued in 2005 with new 
recommendations on the use of ACE-inhibitors or angiotensin receptor blockers 
(ARBs), and on beta blocker treatment.16 
In addition, we developed a form that summarized the various therapeutical 
options. We offered two-page case registration forms on which the GP could 
register the treatment at the start of the program for each individual patient. The 
first page of the form guided the GP, nurse or practice assistant through the 
lifestyle issues and recommended giving advice when appropriate. The second 
page offered a stepwise overview through the drug treatment options. Possible 
changes in treatment could be noted. When a patient did not receive a certain 
indicated treatment option a question about the reason followed. 
The organizational component of the program comprised tailored advice on the 
practice organization. Practices were encouraged to come to agreement about 
collaboration with other care providers and on the delegation of clinical tasks to 
nurses within the practice. To support this, a model for cooperation and task 
delegation was presented. We suggested that nurses and assistants could give 
non-pharmaceutical advice and have follow up contacts for monitoring side effects, 
blood pressure and other relevant clinical parameters during drug treatment 
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titration. Also, in a stable phase periodical control visits could be delegated. A 
scheme was provided, offering an overview of tasks that could be delegated and 
offering advised moments of consultation with the GP. Furthermore, practices 
were encouraged to build a structured organization of the care for heart failure 
patients, which included regularly planned contacts with heart failure patients to 
evaluate their treatment, on a 3-months basis in a stable phase and with 2 to 4 
weeks intervals during medication adjustments. Another organizational aspect of 
the improvement program was that practices were encouraged to establish 
collaboration with physiotherapists and dieticians. 
All materials were included in a package: the educational material, supportive 
materials, information on organization, a scheme for task delegation, and the 
guiding patient information form. A trained practice visitor visited all practices. This 
practice visitor, a former practice assistant, was an experienced practice 
consultant trained in data collection and supporting practices in organizational 
changes. She clarified the project, introduced the folder, and checked if practices 
were able to select patients with heart failure appropriately. Six randomly assigned 
practices were offered three extra visits during the six-month period to study 
whether just introducing the material would be a feasible method and whether 
follow-ups were considered useful by the participating GPs. All other practices 
received one telephone call after four weeks to check whether they managed to fill 
in the patient registration forms. In follow up visits practices were encouraged to 
make organizational adjustments and to use the patient registration forms. 
Throughout the project period a GP with specific knowledge of treatment of CHF 
was available for questions raised by the participating GPs. 
Measures 
Impact on patient care was assessed in terms of changes in drug treatment and 
life style advice given during the pilot period. This was based on the patient 
registration forms, which were completed by the GP, nurse or practice assistant for 
each included patient. The measures concerned treatment at the start of the 
program, information on non-pharmaceutical treatment and medication changes 
with respect to heart failure during the program period of 6 months. Practices were 
asked to send in anonymized duplicates of all patient registration forms at the end 
of the project period. 
The feasibility of the program was assessed in terms of GP reported experiences, 
using data from telephone interviews at the end of the project period. Our semi-
structured questions focused on changes in collaboration with other care providers 
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and task delegation within the practice, on time spent by GPs for our program, and 
on the GPs views on the various components of the program. 
Data analysis 
Results were categorized and presented descriptively. 
Ethical approval 
The medical ethical committee (CMO Regio Arnhem-Nijmegen) assessed the 
study proposal and judged an approval was not necessary. 
Results 
Sample 
In total 654 GPs were informed about our project by letter, of which 22 GPs 
agreed to participate in the study. Three GPs dropped out because of lack of time. 
Thirteen practices were visited just once at the project start. Six practices were 
visited three times; after the third visit they were offered another contact either by 
telephone or a visit. They all decided an extra visit was not necessary. When 
planning the telephone evaluations 4 GPs, all visited once, declared that they did 
not work with the materials at all. Therefore they did not participate in the 
evaluation. So, finally, 15 GPs participated in the evaluation; 10 of them sent in 77 
patient registration forms. All GPs were able to select patients using ICPC codes. 
Table 1 summarizes these data. The study period was from October 2007 until 
April 2008. 
Table 1. Flow of included practices and patients. 
Included practices 
Refused to participate 
Participating practices 
Number of practices participating in the evaluation 
Number of practices returning patient information forms 
Number of patient registration forms 
Group 1 
(three visits) 
7 
1 
6 
6 
5 
35(4-10) 
Group 2 
(one visit) 
15 
2 
13 
9 
5 
42(4-10) 
Total 
22 
3 
19 
15 
10 
77(4-10) 
Table 2 shows data on the 19 participating GPs and their practices and Table 3 
shows demographic data of the patients included. All but one participating 
practices had one or more practice nurses. In seven practices these nurses 
already had clinical tasks in CHF care. Most GPs judged the DCGP's clinical 
practice guideline program in general and the guideline on CHF in particular, 
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positively. Involvement of a dietician or a physiotherapist in the care for heart 
failure patients was formalized in three and two practices respectively. Eleven GPs 
reported formal involvement of a cardiologist, one reported formal involvement of a 
heart failure nurse and one involved a heart failure outpatient clinic. 
Table 2. Baseline characteristics of the general practices (total n=19). 
η % 
Number of GPs in the practice 
Solo practice 
Duo practice 
Group practice 
Number of practices with practice support 
Practice supportive staff member with tasks in heart failure 
Number of practices accreditateci 
Agreement with contents of heart failure practice guideline 
Positive attitude towards practice guidelines in general 
Formalized cooperation with dietician 
Formalized cooperation with physiotherapist 
Formalized cooperation with cardiologist 
Formalized cooperation with others (heart failure nurse, heart failure outpatient clinic) 2 11 
The patient sample included slightly more females (58%) than males, and the 
mean age was 78. About one third of the patients (37%) was in NYHA class III or 
IV, indicating more severe CHF. The GPs reported hypertension as one of the 
causes of heart failure in 57% of the patients and coronary heart disease in 47%. 
The expert GP had telephone contacts with 3 GPs and email contacts with another 
3 practices. One of the participating GPs had questions considering treating 
octogenarians; other issues were organizational. 
12 
5 
2 
18 
7 
5 
16 
17 
3 
2 
11 
63 
26 
11 
95 
37 
26 
84 
89 
16 
11 
58 
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Table 3. Patient characteristics at baseline (n=77) 
Sex Male 
Female 
Mean age (youngest and oldest) 
Years since diagnosis on average 
NYHA class I 
II 
III 
IV 
Smoking Yes 
No 
Causes of heart failure (more than one 
Coronary heart disease 
Hypertension 
Others ( e.g. rhythm disorders) 
possible). 
n=77 
32 
44 
78 
sd 10,3 
(44-92) 
6 
16 
29 
19 
7 
9 
60 
36 
44 
19 
% 
42 
58 
23 
41 
27 
10 
13 
87 
47 
57 
25 
Co morbidity 
Myocardial infarction in medical history 
Angina pectoris 
CABG or PCI in medical history 
Hypertension 
Asthma 
COPD 
Diabetes mellitus 
Hypothyroid disease 
Hyperthyroid disease 
Rhythm disorders, e g atrial fibrillation 
Others 
16 
25 
8 
34 
3 
13 
24 
3 
3 
11 
52 
21 
32 
10 
44 
4 
17 
31 
4 
4 
14 
68 
Legend. Percentages are from the forms with data on the question, ignoring forms with missing data. 
Impact 
Table 4 shows the impact on lifestyle advice and drug treatment. Eight out of the 
17 patients who received (renewed) dietary advice were referred to a dietician. 
Also, out of 28 patients who were advised on physical activity 5 patients were 
referred for physical activity therapy. Seasonal influenza vaccination grade was 
already high (94%, 72/77), but during the winter in the project period 3 more 
patients were vaccinated. Of the patients registered as smokers 4 were (again) 
advised to stop smoking. None of them actually quitted smoking. 
In 4 patients their GP started a diuretic and in 3 patients an ACE inhibitor or ARB 
in accordance with the recommendations. Furthermore, in one patient ACE 
inhibitor dosage was optimized. Although just over half of the patients were treated 
with a beta blocker, the GPs did not start beta blocker treatment with any patient. 
On the patient registration, all patients with beta blockers indicated but not 
prescribed were said to have a contra indication. In one patient the beta blocker 
dosage was optimized. In total, medication was adjusted in 9 patients (12%). 
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Table 4. Medical treatment at baseline and changes during the 6-month programme period. 
Baseline scores Patients with changes since baseline 
Non pharmaceutical treatment 
Stop smoking advise given 
Dietary advice given 
Advise on physical activity given 
Influenza vaccination provided 
Drug treatment 
Diuretics (thiazide or lisdiuretic) prescribed 
ACE-mhibitor or ARB prescribed 
Beta blocker prescribed 
Spironolacton prescnbed 
Digoxin 
n=77 
6 
39 
18 
72 
63 
58 
43 
15 
5 
% 
8 
51 
23 
94 
82 
75 
56 
19 
6 
n=77 
4 
17 
28 
3 
4 
31 
O1 
0 
0 
One patient on medication already had dosage adjustment according to the recommendations 
Feasibility 
All elements of the program were evaluated positively by the vast majority of the 
15 GPs involved in the evaluation. Of them, 14 had positive judgements about 
both the written materials and the practice visits, and 12 about the patient 
registration forms. Thirteen GPs would advise colleagues to participate in this 
heart failure program and would participate in a program like this again. The mean 
time investment for the GP was 2.5 hours, ranging from 0.5 to 5 hours. 
Six GPs made organizational changes in the management of chronic heart failure 
care. Only a few GPs considered cooperation with other disciplines in the care 
improved: three GPs with a dietician, one with a physiotherapist, and one with a 
cardiologist. Nine GPs considered care for heart failure patients in their practice as 
improved. 
In the group with repeated visits all practices were satisfied in their need for 
support after 3 visits although another follow up visit was offered. One GP thought 
the support was more than necessary. In the group with just one practice visit 4 
GPs would have welcomed more support; the other 5 GPs were satisfied with just 
one visit. 
Discussion 
Main conclusions 
The program to improve primary care for patients with CHF proved to be feasible 
and to be associated with clinically relevant improvements in at least some 
patients, particularly regarding lifestyle advice. All components of the program -
the written material including the patient registration forms and the practice visits 
by the outreach visitor - were positively assessed. There was no clear optimum 
number of visits by the practice visitor (one or three). Obviously, the need for visits 
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will differ between practices. In a number of practices one practice visit did not 
suffice, as in the group of 13 practices that were visited once only 9 GPs finally 
worked with the materials provided, and 4 of these 9 GPs considered support with 
one visit insufficient. 
Interpretation 
Especially in specialist medical care, there have been several initiatives for 
improving healthcare for patients with CHF. Many of these programs include more 
frequent contacts with the patients by specialized heart failure nurses than usual 
care provides. The outcomes of these heart failure programs were not 
consistent.17"19 
A limited number of randomized controlled trials evaluated improvement programs 
for the treatment of heart failure in primary care.20"24 Interventions consisted of 
nurse-led contacts, computer based treatment suggestions, practice guideline 
recommendations and disease management programs, for instance. Again, 
outcomes were not consistent, with significant differences in some endpoints 
defined, but not in all. Therefore, also in primary care, further effort is necessary to 
develop effective improvement programs. 
Our program aimed to achieve changes by reducing various types of barriers for 
change, the complexity of the prevailing practice guideline with recently changed 
treatment recommendations being one. Therefore we provided educational 
interventions. Secondly, in CHF care there was no structured approach as there is 
in diabetes care. We proposed organizational interventions, which were tailored to 
the practice. Although the impact of tailoring and combining interventions has not 
been found to be consistently more effective than single interventions13, many 
experts have proposed that these two aspects contribute to the effectiveness of 
programs for improving healthcare.25 A problem, however, is that tailoring 
interventions to organizational barriers is difficult.26 
Our patient sample seemed to represent the population quite well, considering 
sex, age, pathology underlying CHF, and co-morbidity.8,11 The rather high 
percentage of NYHA class III or IV (37%) might be unexpected in primary care. 
Yet, especially in the group of old and severely ill, patients usually do not visit the 
outpatient clinic and are treated in primary care with home visits. 
Several studies showed that pharmaceutical treatment of heart failure patients in 
general practices is not optimal. Forty to 78% of the heart failure patients were 
treated with an ACE-inhibitor or ARB.6"11 In our sample 82% of the patients were 
using an ACE-inhibitor or ARB. The use of beta blockers in previous studies varied 
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from 7 to 32%.8'10'11 In our study 56% of the patients used a beta blocking agent. 
Our relatively high percentages may indicate a selection of practices or patients, 
but may also reflect the fact that our data were collected more recently. Revised 
practice guideline recommendations for Dutch GPs have been published in 2005. 
Though treatment was good already there was still room for improvement, and the 
percentage of patients who received improved care reflects percentages found in 
previous studies of implementation interventions.27 
We did not find much change in formalized interdisciplinary cooperation with other 
care providers. Our program did not contain supportive materials for improvement 
of interdisciplinary cooperation (for instance with dieticians). This clearly has to be 
addressed in further development of the program, following for instance a 
comprehensive tool with a list of tasks to make interdisciplinary cooperation 
agreement made by The Dutch Heart Foundation.28 
Strengths and weaknesses 
We carefully developed a program for improving primary care for CHF patients, 
and tested this in real practice. This is an important step in the development of 
effective interventions, which is often overlooked. A serious limitation of our study 
is the practice sample and the patient sample size. The sample of practices is non-
random due to the low response rate, and the patient sample is small (77 patients 
included) because only 10 GPs sent back the registration forms. Generalizing 
results beyond the practices and patients studied is problematic, but for the 
purpose of this study this was regarded as acceptable. 
The strength of our program is the fact that it is multifaceted, addressing 
organizational and educational aspects with a variety of materials and visits. 
Especially, the patient registration form with an algorithm was guiding and very 
helpful. 
Implications for research, policy and practice 
Some aspects of the program can be improved, particularly regarding collaboration 
with other care providers, making use of existing materials. Our program was 
entirely focused on treatment; medical education on the diagnostic work up could 
serve as a starting point for a kick off of the program. The program held many 
elements. A barrier analysis in each participating practice could identify the need 
for specific elements and form the basis of a tailored made intervention. Within one 
region other disciplines could be invited to participate, reinforcing treatment in 
primary care in general. Also, cooperation with cardiologists could be enforced 
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with local agreement meetings on diagnostic procedures, referral and referring 
back to primary care, and shared care. In such a new approach the program 
should be evaluated again. Then, the major challenge is to make the program 
available for larger groups of primary care practices. The program could gain 
strength with a more regional approach, which would give opportunities for 
cooperation especially when functioning regional organizations or structures are 
available. 
Conclusion 
A feasible and promising program for improving primary care for patients with CHF 
is now available. Its effectiveness needs to be tested in a larger study after making 
program adjustments taking advantage of the lessons learned in this pilot study. 
Further implementation of the program could be organized on a regional level. 
Extra attention should be paid to cooperation with other disciplines and to making 
use of existing structures within these regions. 
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Abstract 
Background: 
Many patients with chronic heart failure (CHF), a common condition with high 
morbidity and mortality rates, receive treatment in primary care. To improve the 
management of CHF in primary care, we developed an implementation program 
comprised of educational and organizational components, with support by a 
practice visitor and focus both on drug treatment and lifestyle advice, and on 
organization of care within the practice and collaboration with other healthcare 
providers. Tailoring has been shown to improve the success of implementation 
programs, but little is known about what would be best methods for tailoring, 
specifically with respect to CHF in primary care. 
Methods/design: 
We describe the study protocol of a cluster randomized controlled trial to examine 
the effectiveness of tailoring a CHF implementation program to general practices 
compared to a standardized way of delivering a program. The study population will 
consist of 60 general practitioners (GPs) and the CHF patients they include. GPs 
are randomized in blocks of four, stratified according to practice size. With a 
tailored implementation program GPs prioritize the issues that will form the bases 
of the support for the practice visits. These may comprise several issues, both 
educational and organizational. The primary outcome measures are patient's 
experience of receiving structured primary care for CHF (PACIC), patients' health-
related utilities (EQ-5D), and drugs prescriptions using the guideline adherence 
index. Patients being clustered in practices, multilevel regression analyses will be 
used to explore the effect of practice size and type of intervention program. In 
addition we will examine both changes within groups and differences at follow-up 
between groups with respect to drug dosages and advice on lifestyle issues. 
Furthermore, in interviews the feasibility of the program and goal attainment, 
organizational changes in CHF care, and formalized cooperation with other 
disciplines will be assessed. 
Discussion: 
In the tailoring of the program we will present the GPs a list with barriers; GPs will 
assess relevance and possibility to solve these barriers. The list is rigorously 
developed and tested in various projects. The factors for ordering the barriers are 
related to the innovation, the healthcare professional, the patient, and the context. 
CHF patients do not form a homogeneous group. Subgroup analyses will be 
performed based on the distinction between systolic CHF and CHF with preserved 
left ventricular function (diastolic CHF). 
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Background 
Chronic heart failure (CHF) is a highly prevalent chronic disease with high 
morbidity and mortality rates. The prevalence of CHF in the Western world is 1% 
to 2% in the general population and at least 10% among the age group of 85 years 
and older.1,2 Mortality in CHF patients is high compared to their age group.2,3 High 
morbidity is associated with high hospital admission rates and reduced quality of 
life4. There are effective, evidence-based treatments which improve mortality and 
morbidity but use of and adherence of treatments is suboptimal despite clinical 
guidelines.5"9 
A large group of patients with CHF receive treatment in primary care. There are 
many programs for the management of long-term conditions in primary care - e.g., 
diabetes, COPD and depression - but at present not for CHF, though several 
disease management programs exist for CHF related to outpatient clinics. As a 
substantial proportion of CHF patients do not attend such clinics but visit their 
general practictioner (GP) instead, these patients are not enrolled in a structured 
care program. 
To improve the management of CHF in primary care, we have developed an 
implementation program, comprising both educational and organizational 
components, the latter aimed at improved and structured care. We pilot tested this 
program in 19 general practices.10 The pilot program was targeted at implementing 
the prevailing practice guideline for general practice.11 In the mean time, in the 
Netherlands an interdisciplinary guideline on CHF, based on the European Society 
of Cardiology (ESC) guideline, was developed and published in May 2010.12 So, 
we adapted the implementation program according to this new guideline, taking 
into account the lessons learned in the pilot study. 
Apart from offering a standard implementation program, another approach is to 
tailor an intervention to the special needs and conditions in a general practice. 
Ideally, tailoring has three components: identification of factors associated with 
implementation (or labeled as 'barriers to change'), to match implementation 
interventions to those factors, and evaluation of the tailored implementation 
program. Tailoring has been shown to have a modest effect on the success of the 
implementation program13, but little is known about what would be best methods 
for tailoring.14 In addition, research evidence specifically supporting this hypothesis 
with respect to improving primary care for CHF patients is not yet available. In one 
study no relation was found between barriers perceived and ACE inhibitor 
prescription behavior.15 Earlier studies to improve CHF patients care focused on 
182 Chapter 12 
disease management programs, mainly case management, and on education and 
drug prescription.16,17 
Patients being clustered in practices, we planned to conduct a cluster randomized 
controlled trial with randomization at the practice level. The aim of the study will be 
to examine the effectiveness of tailoring the implementation program to general 
practices compared to a standardized way of delivering the implementation 
program to general practices. 
Methods 
The project will be a collaborative project of IQ healthcare, a research department 
of Radboud University Nijmegen Medical Centre, and the four regional supportive 
structures for primary care ('ROS') in the south of the Netherlands and their 
cooperative bond Robuust. The medical ethical committee (CMO Regio Arnhem-
Nijmegen) assessed the study proposal and waived approval. 
Participants 
The study population will consist of 60 GPs and the CHF patients they will include. 
GPs will be recruited in the south of the Netherlands, contacted either directly or 
indirectly via various regional organizations by advisors of the regional supportive 
structures for primary care. GPs will be informed about the project, and when they 
agree to participate they will be instructed to send in an admission form with data 
on practice organization necessary for stratification and randomization. 
Evidence of change will be assessed by studying the effects of the intervention on 
patients with CHF registered with the participating GPs. As in the pilot10, GPs will 
include all CHF patients from their practices who are over 18 years of age of whom 
the GPs consider themselves to be the physician taking care of the treatment of 
this condition in the patient. We expect eight to ten patients per practice.18,19 
Patients will be sent explanation about the study and asked for informed consent 
to participate in a patient questionnaire. Data collection will be anonymized. 
Interventions 
Standardized delivery of the implementation program 
The implementation pack contains educational materials for the professionals and 
patients. There is a recommended protocol for multidisciplinary management and 
a template for clinical care presented as a guiding registration form. Furthermore, 
we offer support by a visiting practice consultant and the possibility to contact a 
GP with a special interest in CHF management. 
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The project materials from the pilot were amended following the pilot study and the 
development of the new interdisciplinary practice guideline.12 Participating GPs will 
be informed about healthcare professionals from other primary care disciplines, 
e.g., dieticians and physiotherapists, and these professionals will be informed 
about the project, encouraging the role of the multidisciplinary team in CHF 
management. The paragraph on non-pharmaceutical treatment was enlarged and 
the pharmaceutical paragraph had some changes. Now, recommendations on 
drug treatment are different for patients with systolic CHF compared to patients 
with a preserved systolic heart function, so called diastolic CHF (See Table 1). 
Finally, new recommendations on the use of devices were formulated. 
The paper template is used to direct care and collect data to demonstrate the 
effectiveness of the interventions. Demographic data is collected in particular the 
aetiology of the CHF and the diagnostic category, whether diagnosis was 
echocardiography based, on the existence of diastolic or systolic CHF, and 
pharmaceutical treatment at the start of the project period. A second page poses 
questions about non-pharmaceutical issues such as advice about physical activity 
and influenza vaccination. Finally, we offer different forms for patients with systolic 
or diastolic CHF, based on the recommendations on medication as summarized in 
Table 1. 
Table 1. Changes in medication advice. 
Medication advice based on the 2005 Medication advice based on the 2010 multidisciplinary 
GP practice guideline guideline 
One scheme: Systolic heart failure 
- Diuretics - ACE inhibitor (or ARB if not tolerated) in evidence based doses 
- ACE inhibitors or ARB - Diuretics for fluid retention 
- Beta blocker - Beta blocker blockers licensed for heart failure in evidence 
- Aldosteron antagonist based doses 
- Digoxin - Aldosterone antagonist or ARB 
- Digoxin or H + ISND 
Diastolic heart failure. 
- Diuretic if signs of fluid retention 
Adequate treatment of co morbidity 
- Strict blood pressure control 
ARB = angiotensin II receptor blocker 
H + ISDN = Hydralazine + isosorbide dimtrate 
The pilot study demonstrated that three practice visits was the optimum number 
and these shall be offered to all participating practices. The practice visitor is an 
educational facilitator trained in supporting behavior change in practices. 
The pilot study also demonstrated that there was little multidisciplinary clinical 
activity in the improvement of care for CHF patients, and this has been addressed 
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in this project. We now use the multidisciplinary practice guideline as a starting 
point instead of the monodisciplinary GP's practice guideline. Furthermore, the 
regional advisors will determine the social network in the practice area, providing 
information on other primary care disciplines, e.g., dieticians and physiotherapists, 
with extra expertise and interest in CHF treatment. These workers in the other 
disciplines will be informed about the project and receive relevant information in 
line with the multidisciplinary guideline. 
All materials are offered paper based in a binder. We will also present all materials 
on a website and examine the possibilities for designing the guiding patient 
registration forms on this website as well. 
Tailored delivery of the implementation intervention 
The intervention group of practices will have the agenda of their practice visits 
determined by the results of a questionnaire identifying the barriers they perceive 
to the introduction of a program for the management of CHF in primary care. The 
barriers listed in the questionnaire are based on previous research and grouped in 
relation to the innovation, the healthcare professional, the patient, and the 
context.20 GPs are asked to indicate the relevance of each barrier in their practice 
situation on a five-point scale, and whether or not they think that the barrier can be 
solved. Table 2 shows some examples of barriers suggested in the format of the 
questionnaire. GPs are offered the possibility to add barriers they perceive that are 
not yet identified. When barriers are identified, those that are relevant and solvable 
will be prioritized and addressed during the practice visits. 
Objectives 
The objective of the study is to examine the effectiveness of identifying barriers to 
change, and tailoring education and support in comparison with a standard 
intervention program, to improve the management of patients with CHF in primary 
care. 
Our null hypothesis is that tailoring does not result in better implementation of the 
guidelines for CHF compared to a standardized delivery of our implementation 
program. In addition, we will also examine whether either of the two programs are 
associated with improvements in healthcare delivery and patient outcomes. 
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Table 2. Examples of possible barriers as 
1 
2 
3 
4 
intervention. 
Innovation 
The recommendations in the 
multidisciplmary practice guideline heart 
failure ask for changes in our existing 
practice routines that are too big 
Health care professional 
I lack sufficient knowledge of the 
recommendations in the multidisciplmary 
practice guideline heart failure 
Patient 
Considenng patients with complex health 
issues all time reserved usually is taken 
completely by the actual problems and we 
do not manage to provide a more structurée 
approach for the heart failure problems 
Context 
; presented in the GP's 
To what extend is this 
barrier relevant for your 
practice situation? 
Not at all 
A little 
Neutral 
U Relevant 
ZI Very relevant 
Not at all 
A little 
I l Neutral 
H Relevant 
ID Very relevant 
Not at all 
A little 
Neutral 
I Relevant 
Very relevant 
We lack sufficient supportive staff to provide D Not at all 
care according to the practice guideline A little 
Neutral 
Relevant 
H Very relevant 
questionnaire for the tailored 
Do you consider it possible 
to solve this barrier in your 
practice situation? 
Π 
u 
u 
'—' 
u 
u 
Yes 
No 
Doubtful 
Yes 
No 
Doubtful 
Yes 
No 
Doubtful 
Yes 
No 
D Doubtful 
Measures 
Data collection will comprise the following measures, patient questionnaires, 
patient registration forms, and telephone interviews with the GPs. Practices will 
send out patient questionnaires based on validated and previous used 
questionnaires: PACIC21, EQ-5D22, questions about 'continuity of care', and 
Mohsky's questionnaire on medication adherence.23 In the patient registration 
forms, data about non-pharmaceutical and drug therapy are registered by the GPs 
and their staff: they register the baseline treatment at inclusion, and during the 
patient contacts throughout the study period they register all advice given, 
referrals, drug therapy changes, and information on hospitalization and mortality. 
The GP interview will score goal attainment and a qualitative assessment of the 
program. All measures have been applied by our group in previous studies. 
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Oufcomes 
The primary outcome measures are determined at the patients' level and consist 
of experience of receiving structured primary care for CHF (PACIC) and health-
related utilities (EQ-5D), and of drug prescriptions. 
PACIC is a questionnaire consisting of 27 items, which is related to the Chronic 
Care Model.24 We translated and validated PACIC for use in general practice in 
the Netherlands.25 EQ-5D consists of five questions and a Visual Analogue Scale 
(VAS), which has been validated for use in the Netherlands.26 These outcome 
measures reflect key aspects of medical treatment, organization of care, and 
patient reported quality of life, and were chosen pragmatically because of the 
availability of relevant, validated, responsive, composite measures. 
Drug prescription scores are assessed using the guideline adherence index (GAI), 
indicating the proportion of indicated drugs that is prescribed.27,28 These include 
ACE inhibitors and beta blockers, and - depending on the patient's CHF severity 
according to the NYHA classes - further drug classes.12 
Secondary outcome measures at the patients' level concern lifestyle advice and 
medication during the study period, based on the patient registration forms 
providing information on non-pharmaceutical advice and drug prescriptions, 
continuity of care, and medication adherence. Considering drug therapy we will 
assess the percentages of ACE inhibitors and beta blockers prescribed in the 
evidence-based target dosages. Secondary outcome measures at the practice 
level are goal attainment and qualitative assessment of the program, focusing on 
the subjective GP's experiences, for instance on improvement of practice 
organization and collaboration with other primary care professionals. 
Randomization 
The study will be a randomized controlled trial, with a one-year follow-up period. 
Practices are stratified according to practice size as solo, duo, or group practice. 
On inclusion, practices are assigned to one of the study groups using 
randomization in blocks of four per stratum by a research assistant. Blocks were 
generated electronically with the help of a statistician. The randomizing procedure 
itself is concealed for practices, consultants, and researchers (JvL, MW). The 
regional advisors including the practices have no access to the randomization 
process. After randomization, both the practice and the regional advisor are 
informed. The intervention is open to all involved. 
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Data analysis 
The primary analysis is a comparison of primary outcomes at follow-up between 
the study groups, taking into account clustering of patients within practices. 
Multilevel regression analyses will be used to explore the effect of practice size 
and type of intervention program. In addition, we will examine both changes within 
groups and differences at follow-up between groups with respect to percentage of 
patients on the maximum tolerated dosage of ACE inhibitor or angiotensin II 
receptor blocker and of beta blockage; medication completely according to the 
guideline; having received influenza vaccination in the winter season 2010-2011; 
having received professionally guided physical activity training; and the number of 
non-pharmaceutical issues addressed. If possible, subgroup analyses will 
comprise type of CHF (systolic or diastolic) and diagnostic certainty (secondary 
care diagnosis, echocardiography diagnosis) The interviews will be used to assess 
the feasibility of the program and goal attainment, organizational changes in CHF 
care, and formalized cooperation with other primary care disciplines and specialist 
care. 
Sample size 
Power calculations are based on the primary outcome measurement PACIC. The 
PACIC comprises 27 questions with an answering scale from 1 to 5. A previous 
unreported study showed that its standard deviation was 1.0. To detect a 
difference of 0.3 points with a standard deviation of 1 (a relatively small effect), 
with alpha=0.05 and beta=0.20> ICC=0.05, a total of 51 practices with 10 patients 
each would be required, or 59 practices with 8 patients. 
Time frame 
Practice inclusion is planned from June until October 2010. After inclusion, 
practices participate in the program during one year. At the start of the year, the 
GPs include all their patients with CHF they treat at least in part themselves. 
During that year, patients with newly diagnosed CHF can also be included. Data 
management in the patient registration forms is a continuous process during the 
project year. After the project period of a year, the forms are anonymized and sent 
to the researchers coded. Furthermore, practices will send coded patient 
questionnaires with explanation of the survey and ask for an informed consent; 
these will be returned to the researchers. Finally the researchers will contact the 
GPs participating for the telephone interview. The GPs will receive feedback based 
on the patient registration forms and the questionnaires. 
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Discussion 
There exist various classifications of barriers (and facilitators) and multiple 
approaches for linking interventions to barriers.2931 In their systematic review, 
Legare and colleagues propose a conceptual framework with knowledge, attitude, 
and behavior as main factors.31 Our choice of barriers is based on a list rigorously 
developed in the Netherlands with a literature study in 2002, expert input, and 
tested in various projects in the Netherlands.20 Our main factors for ordering the 
barriers are related to the innovation, the healthcare professional, the patient, and 
the context. The barriers presented in this study correspond very well to the 
barriers found most often in the Legare review, including time pressure and lack of 
applicability. Looking for the barriers for each individual practice and not for the 
practices participating in general, we decided to have the barriers proposed scored 
in email contact with the GPs in two rounds. 
Several studies were conducted to assess the effect of tailoring implementation. In 
a systematic review, the authors conclude that identifying barriers and tailoring 
intervention to these barriers may improve clinical practice compared to no 
intervention and to guideline dissemination. In their meta analysis including eight 
studies identified with a non-tailored intervention in the control group, they report a 
modest effect of tailoring.13 
All data collection will take place at the end of the project period. Within the 
context of the evaluation of the implementation project, it is not feasible to have 
data collection both at the start and at the end, but the patient registration form will 
have baseline data on treatment issues. This also will allow for within group 
analyses, giving information about the effectiveness of both implementation 
strategies separately. Unfortunately, this data collection, either paper based or 
electronically, will require additional administrative actions from the practices. 
Enabling data collection from the electronic medical record will be beyond the 
scope of this project. Considering the patient questionnaire's results, with one 
measurement at the end, this restricts us to intergroup analyses. 
Our sample size is based on power calculation considering the PACIC outcomes. 
In previous research, a difference of 0.5 was found in the evaluation of a CHF and 
a diabetes program.32,33 Thus, an effect size of 0.3 on PACIC can be considered a 
modest effect. We aim at a lowered effect because we compare two strategies that 
are both to be expected to have some impact. 
Drug prescription is also a primary outcome measure. We will present the GAI as a 
measure for the percentage of indicated drugs prescribed. In previous research, 
many patients appeared to receive suboptimal dosages. When considering ACE 
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inhibitors and beta blockers, we will report on the percentage of prescriptions in 
the indicated, high-target dosages.34 
We decided to stratify practices included based on practice size. There is some 
evidence of a relation between practice size and quality of care.35,37 In one study, 
larger practice size was associated with more structured care.35 Stratification of 
practices based on practice size could be defined as the number of GPs in the 
practice and based on patient list size. We choose a stratification scheme based 
on the former, with the strata solo, duo, and group practices, which appeared 
feasible in previous research leading to strata of comparable size. 
CHF patients do not form a homogeneous group; apart from aetiology, we make a 
distinction between systolic CHF and CHF with preserved left ventricular function 
(diastolic CHF). In our study, both patient groups may be included, as the practice 
guideline gives recommendations for both the patients with and without left 
ventricular systolic dysfunction. Subgroup analyses will be performed. 
190 Chapter 12 
References 
1. Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 2007;93.1137-46. 
2. Mosterd A, Hoes AW, de Bruyne MC, Deckers JW, Linker DT, Hofman A, Grobbee DE. Prevalence 
of heart failure and left ventricular dysfunction in the general population, The Rotterdam Study. Eur 
Heart J 1999,20:447-55 
3. Hartfalen. Omvang van het probleem. Hoe vaak komt hartfalen voor en hoeveel mensen sterven 
eraan. [http7/www.nationaalkompas.nl/gezondheid-en-ziekte/ziekten-en-aandoeningen/hartvaat-
stelsel/hartfalen/cijfers-hartfalen-prevalentie-incidentie-en-sterfte-uit-de-vtv-2010/]. 2010. 
4. Hobbs FD, Kenkre JE, Roalfe AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left 
ventricular systolic dysfunction on quality of life: a cross-sectional study comparing common chronic 
cardiac and medical disorders and a representative adult population. Eur Heart J 2002;23:1867-76. 
5. Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European 
Society of Cardiology, Dickstem Κ, Cohen-Solai A, Filippatos G, McMurray JJ, Pomkowski P, Poole-
Wilson PA, Strömberg A, van Veldhuisen DJ, Alar D, Hoes AW, Keren A, Mebazaa A, Nieminen M, 
Priori SG, Swedberg K, ESC Committee for Practice Guidelines, Vahaman A, Camm J, De Caterina 
R, Dean V, Dickstem Κ, Filippatos G, Funck-Brentano C, Hellemans I, Knstensen SD, McGregor Κ, 
Sechtem U, Silber S, Tenderà M, Widimsky P, Zamorano JL. ESC Guidelines for the diagnosis and 
treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of 
Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in 
collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European 
Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29:2388-442. 
6. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Gamats TG, Jessup M, Konstam MA, 
Mancini DM, Michl K, Dates JA, Rahko PS, Silver MA, Stevenson LW, Yancy CW, Antman EM, 
Smith SC Jr, Adams CD, Anderson JL, Faxon DP, Fuster V, Halpenn JL, Hiratzka LF, Jacobs AK, 
Nishimura R, Ornato JP, Page RL, Riegel Β, American College of Cardiology; American Heart 
Association Task Force on Practice Guidelines; American College of Chest Physicians; International 
Society for Heart and Lung Transplantation; Heart Rhythm Society: ACC/AHA 2005 Guideline 
Update for the Diagnosis and Management of Chronic Heart Failure in the Adult a report of the 
American College of Cardiology/American Heart Association Task Force on Practice Guidelines 
(Wntmg Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart 
Failure): developed in collaboration with the American College of Chest Physicians and the 
International Society for Heart and Lung Transplantation, endorsed by the Heart Rhythm Society. 
Circulation 2005;20:e154-235. 
7. Kasje WN, Demg P, Stewart RE, de Graeff PA, Haaijer-Ruskamp FM. An educational programme for 
peer review groups to improve treatment of chronic heart failure and diabetes mellitus type 2 in 
general practice J Eval Clin Pract 2006;12:613-21. 
8. Bongers FJ, Schellevis FG, Bakx C, van den Bosch WJ, van der Zee J Treatment of heart failure in 
Dutch general practice. BMC Fam Pract 2006;7:40. 
9. Majeed A, Williams J, de Lusignan S, Chan T. Management of heart failure in primary care after 
implementation of the National Service Framework for Coronary Heart Disease: a cross-sectional 
study. Public Health 2005,119:105-11. 
10. van Lieshout J, Wensmg M, Grol R. Improvement of primary care for patients with chronic heart 
failure: a pilot study. BMC Health Serv Res 2010; 10:8. 
11. Rutten FH, Walma EP, Kruizmga Gl, Bakx HCA, van Lieshout J. NHG Standaard Hartfalen, eerste 
herziening Huisarts Wet 2005;48:64-76. 
12. Hoes AW, Walma EP, Rutten FH, Twickler TB, Rohling R, Jansen RWMM, Jaarsma T, Feenstra TL, 
Bouvy ML, Buskens E, De Graaff M, De Kok IHM, Dijkgraaf R, Duin M, Fischer E, Flikweert S, 
Hammelburg R, Honig A, Hulzebos E, In den Bosch HJH, Janssen-Boyne J, Koers H, Kortrijk M, 
Nmaber PA, Poot E, Post PN, Rosenbrand CJGM, Schiffer AAJJ, van Dijk JL, van Dijk P, van Erp J, 
van Erven L, van Leen M, van Lieshout J, van Veldhuisen DJ, Weerts M, Voors AA Multidisciplinaire 
richtlijn Hartfalen. 2010 [http://www.cbo.nl/Downloads/1081/rl_hartfalen_2010.pdf], Accessed 15-7-
2010. 
13. Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S, Robertson Ν: Tailored 
interventions to overcome identified barriers to change effects on professional practice and health 
care outcomes. Cochrane Database Syst Rev 2010,3: CD005470. 
14 Bosch M, van der Weijden T, Wensmg M, Grol R. Tailoring quality improvement interventions to 
identified barriers- a multiple case analysis. J Eval Clin Pract 2007;13:161-8 
A study protocol for a cluster randomized trial comparing two strategies 191 
15. Kasje WN, Demg P, de Graeff PA, Haaijer-Ruskamp FM. Perceived barriers for treatment of chronic 
heart failure in general practice; are they affecting performance? BMC Fam Pract 2005;6.19 
16. Taylor SJC, Bestall JC, Cotter S, Falshaw M, Hood SG, Parsons S, Wood L, Underwood M: Clinical 
service organisation for heart failure. Cochrane Database Syst Rev 2005, 2, Art. No CD002752. 
17. Jaarsma T, Strömberg A, De Geest S, Fndlund Β, Heikkila J, Màrtensson J, Moons P, Schölte op 
Reimer W, Smith K, Stewart S, Thompson DR. Heart failure management programmes in Europe 
Eur J Cardiovasc Nurs 2006;5:197-205. 
18. Bongers FJM, Bakx JC, Heesakkers WHJ, van de Lisdonk EH. De patiënt met hartfalen m de 
huisartspraktijk. Hart Bull 2003;34:4-7 
19. Bosch M, van der Weijden Τ, Grol R, Sehers Η, Akkermans R, Niessen L, Wensing M. Structured 
chronic primary care and health-related quality of life in chronic heart failure BMC Health Serv Res 
2009;19:104. 
20. Peters MAJ, Harmsen M, Laurant MGH, Wensing M Room for improvemenf Barriers to and 
facilitators for improvement in patient care Nijmegen, Centre for Quality of Care Research (WOK), 
2002 [http://www.wokresearch.nl/UserFiles/Docs/product_112.pdf], Accessed 15-7-2010. 
21 Patient Assessment of Care for Chronic Conditions (PACIC). 2010 
[http://www.improvingchroniccare.org]. 
22. EQ-5D. A standardised instrument for use as a measure of health outcome. 2010 
[http://www.euroqol.org/home.html]. 
23 Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of 
medication adherence. Med Care 1986;24:67-74. 
24 Wagner EH, Austin BT, Von Korff M. Organizing care for patients with chronic illness. Milbank Q 
1996;34:511^4 
25. Wensing M, van Lieshout J, Jung HP, Hermsen J, Rosemann T. The Patients Assessment Chronic 
Illness Care (PACIC) questionnaire in The Netherlands a validation study in rural general practice. 
BMC Health Serv Res 2008;8:182. 
26. Lamers LM, Stalmeier PF, McDonnell J, Krabbe PF, van Busschbach JJ. Measuring the quality of life 
in economic evaluations: the Dutch EQ-5D tariff. Ned Tijdschr Geneeskd 2005; 149 1574-8. 
27 Oertle M, Bal R. Understanding non-adherence in chronic heart failure: a mixed-method case study. 
Qual Saf Health Care 2010;19:e37. 
28. Komajda M, Lapuerta P, Hermans N, Gonzalez-Juanatey JR, van Veldhuisen DJ, Erdmann E, 
Tavazzi L, Poole-Wilson P, Le Pen C. Adherence to guidelines is a predictor of outcome in chronic 
heart failure: the MAHLER survey. Eur Heart J 2005:26.1653-9. 
29. Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR Why don't physicians 
follow clinical practice guidelines? A framework for improvement JAMA 1999:282.1458-65. 
30. Espeland AA, Baerheim AA. Factors affecting general practitioners' decisions about plain 
radiography for back pain: implications for classification of guideline barners-a qualitative study. 
BMC Health Serv Res 2003;3:8. 
31. Legare F, Ratte S, Gravel Κ, Graham ID. Barriers and facilitators to implementing shared decision­
making in clinical practice: update of a systematic review of health professionals' perceptions. Patient 
Educ Couns 2008;73:526-35 
32. Peters-Klimm F, Campbell S, Hermann K, Kunz CU, Mùller-Tasch T, Szecsenyi J. Case 
management for patients with chronic systolic heart failure in pnmary care the HICMan exploratory 
randomised controlled trial. Competence Network Heart Failure. Trials 2010,17:56. 
33. Schillmger D, Handley M, Wang F, Hammer H. Effects of self-management support on structure, 
process, and outcomes among vulnerable patients with diabetes: a three-arm practical clinical trial. 
Diabetes Care 2009;32:559-66. 
34. Bosch M, Wensing M, Bakx JC, van der Weijden T, Hoes AW, Grol RP. Current treatment of chronic 
heart failure in primary care; still room for improvement. J Eval Clin Pract 2010;16:644-50. 
35. Wensing M, van den Hombergh P, Akkermans R, van Doremalen J, Grol R. Physician workload in 
primary care: what is the optimal size of practices? A cross-sectional study Health Policy 2006, 
77:260-7. 
36. Morgan CL, Beerstecher HJ. Practice size and service provision in primary care: an observational 
study. Br J Gen Pract 2009,59:e71-77. 
37. Campbell SM, Hann M, Hacker J, Burns C, Oliver D, Thapar A, Mead N, Safran DG, Roland MO. 
Identifying predictors of high quality care in English general practice: observational study. BMJ 
2001;323:784-7. 

Chapter 13 
General discussion 
194 Chapter 13 
In this chapter we will first present the most important findings of the studies 
described in this thesis. We will then discuss the results and, after providing some 
methodological considerations, we will discuss the implications for practice and for 
further research. 
Main findings 
Section I: Cardiovascular risk management: performance indicators and current 
primary care 
Data from the EPA Cardio project provided actual international information on 
cardiovascular risk management. With respect to coronary heart disease (CHD) 
patients, primary care practices in Europe achieved indicator scores (expressed as 
a percentage of the maximum score) from 45% (recording of advice on physical 
activity; systolic blood pressure and LDL cholesterol below treatment targets) up to 
about 95% (blood pressure recording). We found differences between countries, 
but also room for improvement in all countries. The results from the high risk 
patient group were comparable to those from the CHD group. In addition, we 
assessed patient-reported risk factors and lifestyle in adults aged 18 to 45 without 
cardiovascular disease (CVD) or diabetes. Sixty percent reported on the presence 
of at least one risk factor and higher numbers of risk factors were related to more 
visits to the primary care practice, offering possibilities for preventive interventions. 
A separate study on the performance indicators used to assess quality of 
cardiovascular risk management showed that the results of an indicator 
development procedure partly depends on the panel composition. Though we 
found high consistency between health professionals and other stakeholders, 
differences were found between the panels on indicators related to innovative 
organizational aspects. Health care professionals tended to include fewer 
indicators than other stakeholders. In the process of developing indicators, careful 
consideration on the panel composition is thus essential. 
Section II: Organization of chronic illness care and prevention 
Use of clinical information systems and availability of decision support was highly 
prevalent across general practices in the EPA Cardio project, reflecting high levels 
of information technology in the practices included. In other domains of practice 
organization, such as self-management support and delivery system design, mean 
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scores were about 50% with high variation between and within countries Use of 
information technology and self-management support appeared to be linked to 
better quality of cardiovascular care The UK and Spam had the highest scores on 
the various organizational domains These countries were among those with the 
largest practice populations and the largest number of supportive staff members 
Information exchange within primary care practices provides a new angle for 
research on contextual factors associated with cardiovascular risk management 
We developed and successfully tested a method for measuring the network of 
information exchange connections between health professionals We also 
examined the wider healthcare systems Countries have various health care 
systems with a different strength of primary care We found that successful 
programs for improving cardiovascular risk management shared a number of 
characteristics targeting at health care professionals, educational aspects 
included, and evaluation included Furthermore, we found a focus on disease 
management in countries with a strong primary care system versus a focus on 
lifestyle programs in countries with a weaker primary care system 
Section III Improving primary care for patients with chronic heart failure 
We developed a practice-based implementation program to improve primary care 
for chronic heart failure We pilot tested the program and it proved to be feasible 
as well as to provide promising results A vast majority of the GPs positively 
judged the various elements of the program In 9 out of the 77 included patients, 
drug therapy or dosage had been adjusted in line with the recommendations A 
larger group received lifestyle advice and three extra patients received an 
influenza vaccination To better address the collaboration we adapted the program 
materials to the newly launched multidisciplmary practice guideline on CHF On 
the basis of this pilot we developed a study protocol for an RCT to test the 
program on improving primary care for chronic heart failure, comparing a standard 
and a tailor-made approach 
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Discussion of the main findings 
Section I: Cardiovascular risk management: performance indicators and current 
primary care 
We did not identify other large-scale international studies on CVRM in European 
primary care. In hospital settings, large international surveys have been launched 
by the European Cardiology Society: EUROASPIRE I, II, and III. In these three 
surveys CHD patients were recruited from hospitals.1 Uncontrolled blood pressure 
(SBP>140 mmHg and/or DBP>90 mmHg) was found in about 60% of these survey 
samples. Raised cholesterol levels (defined as >4.5 mmol/l) were reduced from 
95% in EUROASPIRE I, to 77% in the second survey and finally to 46% in the last 
survey. The results of the most recent EUROASPIRE survey in 2006 and 2007 are 
comparable to our results. In the Pinnacle program, data regarding outpatients 
from cardiology offices, too, show results comparable to our results. Patients 
received for instance antiplatelet and statin therapy in about 85%.2 In drug trials, 
with an optimum situation for drug therapy, efficacy of statins varies from 60 to 
90% in achieving LDL < 2.5 mmol/l.3"6 Therefore, the real life results in our 
observational study, with a random sample of all patients known to have CHD, can 
be judged to be as good as those within the same range, albeit on the lower end. 
Risk factor recordings showed marked deficiencies across Europe with room for 
improvement in all countries. The results in the UK were significantly better than 
the average of all countries, which may be related to the UK Quality and Outcome 
Framework (QOF), as the EPA Cardio matched closely with the QOF indicators for 
CVRM.7 In the Netherlands, the one indicator with a financial incentive - the 
influenza vaccination - outperformed all others, though Dutch indicator scores in 
general were below the average across the European countries participating in 
EPA Cardio. This suggests that financial incentives are associated with better 
performance, but the observational design of our research does not allow for firm 
conclusions. 
Furthermore, differences in quality of CVRM between countries may be partly 
explained by differences in the quality of recording. Medication and blood pressure 
or cholesterol levels are probably well recorded, but this is less the case for 
smoking status or exercise advice. The same is true for promoting physical 
activity, although it remained uncertain whether such advice had been provided 
but had not been recorded. It might be argued that recorded care does not mirror 
the care provided. But in chronic illness care recording is thought to be essential, 
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being a prerequisite to select patients for treatment. Furthermore, collaboration 
between various health care professionals, who will need to rely on the data in the 
patient records, is crucial. 
In our Dutch procedure (Vitale Vaten), in which we developed indicators related to 
CVRM, we involved a multidisciplinary health care professional (HCP) panel and a 
stakeholder panel. The stakeholder panel comprised among others 
representatives of patient organizations and insurance companies, members of 
scientific organizations, a panelist from the health department and from the health 
inspectorate. Only a few of the stakeholders rated the clinical indicators, so the 
HCP panel determined the selection of these indicators. The high consistency 
between EPA Cardio and Vitale Vaten indicators may be a result from the fact that 
cardiovascular risk management is a primary care activity, so the perspective of a 
multidisciplinary panel may not have changed much compared with a panel of GPs 
only (as in EPA Cardio). Our findings underlined the robustness and validity of the 
indicators used in EPA Cardio.9 
Organizational indicators on an individual treatment record and an explicitly 
appointed central care giver were rated valid by the stakeholders but not by the 
HCP. Lack of supportive evidence may be a reason, although in diabetes care 
similar organizational working methods were evaluated positively.10,11 Another 
explanation may be that HCPs do not favor organizational characteristics like self-
management support. Our preset requirement that indicators were validated when 
rated valid by both panels gave a decisive role to the most restrictive panel, the 
HCP in our study, as in previous studies.12,13 
Scope and aim of the indicators will have to define the role of the HCP and the 
stakeholders. Apparently, clinical indicators are best validated by HCP. On the 
other hand, indicators linked to innovation and organization of care may very well 
be developed with the help of stakeholders. Other procedures like focus group 
discussions may be more appropriate. The outcomes of our procedure were used 
as input by a steering committee and finally a set of indicators was agreed upon by 
consensus.14 
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Section II: Organization of chronic illness care and prevention 
We explored the role of various organizational factors in providing structured 
chronic care. In the organizational framework of the Chronic Care Model (CCM) 
these factors have been categorized according to six domains.15,16 Scores on the 
domains 'clinical information systems' and 'decision support' were high across 
countries, reflecting high levels of information technology implemented in the 
practices included. In the other domains, such as self-management support, mean 
scores were about 50% with much variation between and within countries. 
In several studies primary care practices with an organization of care in line with 
one of the domains of the CCM or with the CCM in general showed better 
outcomes.17"25 However, the research evidence related to structured chronic care 
does not overwhelmingly support its positive impact on health outcomes.26,27 It 
may be equally important to strengthen the capacity of the wider health system to 
provide optimal chronic illness care. Features that have been linked to the strength 
and integration of primary care within the health care system comprise features 
such as 'first contact', longitudinality, comprehensiveness, coordination, 
community orientation, access, location and family centeredness.28 Indeed, we 
found that a stronger primary care orientation was associated with higher scores 
on the organizational aspects. 
Offering preventive services is one of the characteristics of the 
comprehensiveness of the care system, requiring a well-defined patient 
population.29 This proactive approach is much favored by a system where patients 
have been registered. Austria, Germany and Switzerland did not report on patients 
listed or registered, which was reflected in rather low scores in the domain 
'delivery system design'. In some countries GPs are - at least to some extent - not 
allowed to contact patient populations. As part of disease management programs, 
some interesting developments occur in several countries with a weak position of 
primary care, as for instance in Germany. 
'Self-management support' showed considerable variation between countries and 
between practices within countries. It is one of the pillars of the CCM, as it is the 
factor that should empower patients to take an active role in the management of 
their disease. The score was only high in the UK; in all other countries scores 
varied from 20 to 70%. Patient empowerment and self-management support very 
much involve the roles of both parties in the medical contact, the patient and the 
doctor or the medical team, and sharing responsibilities. There is much to win with 
a better implementation of tools that support patients' self-management. Better 
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practice organization was associated with better risk factor registration, antiplatelet 
prescription and influenza vaccination in CHD patients. When testing the various 
domains, we found that not all had equal effects on performance. The components 
'self-management support' and 'clinical information system' proved to be most 
consistently related to cardiovascular risk management. This finding underpins the 
importance of self-management support as emphasized in models of chronic 
illness care. 
In several national studies, the influence of practice size on care processes and 
outcome indicators showed a tendency to more or better services in larger 
practices.19,30 33 However, our results did not support this effect of larger practice 
size. The relatively small sample of practices may have made it difficult to identify 
significant associations. The variable presence of assistants and nurses in the 
practices could be another practice-related factor associated with better 
outcomes.34,35 Across countries, we found large differences in numbers of staff 
members. The presence of nurses or clinical assistants may be crucial to deliver 
comprehensive chronic care for large groups. In countries such as Finland, Israel, 
Spain, and the UK sufficient staff seems available in practices to achieve this. 
A substantial proportion of the variation in risk factor recording, antiplatelet 
prescribing, and influenza vaccination in patients with CHD was accounted for at 
practice level. Differences between primary care practices within a country were 
often larger than those between countries, even though several practice 
organization characteristics are determined by the national health systems. For 
instance approaching patients for preventive activities, on the basis of registration 
of these patients on a list, is highly dependent on the national organization of the 
health care system. This underlines the importance of practice organization for the 
quality of cardiovascular risk. 
Section III: Improving primary care for patients with chronic heart failure 
We developed a program to improve primary care for patients with CHF, which in a 
pilot test proved to be feasible. We also found clinically relevant improvements, 
particularly regarding lifestyle advice. The program was positively assessed 
regarding all elements. 
So far, only few randomized controlled trials evaluated programs for the 
improvement of heart failure care in primary care.36Jt0 These programs were 
mostly nurse-led, used computer-based treatment suggestions, or focused on 
practice guideline recommendations and disease management programs. As 
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results were not consistent, further effort is necessary to develop effective 
improvement programs. Our program is multifaceted, providing educational and 
organizational elements. 
In our sample more patients used ACE-inhibitor or ARB and beta-blocking agents 
than found in previous research.41^6 These relatively high percentages may 
indicate a selection of practices or patients, but may also reflect the fact that our 
data had been collected more recently. Though treatment was already good there 
was still room for improvement, and the percentage of patients who received 
improved drug therapy during the pilot phase reflects percentages found in 
previous studies of implementation interventions.47 
As we evaluated results in 15 general practices, further research is necessary to 
prove the effects on patient outcomes. We adapted the program materials from the 
pilot phase to be consistent with the new multidisciplinary practice guideline. We 
designed a study with a focus on tailoring the intervention to barriers assessed by 
the GPs in half of the practices. 
Various classifications of barriers (and facilitators) exist. In a systematic review a 
conceptual framework with knowledge, attitude, and behavior as main factors is 
proposed.48 Our choice of barriers is based on a list rigorously developed in the 
Netherlands with a literature study in 2002, expert input, and tested in various 
projects in the Netherlands.49 Our main factors for ordering the barriers are related 
to the innovation, the healthcare professional, the patient, and the context. The 
barriers presented in this study correspond very well to the barriers found most 
often in the review, including time pressure and lack of applicability. Several 
studies were conducted to assess the effect of tailoring implementation. In a 
systematic review, the authors conclude that identifying barriers and tailoring 
intervention to these barriers may improve clinical practice compared to no 
intervention and to guideline dissemination.50 In their meta-analysis including eight 
studies identified with a non-tailored intervention in the control group, they report a 
modest effect of tailoring. 
Methodological considerations 
Most studies in this thesis have been based on the European EPA Cardio 
project.51,52 This project in 11 countries encompassed several work packages, one 
building upon the other. This project includes various strong elements, among 
others the rigorous indicator development and the extensive testing of the 
materials and procedures used in the study.9,53 The main body of the project 
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comprised of observational research. The project was launched with initially a 
convenience sample of nine European countries: Austria, Belgium, Finland, 
France, Germany, the Netherlands, Slovenia, Switzerland, and the UK. Israel 
participated in the project meetings and in most work packages. Spain (or more 
precisely Cataluna) joined in later. The national situation in each country 
influenced possibilities for participation in the study, for instance for practice and 
patient inclusion. Ideally, inclusion was random from a national or regional list.54 
To approach this optimum as well as possible every country was asked to provide 
a stratified sample, considering the number of GPs working in the practice and 
urbanization. Within these strata countries were encouraged to form extra strata 
when few strata would encompass almost all practices. Practice size was 
considered large with two or more full time equivalent (fte) GP and small with up to 
two fte GP. Defined like this, in the UK almost all practices are large. In the UK the 
large practices were further stratified (up to or more than five fte GP). In the 
Netherlands on the other hand, most practices are small according to this 
definition. This stratum was split up in single handed and duo practices. Likewise, 
Germany and Slovenia made extra urbanization strata. Some inclusion bias 
related to practices was inevitable because of the fact that practices that 
consented to participate in the project were asked to perform some extra work. In 
two countries, Austria and Switzerland, practices had to be contacted by the 
country coordinator and here only a convenience sample was possible. Still, we 
think that we managed to gather information on a unique practice sample, as close 
as possible to normal practice across our country sample without confining to for 
instance academic practices. 
Patient selection was slightly different across countries. In most countries patients 
were selected from practice patient lists. In France eligible patients were asked for 
participation during a practice visit and in Austria, Switzerland, and some German 
practices patients were included based on recalling patients. Data collection from 
the patient files was done with a paper-based audit form and performed uniformly 
in all countries except Spain. Here, data extraction was performed electronically, 
limiting the data extraction results to those data recorded in a coded way. 
On the other hand, a potentially strong feature of our study was the international 
focus, which controls to some extent the variation across health care systems. 
Conclusions valid in an international sample are more robust than conclusions 
based on data from one healthcare system with its peculiarities. For this reason 
many analyses are multilevel controlling for the fact that patients are nested in 
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practices, and practices nested in countries. Outcomes allow for conclusions 
across countries. 
During the project phase, a discussion emerged on patient inclusion in the 
Netherlands. All patients coded with CHD were selected and from this list a 
random sample was included. During data collection participating GPs wondered 
whether their scores might be negatively influenced because of missing data in the 
patient records for the patients treated in secondary care. From that point on we 
added a question about the responsible physician for treating CHD. Comparing 
data with this extra information showed that the audit results for patients treated in 
secondary care did not deviate negatively from those treated in primary care. 
[Unpublished data] Therefore, this did not introduce bias. 
In some countries results may deviate positively because of inclusion bias. 
Including patients while they visited the practice, based on drug therapy lists or by 
remembering them will favor the inclusion of patients being treated and showing 
up. Although inclusion bias may have played a role, we feel confident that our 
sample with the possibilities given in this international project was the best 
possible within the constraints of time and budget. Furthermore, multilevel 
techniques were used in our analyses across countries relating practice 
characteristics to patient outcomes. In our research, we are not that much 
interested in differences between countries but rather in associations across 
countries and due to the multilevel approach these analyses will suffer less from 
patient inclusion bias. 
Implications for practice and future research 
In our EPA Cardio project we focused on three patient groups: 1. patients with 
established CVD, that is coronary heart disease; 2. patients without established 
CVD but at high risk, based on a risk factor assessment; and 3. healthy adults 
aged 18 to 45 years. Our large international studies showed that primary care can 
provide high quality cardiovascular risk management. Nevertheless, there is room 
for further improvement and further research is needed to study how this 
cardiovascular prevention can be improved. The variation between practices within 
each country is unwanted. Specific examples of 'best practices' in some countries 
can provide lessons for other countries. For instance, the Quality and Outcomes 
Framework from the UK is an interesting example for other countries, although the 
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use of a pay for performance strategy in other countries may require adaptations 
according to the national situation. 
A number of specific organizational characteristics of a practice showed to be 
related to better CVRM in CHD patients. Working in line with the Chronic Care 
Model in general appeared beneficial; especially the use of information technology 
and self-management support is important. Information technology certainly opens 
up many opportunities for chronic care management (although they have not been 
fully utilized yet), including computerized protocols guiding the health care 
professionals through all relevant issues, helping with recording; reminders and 
warnings related to drug therapy; information systems with access for health care 
professionals from different disciplines and with access for patients. But 
computerization is also helpful in other domains of organization. It can be used to 
select and monitor patient groups as well as for self-management support, 
providing information tailored to the patient. 
Well-organized self-management support concerns activities to enhance patients 
managing their own condition. The patient has a basic right to participate in 
decisions about his or her condition and treatment. An active and involved patient 
can support improved outcomes. This requires an informed patient taking his or 
her responsibility, as well as a practice team with a policy and attitude allowing for 
such a role. Self-management demands tailoring care to the patient's needs, 
desires, and possibilities. However, such a tailoring will take great effort to 
implement. 
The patient and consumer organization in the Netherlands recognized the 
importance of self-management support and initiated a project focusing on several 
patient groups with chronic conditions. In this project condition oriented groups 
worked parallel to make an inventory of self-management programs available.55,56 
Next, cross sectional groups will develop materials for special groups independent 
from the underlying condition. This should lead to self-management tools for 
patients with chronic conditions like chronic heart failure or COPD, taking into 
account ethnicity, social class, literacy, etc. 
In contrast to previous research we found that practice size had little influence on 
the quality indicator scores. In various studies larger practices tended to perform 
better, supporting the development of practice collaboration with consequently 
larger groups of CHD patients to organize care.19,3033 Practice size is a crude 
measure, which may have little explanatory power itself but is associated with 
many other practice features. A single-handed practice might provide specific 
advantages, for instance due to contact from person to person. More research is 
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needed to assess the optimal practice size. Optimal practice size for 
cardiovascular risk management might differ from the optimum for other chronic 
conditions. 
All together, this may suggest that a checklist of characteristics of an ideal general 
practice (from the perspective of CVRM) may be a helpful tool for improving 
CVRM. Such a checklist would include items related to the domains of the chronic 
care model. 
The strength of primary care in previous research very much determined the 
possibilities for chronic care. A strong primary care system with patients being 
listed and the possibility to contact them to offer preventive services is beneficial 
to chronic care management. All countries have large implementation programs for 
the improvement of chronic care. Interesting developments occur in several 
countries with a weak primary care. In disease management programs (DMP) in 
e.g. Germany and France the position of the GP is strengthened, helping to 
implement better chronic care for various patient groups. A pitfall in countries with 
a strong primary care system seems to be that lifestyle improvement advice might 
gain less attention. 
Adults without established CVD or diabetes and aged 18 to 45 years formed our 
third group in the EPA Cardio project. At this moment, primary prevention related 
to CVD in this age group is largely addressed by public health with population 
oriented lifestyle programs. Our study showed that even in this age group over half 
of the people have one or more risk factors. Those with several risk factors will 
eventually develop high risk with an indication for drug therapy and lifestyle advice. 
To prevent this they could be included in personalized preventive activities. Here, 
primary care can play an important role. We showed that people - not patients, we 
included only those without established CVD or diabetes - with more risk factors 
visit their primary care practice more frequently. This offers opportunities for case 
finding. Both in the UK and in the Netherlands initiatives have been launched to 
enhance a programmatic approach to cardiovascular prevention (in the 
Netherlands e.g. the practice guideline on prevention, module cardio metabolic 
risk).57 Further research will be needed to test what method is to be preferred by 
the patients and in terms of effectiveness and cost effectiveness. Such attention 
for this yet healthy group demands extra efforts and extra staff. Here, larger 
practices or collaboration between practices may have the advantage of scale, 
with differentiation and expertise. Moreover, with larger patient groups care might 
become more cost-effective. 
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The information exchange network within a primary care practice is a practice 
characteristic that has hardly been studied yet. This field of research is highly 
relevant to primary care, because primary care professionals collaborate most of 
the time in networks rather than in formalized patient care teams. Only one 
previous study reported assessing information networks within a primary care 
center, based on time-consuming direct observations by researchers.58 The way of 
thinking on health care professionals related to one patient or patient group in 
terms of information exchange networks opens up new possibilities, but also asks 
for new methods to be developed and tested. In a recent study we related quality 
of care to network characteristics in two patient groups: patients with diabetes and 
patients with heart failure.59 We were able to show differences between practices, 
with differences in practice performance as well. In future research we hope to 
assess possibilities to improve patient care making use of the knowledge on 
network characteristics, for instance by targeting the most influential health care 
provider within the network or by strengthening network characteristics that 
support implementation. 
In our planned chronic heart failure implementation program we will study the 
effect of tailoring the implementation. Much research is needed on the best ways 
to analyze barriers and facilitators and to tailor interventions to these findings. In 
an international collaboration our research group started with a project to research 
the role of tailoring in the implementation of better quality of chronic primary care 
(TICD). Our group will focus on chronic kidney disease (CKD) and CVRM, 
comparing several methods of tailoring and assessing the contribution of tailoring. 
Other countries focus on multi morbidity, obesity, depression, and COPD. The aim 
of this project is to provide recommendations on how to develop implementation 
programs best suited for the problems encountered. 
In the Netherlands diabetes care is relatively well developed in care groups, which 
provide support to care providers on a regional level. As patients are listed within 
general practices, the GPs form the starting point for the multidisciplinary 
collaborative. The care group support includes content support but also the 
collaboration between various disciplines engaged in diabetes care and the 
financial contracts with the insurance companies. Similar programs for other 
chronic conditions have been developed related to COPD care and CVRM. 
Furthermore, health care professionals may develop local networks within the 
communities to provide CVRM. In the general practices, in close collaboration with 
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healthcare professionals from other disciplines, the challenge is to provide patient 
oriented care based on the disease oriented programs. This demands an effort 
especially in those -mostly elderly- patients with several chronic conditions, 
preventing several parallel working programs, asking for case management. 
From the results in this Ph.D. thesis it appears to be important that especially self-
management support and the use of information technology are strengthened. 
Both the Dutch College of GPs (DCGP) and the Association of GPs (LHV) invest in 
chronic illness care, on the contents and requirements respectively, and it is 
important that they focus on these elements. The care group model as used in 
diabetes care will meet the requisites for patients with established CVD and 
patients at high risk for CVD. The best policy related to primary prevention in 
young adults has yet to be found. Public health programs will probably continue to 
play a role, and the role of e-health is likely to expand, but the role of the GP in risk 
assessment and personalized primary prevention is not clear yet. The recently 
launched module on prevention of cardiovascular disease, diabetes and chronic 
kidney disease needs to be evaluated.57 
In the Netherlands, the Ministry of Health faces budgetary problems. Integrated 
care, largely comprising the care groups, is held responsible for € 70 million 
budget deficit in 2010 and GPs will face a tariff cut down for this.60 It remains 
unclear to what extent a better organized primary care for chronic conditions pays 
off in terms of lowered expenses in hospital and homecare services, but the costs 
of primary care for chronic conditions tend to be substantially lower compared to 
ambulatory hospital care. The overall quality of chronic primary care, at least for 
CVRM, is good, suggesting good value for money. 
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Chapter 1 
In the first chapter we introduce the topics of this thesis. All studies focus on 
practice characteristics and practice organization related to the quality of care of 
cardiovascular risk management (CVRM) in primary care. Both patients with 
established cardiovascular diseases (CVD), chronic heart failure included, and 
healthy people with risk factors to develop CVD are considered. 
Chapter 2 
Most studies in this thesis are based on the EPA Cardio project. This international 
project was designed to improve CVRM in primary care. An important part of the 
project was an observational study; in chapter 2 we describe the study protocol. 
This study aims to provide internationally comparative data on CVRM provided in 
primary care and on health-related lifestyles of patients in Europe. The study also 
explores the views of doctors and patients on innovative preventive services for 
CVD. 
An observational cross-sectional study was planned. In 10 European countries, 
stratified samples of 36 practices per country were to be recruited, and in each 
practice, three samples of 15 patients each were to be sampled: patients with 
coronary heart disease, patients at high risk for CVD, and healthy adult patients. 
The quality of CVRM was specified in terms of 44 performance indicators that 
resulted from an international Delphi-procedure with general practitioners (GPs). 
Most indicators were based on medical records, while others were based on a 
structured interview with a contact person from the practice. Lifestyle (smoking, 
physical activity, diet) was to be measured with previously validated patient 
questionnaires. Additional measures included practice characteristics and their 
exposure to programs to improve cardiovascular care. 
Chapter 3 
In chapter 3 we present the results of audit data related to the quality of CVRM in 
patients with coronary heart disease (CHD) in primary care. In an observational 
study in 8 countries we sampled CHD patients in primary care practices and 
collected data from the patient records. CVRM was measured on the basis of 
internationally validated quality indicators. Furthermore, we explored the impact of 
practice size. 
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In 2960 CHD patients from 181 practices we found substantial variation across 
countries on all CVRM indicators. Rates of risk factor recording varied from 55% 
for physical activity to 94% for blood pressure. Success rates for the treatment 
targets for systolic blood pressure, diastolic blood pressure and LDL cholesterol 
were 46%, 86% and 48% respectively. Rates for providing recommended 
cholesterol lowering and antiplatelet drugs were around 80%, and 70% of the 
patients obtained an influenza vaccination. Practice size was not associated to 
indicator scores with one exception: In Slovenia larger practices performed better. 
Variation was explained at the practice level more than at the country level. 
We concluded that CVRM showed wide variation within and between countries 
and can improve in all countries involved. Practice size was not found to be 
associated with higher scores except in Slovenia. 
Chapter 4 
Clinical guidelines recommend the detection and registration of patients with a 
high risk to develop CVD. For this reason individual's absolute cardiovascular risk 
needs to be assessed. Effective interventions to reduce cardiovascular risk are not 
fully implemented. The aim of the study presented in this chapter was to assess 
the quality of cardiovascular risk factor recording and lifestyle counseling in high 
risk patients in European primary care and to identify factors related to these 
clinical processes. We performed an international cross-sectional observational 
study in stratified samples of primary care practices in nine European countries. 
Patient records were audited and to identify associated factors, additional data 
were collected in a patient questionnaire. 
In 268 general practices across Europe, 3723 records of individuals at high risk for 
cardiovascular diseases were audited. 
The quality of documentation of risk factors and lifestyle intervention varied. Risk 
factor recording was best for blood pressure (92.5% of audited records, 95% CI 
0.89-0.96). Regarding lifestyle advice, recording was best for smoking cessation 
(65.6%, 95% CI 0.58-0.73) and worst for physical activity (38.8%, 95% CI 0 .31-
0.47). Of the study population, 50.6% (0.42-0.59) had elevated blood pressure 
levels, 59.8% (0.51-0.69) had total cholesterol >5 mmol/l, and 30.5% (0.22-0.39) 
was smoker. Multivariate analyses showed that the recording of risk factors and 
counseling were more related to specific patient characteristics than to country 
effects. The analysis of different country results can be helpful for developing 
quality-improvement strategies. 
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Chapter 5 
Chapter 5 describes a study focussing on lifestyle and cardiovascular risk factors 
among adults aged 18-45. Many young adults have unhealthy lifestyles, which 
puts them at increased risk of poor health outcomes. Most individuals in this age 
group attend GPs infrequently, limiting the opportunities for opportunistic case 
finding and health promotion. In this study we aim to describe health-related 
lifestyles associated with cardiovascular risk in this age group. 
A postal survey study was conducted in samples of adults within the pre set age 
group; patients with establishes CVD or diabetes were excluded. Patients were 
recruited from samples of GPs in Austria, Belgium, England, Finland, France, 
Germany, Israel, the Netherlands, Slovenia and Switzerland. We measured six risk 
factors: smoking status, body mass index (BMI), diet, physical activity, 
hypertension, and hypercholesterolemia through the use of a patient 
questionnaire. With the number and variety of risk factors as outcomes we 
performed a logistic multilevel analysis with predictors including patient's age, 
gender, having a partner, being employed, level of education, and number of 
practice visits annually. 
A total of 3892 adults provided valid data; 40% reported no risk factors, 35% one, 
19% reported two, and 6% three or more. Adults visiting their GP more than once 
a year showed to have more risk factors. The average number of risk factors 
raised from 1.41 in patients with up to 1 yearly practice visit to 1.71 with more than 
3 visits. 
We concluded that a majority of adults had an increased cardiovascular risk due to 
the presence of one or more risk factors. These adults tended to visit their GPs 
more than once a year, offering opportunities for prevention. Further research 
should examine the effectiveness of preventive activities in this age group. 
Chapter 6 
Delphi procedures are frequently used to develop performance indicators, yet little 
is known about the validity of this method. In chapter 6 we describe a study aiming 
to examine the consistency of indicator selection across different procedures and 
across different panels. 
For this reason we analyzed three indicator set development procedures related to 
CVRM: the EPA Cardio project, which worked with international GP panels; the 
UniRap project, a Dutch GP indicator project; and the Vitale Vaten project, which 
used a national multidisciplinary health professional panel and a stakeholder 
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panel. Indicator sets from EPA Cardio and UniRap were rated in the Vitale Vaten 
procedure. 
With respect to clinical indicators, consistency between procedures varied 
according to the origin of the indicators. In Vitale Vaten the multidisciplinary panel 
of health professionals validated 63% of the international EPA Cardio indicators 
again. From the UniRap GP set only 13% revalidated. Considering organizational 
indicators, 27 indicators were rated in both EPA Cardio and Vitale Vaten. In the 
Vitale Vaten project 17 indicators (63%) were validated, including eight of the nine 
indicators validated in EPA Cardio. Consistency between panels was moderate, 
giving a decisive role to the health professional panel, being the most critical. 
The consistency of selected performance indicators varied across procedures and 
panels. Further research is needed to identify underlying determinants leading to 
this variation. 
Chapter 7 
The number of patients with chronic diseases is increasing, which poses a 
challenge to healthcare organizations. A proactive, structured, and population-
orientated approach is needed: the Chronic Care Model (CCM) provides such a 
framework. 
With our international observational study described in this chapter we aimed to 
assess organizational conditions for providing structured chronic care according to 
the CCM across different healthcare systems. 
We collected data with practice questionnaires and interviews in a stratified 
sample of 315 primary care practices in Austria, Belgium, England, Finland, 
France, Germany, Israel, the Netherlands, Slovenia, Spain, and Switzerland. 
Outcome measures were mean practice scores on CCM domains per country, as 
a percentage of the maximum score, and the influence of practice size and 
urbanization on these scores. 
Practice size showed large differences with the largest practices in Spain, 
England, Finland, and Israel. These countries, with a strong primary care 
orientation, had most physicians and staff involved per practice. The CCM 
domains 'clinical information systems' and 'decision support' had total practice 
means of 90% while other domains scored about 50%. Spain and England scored 
above average on almost all domains. Practice size and urbanization had little 
impact. 
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We concluded that characteristics for chronic care delivery differed across 
countries for most CCM domains. The most common characteristics related to 
computerization, providing a good starting point and high potential in all countries. 
Further research should focus on relations between practice characteristics and 
organizational features, including health system and primary care orientation, and 
outcomes. Primary care seems suited for chronic care delivery; however, a 
stronger primary care was associated with better scores. 
Chapter 8 
Policies in many countries are aimed at strengthening primary care in order to 
provide reliably recommended treatments to patients with chronic diseases. The 
international study in chapter 8 examined the associations between primary care 
organization and CVRM provided to coronary heart disease (CHD) patients in 
Europe. 
We performed a chart audit in randomly sampled patients from primary care 
practices in Austria, Belgium, England, Finland, France, Germany, the 
Netherlands, Slovenia, Switzerland, and Spain. CVRM was measured using 
validated indicators: risk factor recording, anti platelet therapy, influenza 
vaccination, blood pressure levels (systolic <140, diastolic <90 mmHg), and LDL 
cholesterol <2.5 mmol/l. Structured questionnaires were used to document 
practice organization. In multilevel regression analyses we examined the effects of 
practice organization on CVRM. 
For the analyses we used the record data from 4563 CHD patients recruited in 273 
primary care practices. Better organization of the primary care practice was 
associated with better scores on three indicators: risk factor registration 
(B=0.0307, p<0.0001), antiplatelet therapy (B=0.0519, p=0.0245), and influenza 
vaccination (B=0.1174, p<0.0001). Practice organization accounted for 21 to 27% 
of the variation on these indicators, while country characteristics accounted for 
another 10 to 20%. No associations between practice organization and recorded 
blood pressure or cholesterol levels were found. Self-management support and 
use of clinical information systems were the organizational dimensions most 
consistently linked to performance indicators. 
So, across different healthcare systems, better organization of primary care 
practices was associated with better CVRM in patients with CHD. This finding 
supports investments in chronic care organization. 
Summary 217 
Chapter 9 
Information exchange networks for chronic illness care may influence the uptake of 
innovations in patient care. Valid and feasible methods are needed to document 
and analyze information exchange networks in health care settings. In the 
observational study presented in this chapter we examined the feasibility of a 
questionnaire for data collection on information exchange networks. We focused 
on the networks within primary care practices, related to chronic heart failure, 
diabetes and chronic obstructive pulmonary disease. 
This study was linked to a quality improvement project in the Netherlands related 
to chronic heart failure care. All health professionals in the 10 participating 
practices were asked to complete a short questionnaire that documented their 
information exchange relations. 
Feasibility was determined in terms of response rates and reliability scores were 
based on the reciprocity of receiving and providing information. For each practice, 
a number of network characteristics were derived for each of the chronic 
conditions. 
The response rates were high in all but one of the participating practices. For the 
analysis we used data from 67 health professionals from eight practices. The 
agreement between receiving and providing information was, on average, 65.6%. 
The values for density, centralization, hierarchy, and overlap of the information 
exchange networks showed substantial variation between the practices as well as 
between the chronic conditions. The most central individual in the information 
exchange network could be either a nurse or a physician. 
Further research is needed to refine the measure of information networks and to 
test the impact of network characteristics on the uptake of innovations. 
Chapter 10 
Primary care plays a central role in the prevention and management of 
cardiovascular disease and various countries have launched programs to improve 
this care. We collected information on 42 programs to improve CVRM in 11 
countries (Austria, Belgium, Finland, France, Germany, Israel, the Netherlands, 
Spain, Slovenia, Switzerland, the United Kingdom). In chapter 10 we present an 
analysis of these programs. We expected that countries with strong primary care 
systems would have programs to improve management of disease, but wondered 
how they dealt with lifestyle interventions delivered in primary care. 
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In this observational comparative study we gathered program data using country 
coordinators and key informants. Most programs (95%) were targeted at health 
professionals; 86% of these provided education. Evaluation was part of all 
programs. In countries with a strong primary care system, 63% of the programs 
focused exclusively on disease management, 29% on lifestyle interventions, and 
8% on both. In countries with a weak primary care system, 22% of the programs 
focused on disease management and 78% on lifestyle improvement. 
Concluding, our findings suggest that a strong primary care system is likely to 
make efforts to improve disease management, but not necessarily efforts to 
improve delivery of lifestyle interventions. This may be a missed opportunity, given 
the potential of primary care to influence lifestyle. 
Chapter 11 
Many patients with chronic heart failure (CHF) receive treatment in primary care, 
but data have shown that the quality of care for these patients needs to be 
improved. Chapter 11 reports the pilot test of a program for improving primary care 
for patients with CHF, evaluating the impact and feasibility. 
We performed an observational study in 19 general practices in the south-eastern 
part of the Netherlands; the evaluation involved 15 GPs and 77 CHF patients. The 
improvement program comprised educational and organizational components and 
was delivered to the practices by a trained practice visitor. For the evaluation we 
used case registration forms completed by health professionals and telephone 
interviews. 
Management relating to diet and physical exercise seemed to have improved as 
eight patients were referred to dieticians and five to physiotherapists. The uptake 
rate of the seasonal influenza vaccination increased from 94% to 97% (75/77). No 
impact on smoking was observed. Pharmaceutical treatment was adjusted 
according to guideline recommendations in 12% of the patients (9/77); 7 patients 
started recommended drug therapy and 2 patients received dosage adjustments. 
GPs perceived the program as feasible. Clinical task delegation to nurses and 
assistants increased in some practices, but collaboration with other healthcare 
providers remained limited. 
The improvement program proved to have moderate impact on patient care. Its 
effectiveness should be tested in a larger rigorous evaluation study using 
modifications based on the pilot experiences. 
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Chapter 12 
We adapted the improvement program for the management of CHF in primary 
care described in the previous chapter. Tailoring has shown to improve the 
success rates of implementation programs, but little is known about what would be 
best methods for tailoring, specifically with respect to CHF in primary care. 
Chapter 12 describes the study protocol of a cluster randomized controlled trial to 
examine the effectiveness of tailoring a CHF implementation program to general 
practices compared to a standardized way of delivering a program. The study 
population will consist of 60 GPs and the CHF patients in their practice. We will 
randomize GPs in blocks of four, stratified according to practice size. With a 
tailored implementation program GPs prioritize the issues that will form the bases 
of the support for the practice visits. These may comprise several issues, both 
educational and organizational. 
The primary outcome measures are patient's experience of receiving structured 
primary care for CHF (PACIC, a questionnaire related to the Chronic Care Model), 
patients' health-related utilities (EQ-5D), and drug prescriptions using the guideline 
adherence index. With patients clustered in practices, we will perform multilevel 
regression analyses to explore the effect of practice size and type of intervention 
program. In addition, we will examine both changes within groups and differences 
at follow-up between groups with respect to drug dosages and advice on lifestyle 
issues. Furthermore, we will assess the program feasibility, goal attainment, 
organizational changes in CHF care, and formalized cooperation with other 
disciplines. Subgroup analyses will be performed based on the distinction between 
systolic CHF and CHF with preserved left ventricular function (diastolic CHF). 
Chapter 13 
In this chapter we summarize and discuss the main findings from the studies 
described. After that we discuss some methodological issues related to the 
observational study in the EPA Cardio project. In the final section we discuss the 
implications. Primary care provides the possibilities to deliver high quality chronic 
care and a good organizational structure favors this quality. Self-management 
support and use of clinical information systems seem to be very important factors 
and especially self management has lately gained attention. The role of general 
practices in the primary prevention of young and healthy adults remains to be 
evaluated. In the Netherlands diabetes care is well structured and our findings 
support a similar disease management approach related to CVRM. Within the 
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general practices such a disease-focused care model needs to be realized within 
the context of the patient population providing personalized care. 
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Hoofdstuk 1 
In het eerste hoofdstuk introduceren we de onderwerpen van deze dissertatie. Alle 
onderzoeken richten zich op praktijkkarakteristieken en praktijkorganisatie in 
relatie tot de kwaliteit van zorg van cardiovasculair risicomanagement (CVRM) in 
de eerstelijnszorg. We richten ons hierbij op zowel patiënten met hart- en 
vaatziekten, inclusief chronisch hartfalen, als op gezonde mensen met 
risicofactoren om hart- en vaatziekten te ontwikkelen. 
Hoofdstuk 2 
De meeste onderzoeken in dit proefschrift zijn gebaseerd op het EPA Cardio 
project. Dit internationale project is ontwikkeld om CVRM in de eerstelijnszorg te 
verbeteren. Een belangrijk onderdeel van dit project was een observationeel 
onderzoek; in hoofdstuk 2 wordt het studieprotocol beschreven. Het doel van dit 
onderzoek is om internationaal vergelijkbare data te leveren met betrekking tot 
CVRM in de eerste lijn, en gezondheid gerelateerde leefstijl van patiënten in 
Europa. De studie onderzoekt ook de opvattingen van artsen en patiënten over 
innovatieve preventieve diensten voor cardiovasculaire aandoeningen. 
We ontwikkelden een observationeel cross-sectioneel onderzoek. In tien Europese 
landen werden gestratificeerde steekproeven van 36 praktijken per land geworven, 
en in iedere praktijk werden drie steekproeven van 15 patiënten geïncludeerd: 
patiënten met coronaire hartaandoeningen, patiënten met een hoog risico op hart-
en vaatziekten, en gezonde volwassen patiënten. De kwaliteit van CVRM werd 
bepaald door middel van 44 prestatie indicatoren die resulteerden uit een 
internationale Delphi-procedure met huisartsen. De meeste indicatoren waren 
gebaseerd op medische dossiers, andere waren gebaseerd op een gestructureerd 
interview met een contactpersoon van de praktijk. Leefstijl (roken, 
lichaamsbeweging, eetpatroon) werd gemeten met vooraf gevalideerde 
patiëntenvragenlijsten. Verdere uitkomstmaten waren praktijkkarakteristieken en 
de deelname van deze praktijken aan programma's met als doel het verbeteren 
van cardiovasculaire zorg. 
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Hoofdstuk 3 
In hoofdstuk drie presenteren we de uitkomsten van dossieronderzoek gerelateerd 
aan de kwaliteit van CVRM in de eerstelijnszorg bij patiënten met coronaire 
hartziekten. In een observationeel onderzoek in acht landen hebben we 
steekproeven genomen van patiënten met coronaire hartziekten in eerstelijnszorg 
praktijken en gegevens verzameld uit hun medische dossiers. CVRM werd 
gemeten op basis van internationaal gevalideerde kwaliteitsindicatoren. Daarnaast 
hebben we de impact van praktijkgrootte onderzocht. 
In 2960 patiënten met coronaire hartziekten uit 181 praktijken vonden we 
substantiële variatie tussen landen op basis van alle CVRM indicatoren. Scores 
voor het rapporteren van risicofactoren verschilden van 55% voor lichamelijke 
beweging tot 94% voor bloeddruk. Slagingspercentages voor de 
behandelingsdoelstellingen voor systolische bloeddruk, diastolische bloeddruk en 
LDL cholesterol waren respectievelijk 46%, 86% en 48%. Scores voor het 
aanbieden van geadviseerde cholesterolverlagende medicatie en plaatjes 
aggregatieremmers was ongeveer 80%, en 70% van de patiënten kregen een 
influenza vaccinatie. 
Praktijkgrootte was niet geassocieerd met indicatorscores met een uitzondering: in 
Slovenië presteerden grotere praktijken beter. De variatie werd voor een groter 
deel verklaard op praktijkniveau dan op landenniveau. 
We concludeerden dat CVRM veel variatie toonde binnen en tussen landen en 
verbeterd kan worden in alle betrokken landen. Praktijkgrootte was niet 
geassocieerd met betere scores behalve in Slovenië. 
Hoofdstuk 4 
In richtlijnen worden aanbevelingen gedaan over de opsporing en registratie van 
patiënten een hoog risico hart- en vaatziekten te ontwikkelen. Hiervoor moet het 
absolute cardiovasculaire risico worden vastgesteld. Effectieve interventies om 
cardiovasculair risico te verminderen worden niet volledig geïmplementeerd. Het 
doel van het onderzoek zoals gepresenteerd in dit hoofdstuk was het bepalen van 
de kwaliteit van rapportage van cardiovasculaire risicofactoren en van leefstijl 
counseling in hoogrisico patiënten in de Europese eerstelijnszorg. Een volgend 
doel was om aan deze klinische processen gerelateerde factoren te identificeren. 
We voerden een internationaal cross-sectioneel observationeel onderzoek uit in 
gestratificeerde steekproeven van eerstelijns praktijken in negen Europese landen. 
Informatie werd geëxtraheerd uit patiëntendossiers, en om geassocieerde factoren 
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te identificeren werden additionele data verzameld door middel van 
patiëntenenquêtes. In 268 huisartspraktijken in Europa werden gegevens 
verzameld uit de dossiers van 3732 individuen met hoog risico op hart- en 
vaatziekten. 
De kwaliteit van verslaglegging van risicofactoren en leefstijlinterventies was 
wisselend. De verslaglegging van risicofactoren was het best voor bloeddruk 
(92.5% van de onderzochte dossiers, 95% Cl 0.89-0.96). Verslaglegging van 
risicofactoren met betrekking tot leefstijladvies was het best voor stoppen met 
roken (65.6%, 95% Cl 0.58-0.73) en het laagst voor lichaamsbeweging (38.8%, 
95% Cl 0.31-0.47). Van de onderzoekspopulatie had 50.6% (0.42-0.59) 
verhoogde bloeddrukwaardes, 59.8% (0.51-0.69) een totaal cholesterol >5 mmol/l 
en 30.5% (0.22-0.39) was roker. 
Multivariate analyses lieten zien dat de verslaglegging van risicofactoren en 
counseling meer gerelateerd was aan specifieke patiëntenkarakteristieken dan 
aan effecten van landen. De analyse van de uitkomsten in verschillende landen 
kunnen gebruikt worden bij het ontwikkelen van strategieën om de kwaliteit van 
risicoregistratie te verbeteren. 
Hoofdstuk 5 
Hoofdstuk 5 beschrijft een onderzoek gericht op leefstijl en cardiovasculaire 
risicofactoren bij volwassenen tussen 18 en 45 jaar. Veel jonge volwassenen 
hebben een ongezonde leefstijl en lopen daardoor meer risico op slechte 
gezondheidsuitkomsten. De meeste individuen in deze leeftijdscategorie gaan niet 
vaak naar hun huisarts, wat opportunistische case finding en gezondheids-
bevordering bemoeilijkt. In dit onderzoek beschrijven we gezondheidsgerelateerde 
leefstijl in relatie tot cardiovasculair risico in deze leeftijdsgroep. 
In dit onderzoek hebben we schriftelijke enquêtes gehouden onder een steekproef 
van volwassenen in de genoemde leeftijdsgroep. Hierbij zijn patiënten die reeds 
hart- en vaatziekten of diabetes hebben, uitgesloten. Patiënten werden 
geselecteerd uit steekproeven van huisartspraktijken in België, Duitsland, 
Engeland, Finland, Frankrijk, Israël, Nederland, Oostenrijk, Slovenië en 
Zwitserland. Door middel van een patiëntenvragenlijst zijn zes risicofactoren 
gemeten: rookstatus, body mass index (BMI), eetpatroon, lichaamsbeweging, 
hypertensie en hypercholesterolemie. We hebben een logistische multilevel 
analyse uitgevoerd met de verschillende risicofactoren en het totaal aantal 
risicofactoren als uitkomsten. Voorspellende variabelen waren geslacht, het 
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hebben van een partner, arbeidsparticipatie, opleidingsniveau en het aantal 
huisartsbezoeken per jaar. Van de 3892 patiënten die bruikbare data leverden 
rapporteerde 40% geen risicofactoren, 35% noemde één risicofactor, 19% 
noemde er twee en 6% rapporteerde drie of meer risicofactoren. Volwassenen die 
hun huisarts vaker dan eenmaal per jaar bezoeken, lieten meer risicofactoren 
zien. Het gemiddeld aantal risicofactoren steeg van 1.41 bij patiënten met ten 
hoogste één huisartsbezoek per jaar naar 1.71 risicofactoren bij meer dan drie 
bezoeken per jaar. 
We concludeerden dat de meerderheid van de volwassenen een verhoogd 
cardiovasculair risico heeft door de aanwezigheid van één of meer risicofactoren. 
Deze groep volwassenen bezoekt de huisarts doorgaans vaker dan eenmaal per 
jaar, wat kansen biedt voor preventie. Verder onderzoek is nodig om de 
effectiviteit van preventieve activiteiten in deze leeftijdsgroep te meten. 
Hoofdstuk 6 
Delphi procedures worden vaak gebruikt om kwaliteitsindicatoren te ontwikkelen. 
Toch is er weinig bekend over de validiteit van deze methode. In hoofdstuk 6 
beschrijven we een onderzoek waarin we de consistentie bepalen van 
verschillende procedures bij indicatorontwikkeling. Ook onderzochten we de 
consistentie tussen de uitkomsten van verschillende panels. Hiervoor hebben we 
drie procedures voor de ontwikkeling van een set indicatoren gerelateerd aan 
CVRM geanalyseerd: het EPA Cardio project, waarin gewerkt werd met 
internationale huisartsenpanels; het UniRap project, een Nederlands 
indicatorproject in de huisartsenzorg; en het Vitale Vaten project, welke gebruik 
maakte van een nationaal multidisciplinair panel van zorgverleners en een 
stakeholderpanel. De indicatoren sets van EPA Cardio en UniRap werden 
beoordeeld in het Vitale Vaten project. 
Met betrekking tot klinische indicatoren was de consistentie tussen de procedures 
verschillend. De zorgverleners van het Vitale Vaten panel valideerden 63% van de 
indicatoren van het internationale EPA Cardio project opnieuw. Slechts 13% van 
de UniRap indicatoren werd opnieuw gevalideerd. Met betrekking tot 
organisatorische indicatoren, werden 27 indicatoren beoordeeld in zowel EPA 
Cardio als Vitale Vaten. In het Vitale Vaten project werden 17 indicatoren 
gevalideerd (63%), waaronder 8 van de 9 in EPA Cardio gevalideerde indicatoren. 
De consistentie tussen de panels was matig, waardoor een beslissende rol 
gegeven werd aan de zorgprofessionals, zijnde het meest kritische panel. 
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De consistentie van geselecteerde prestatie indicatoren varieerde tussen 
procedures en panels. Verder onderzoek is noodzakelijk om de determinanten die 
ten grondslag liggen aan deze verschillen te identificeren. 
Hoofdstuk 7 
Het aantal patiënten met chronische aandoeningen neemt toe, wat een uitdaging 
is voor de organisatie van de gezondheidszorg. Een proactieve, gestructureerde 
en populatiegeoriënteerde aanpak is noodzakelijk: het Chronic Care Model (CCM) 
biedt deze structuur. 
Met ons internationale observationele onderzoek beschreven in dit hoofdstuk, 
trachtten we organisatorische voorwaarden voor het geven van gestructureerde 
chronische zorg volgens het CCM te beoordelen in landen met verschillende 
gezondheidszorgsystemen. 
We hebben gegevens verzameld door middel van praktijkenquêtes en -interviews 
in een gestratificeerde steekproef van 315 eerstelijnszorginstellingen in België, 
Duitsland, Engeland, Finland, Frankrijk, Israël, Nederland, Oostenrijk, Slovenië, 
Spanje en Zwitserland. De resultaten zijn gemiddelde praktijkscores op CCM 
domeinen per land en een percentage van de maximumscore. Andere uitkomsten 
zijn de invloed van praktijkgrootte en verstedelijking op deze scores. 
Er waren aanzienlijke verschillen in praktijkgrootte, met de grootste praktijken in 
Spanje, Engeland, Finland en Israël. Deze landen, met een sterke oriëntatie op 
eerstelijnszorg, hadden het grootste aantal artsen en het meeste personeel per 
praktijk. De CCM domeinen 'klinische informatiesystemen' en 'beslisondersteuning' 
hadden totale praktijkgemiddeldes van 90%, waar andere domeinen ongeveer 
50% scoorden. Spanje en Engeland scoorden bovengemiddeld op vrijwel elk 
domein. Praktijkgrootte en verstedelijking hadden weinig invloed. 
We concludeerden dat karakteristieken van geleverde chronische zorg voor de 
meeste CCM domeinen per land verschillen. De meest voorkomende 
karakteristieken zijn gerelateerd aan automatisering, wat in alle landen een goed 
uitgangspunt is en veel mogelijkheden biedt. Verder onderzoek moet zich richten 
op de relaties tussen praktijkkarakteristieken en organisatorische kenmerken, 
inclusief zorgsystemen en oriëntatie op eerstelijnszorg, en uitkomsten. 
Eerstelijnszorg lijkt geschikt voor het leveren van chronische zorg, maar een 
sterkere eerste lijn werd geassocieerd met betere scores. 
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Hoofdstuk 8 
In veel landen is het beleid gericht op het versterken van de eerste lijn, zodat deze 
eerste lijn betrouwbaar aanbevolen behandelingen gaat leveren aan patiënten met 
chronische aandoeningen. Het internationale onderzoek van hoofdstuk 8 richt zich 
op de associaties tussen de organisatie van eerstelijnszorg en CVRM zoals 
geleverd aan patiënten met coronaire hartaandoeningen in Europa. 
We hebben dossieronderzoeken verricht in gerandomiseerde steekproeven van 
patiënten uit eerstelijnszorgpraktijken in België, Duitsland, Engeland, Finland, 
Frankrijk, Nederland, Oostenrijk, Slovenië, Spanje en Zwitserland. 
CVRM werd gemeten met gevalideerde indicatoren: registratie van risicofactoren, 
behandeling met trombocytenaggregatieremmers, influenzavaccinatie, 
bloeddrukwaarden (systolisch <140, diastolisch <90 mmHg) en LDL cholesterol 
<2.5 mmol/l. Gestructureerde enquêtes werden gebruikt om gegevens over de 
praktijkorganisatie te verzamelen. Het effect van praktijkorganisatie op CVRM is 
getoetst in multilevel regressie analyses. 
Voor deze analyses hebben we gebruik gemaakt van dossiergegevens van 4563 
patiënten geselecteerd uit 273 eerstelijnszorgpraktijken. Betere organisatie van de 
eerstelijnszorgpraktijk was geassocieerd met betere uitkomsten voor drie 
indicatoren: registratie van risicofactoren (B=0.0307, p<0.0001), behandeling met 
trombocytenaggregatieremmers (B=0.0519, p=0.0245), en influenzavaccinatie 
(B=0.1174, pO.0001). 
Tussen de 2 1 % en 27% van de variatie bij bovengenoemde drie indicatoren kan 
worden toegeschreven aan de organisatie van de praktijk. Landelijke 
karakteristieken zorgen daarnaast nog eens voor een variatie van 10% tot 20%. Er 
zijn geen associaties gevonden tussen praktijkorganisatie en vastgelegde 
bloeddruk- of cholesterolwaarden. De ondersteuning van zelfmanagement en het 
gebruik van klinische informatiesystemen zijn de organisatorische dimensies die 
het meest consistent gekoppeld waren aan prestatie indicatoren. 
Dus in landen met verschillende gezondheidszorgsystemen was betere 
organisatie van eerstelijnszorgpraktijken geassocieerd met betere CVRM bij 
patiënten met coronaire hartaandoeningen. Deze bevindingen steunen 
investeringen in de organisatie van chronische zorg. 
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Hoofdstuk 9 
De netwerken waarbij informatie uitgewisseld wordt voor de zorg van chronische 
ziekten kunnen van invloed zijn op de implementatie van innovaties in 
patiëntenzorg. Valide en uitvoerbare methoden zijn noodzakelijk om deze 
netwerken in zorginstellingen vast te leggen en te analyseren. In een 
observationeel onderzoek zoals gepresenteerd in dit hoofdstuk hebben we de 
uitvoerbaarheid van een enquête voor gegevensverzameling met betrekking tot 
deze informatienetwerken onderzocht. Hierbij richtten we ons op netwerken 
binnen eerstelijnszorginstellingen, met betrekking tot chronisch hartfalen, diabetes 
en COPD. Dit onderzoek werd gekoppeld aan een Nederlands verbeterproject met 
betrekking tot de zorg voor chronisch hartfalen. Alle zorgverleners in de tien 
deelnemende praktijken werden gevraagd een korte enquête in te vullen die 
vastlegde met wie zij informatie uitwisselden. 
Uitvoerbaarheid werd bepaald in termen van respons, en betrouwbaarheidsscores 
werden gebaseerd op de wederkerigheid van het geven en ontvangen van 
informatie. Bij elke praktijk werd een aantal netwerkkarakteristieken bepaald voor 
elk van de chronische aandoeningen. De respons was hoog in alle praktijken, op 
één na. Voor de analyse zijn de gegevens gebruikt van 67 zorgverleners uit acht 
praktijken. De overeenkomst tussen het geven en ontvangen van informatie was 
gemiddeld 65.6%. De waardes voor dichtheid, centralisering, hiërarchie en overlap 
van informatienetwerken lieten substantiële variaties zien, zowel tussen de 
praktijken als tussen de chronische aandoeningen. Het meest centrale individu in 
het informatienetwerk kan een verpleegkundige of een arts zijn. 
Verder onderzoek is noodzakelijk om de methodiek van het in kaart brengen van 
informatienetwerken te verfijnen en om de impact van netwerkkarakteristieken op 
de implementatie van innovaties te onderzoeken. 
Hoofdstuk 10 
Eerstelijnszorg speelt een centrale rol in de preventie en het management van 
cardiovasculaire aandoeningen, en verschillende landen hebben programma's 
geïmplementeerd om deze zorg te verbeteren. We hebben informatie verzameld 
over 42 CVRM programma's in 11 landen (België, Duitsland, Finland, Frankrijk, 
Israël, Nederland, Oostenrijk, Slovenië, Spanje, Verenigd Koninkrijk en 
Zwitserland). In hoofdstuk 10 presenteren we een analyse van deze programma's. 
We verwachtten dat landen met een sterke eerste lijn van de gezondheidszorg 
programma's zouden hebben om disease management te verbeteren, maar 
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vroegen ons af hoe deze landen omgaan met leefstijlinterventies in de 
eerstelijnszorg. 
In dit vergelijkende observationele onderzoek hebben we programmagegevens 
verzameld via landencoördinatoren en andere informanten. De meeste 
programma's (95%) waren gericht op zorgprofessionals; 86% van deze 
programma's bevatte scholing. Evaluatie was een onderdeel van alle 
programma's. In landen met een sterke eerste lijn richtte 63% van de programma's 
zich uitsluitend op disease management, 29% alleen op leefstijlinterventie en 5% 
op beide aspecten. In landen met een minder sterke eerste lijn richtte 22% van de 
programma's zich uitsluitend op disease management en 78% op verbetering van 
leefstijl. 
Samenvattend laten onze bevindingen zien dat een gezondheidszorgsysteem met 
een sterke eerste lijn vooral een inspanning levert om disease management te 
verbeteren, maar niet per se investeert in het verbeteren van leefstijlinterventies. 
Dit kan een gemiste kans zijn, gezien de potentie van eerstelijnszorg bij de 
beïnvloeding van leefstijl. 
Hoofdstuk 11 
Veel patiënten met chronisch hartfalen worden behandeld in de eerste lijn, maar 
onderzoek heeft uitgewezen dat de kwaliteit van zorg voor deze patiënten 
verbeterd dient te worden. Hoofdstuk 11 beschrijft een pilot van een programma 
gericht op het verbeteren van eerstelijnszorg voor patiënten met chronisch 
hartfalen, en evalueert de impact en de uitvoerbaarheid van dit programma. 
Een observationeel onderzoek is uitgevoerd in 19 praktijken in het Zuidoosten van 
Nederland; in de evaluatie deden 15 huisartsen en 77 patiënten met chronisch 
hartfalen mee. Het verbeterprogramma bevatte scholingscomponenten en 
organisatorische componenten, welke aangereikt werden door een getrainde 
praktijkconsulent. Voor de evaluatie is gebruik gemaakt van patiëntenregistratie-
formulieren die ingevuld werden door professionals, en telefonische interviews. 
Het beleid rond diëtiek en lichaamsbeweging leek verbeterd, daar acht patiënten 
waren doorverwezen naar een diëtist en vijf patiënten naar een fysiotherapeut. De 
influenza vaccinatiegraad steeg van 94% naar 97% (75 van de 77). Met betrekking 
tot rookstatus is geen effect gevonden. Medicamenteuze behandeling werd 
aangepast volgens de richtlijnen bij 12% van de patiënten (9/77). Zeven patiënten 
startten met een aanbevolen geneesmiddel en twee patiënten kregen een 
dosisaanpassing. Huisartsen beschouwden het programma als uitvoerbaar. In een 
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aantal praktijken werden meer klinische taken gedelegeerd naar verpleegkundigen 
of assistenten, maar samenwerking met andere zorgverleners bleef beperkt. 
Het verbeterprogramma bewijst een redelijke impact te hebben op patiëntenzorg. 
In de toekomst moet de effectiviteit gemeten worden in een groter gedegen 
evaluatieonderzoek inclusief een aantal aanpassingen op basis van de ervaringen 
opgedaan in deze pilot. 
Hoofdstuk 12 
Het verbeterprogramma voor disease management voor chronisch hartfalen in de 
eerstelijnszorg zoals beschreven in het vorige hoofdstuk is aangepast. Ondanks 
bewijs dat maatwerk het succes van implementatieprogramma's verhoogt, is er 
weinig bekend over de beste methodiek voor zulke aanpassingen. Dit geldt zeker 
ook voor programma's met betrekking tot eerstelijnszorg voor patiënten met 
chronisch hartfalen. 
Hoofdstuk 12 beschrijft het onderzoeksprotocol van een cluster gerandomiseerd 
gecontroleerd onderzoek naar een verbeterprogramma in de eerstelijnszorg met 
betrekking tot chronisch hartfalen. Hierin willen we de effectiviteit van een 
programma met maatwerk in vergelijking met een standaard programma 
onderzoeken. De onderzoekspopulatie zal bestaan uit 60 huisartsen en de 
patiënten met chronisch hartfalen in hun praktijken. 
We zullen huisartsen randomiseren in blokken van vier, gestratificeerd voor 
praktijkgrootte. Met een implementatieprogramma op maat stellen de huisartsen 
de prioriteiten die de basis vormen voor de ondersteuning tijdens de 
praktijkbezoeken. Deze prioriteiten kunnen verschillende zaken omvatten, 
waaronder scholing en organisatorische veranderingen. 
De primaire uitkomstmaten zijn patiëntenervaringen van ontvangen 
gestructureerde eerstelijnszorg voor chronisch hartfalen (PACIC, een enquête met 
betrekking tot het Chronic Care Model), kwaliteit van leven in relatie tot de 
gezondheid (EQ-5D), de mate waarin medicatievoorschriften overeenstemmen 
met de aanbevelingen in de richtlijn. In verband met de clustering van patiënten in 
praktijken, zullen we een multilevel regressieanalyse gebruiken om het effect van 
praktijkgrootte en het type interventieprogramma te onderzoeken. Verder zullen 
we zowel veranderingen binnen groepen en verschillen tussen groepen bij de 
follow-up analyseren met betrekking tot medicatiedoseringen en leefstijladvies. 
Ook zullen we de uitvoerbaarheid van het programma beoordelen, evenals het 
bereiken van de gestelde doelen, veranderingen in de organisatie in de zorg voor 
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chronisch hartfalen en geformaliseerde samenwerking met andere disciplines. 
Subgroepanalyses zullen uitgevoerd worden waarbij onderscheid gemaakt wordt 
tussen systolisch hartfalen en hartfalen met behouden linkerventrikelfunctie 
(diastolisch hartfalen). 
Hoofdstuk 13 
In dit hoofdstuk vatten we de belangrijkste bevindingen van de beschreven studies 
samen en bediscussiëren we deze. Daarna bediscussiëren we een aantal 
methodologische zaken met betrekking tot het EPA Cardio project. In het laatste 
bediscussiëren we de implicaties. Eerstelijnszorg biedt de mogelijkheid om 
kwalitatief hoogwaardige zorg te bieden in een goede organisatorische structuur. 
Ondersteuning van zelfmanagement en het gebruik van klinische 
informatiesystemen lijken zeer belangrijke factoren. Met name voor 
zelfmanagement is de laatste tijd steeds meer aandacht. De rol van 
huisartspraktijken in eerstelijns preventie onder jonge en gezonde volwassenen 
moet in de toekomst geëvalueerd worden. In Nederland is diabeteszorg goed 
gestructureerd en onze bevindingen steunen een vergelijkbare disease 
management aanpak voor cardiovasculair risicomanagement. Binnen de 
huisartspraktijken moet zo'n ziektegericht zorgmodel worden gerealiseerd binnen 
de context van de patiëntenpopulatie, waarbij persoonsgerichte zorg geleverd 
wordt. 
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Eckhard Vollbracht proved to be a good host and a pleasant man to have 
discussions (or 'discussions') with. Other participants in the project group were 
Nicole Boffin, Ester Cornells, Glyn Elwyn, Beat Künzi, Esko Kumpusalo, Margalit 
Goldfracht, Hector Falcoff, Janko Kersnik, Kati Kettunen, Liliane Michlig, Ingrid 
Pichler, Marianne Samuelson, Reinhold Glehr, Martin Roland, Joachim Szecsenyi, 
Veerle Vanderstighelen en Trudy van der Weijden. 
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Ik heb zeer veel ondersteuning gehad voor het Nederlandse deel van het EPA 
Cardio project en bij de verwerking van de data die van de verschillende 
deelnemende landen naar Nijmegen kwamen. Ik dank hen allen daar voor. Het 
leeuwendeel van de ondersteuning is geleverd door Marjan Knippenberg, tijdelijk 
(in verband met Loes) vervangen door Janine Liefers. Behalve de daadwerkelijke 
ondersteuning met het regelwerk rond de deelnemende praktijken waren de 
bemoedigende woorden 'komt goed' ook zeer behulpzaam. Soms kan weinig al 
veel betekenen. Verder was er secretariële ondersteuning bij het verwerken van 
de grote aantallen patiëntenenquêtes en lijsten met gegevens van 
dossieronderzoeken. Het succespercentage in Nederland konden we nog 
vergroten doordat Carla Walk al dan niet op locatie hielp met de patiëntenselectie 
of de verzameling van de dossiergegevens. Het even bijkletsen zou ik trouwens 
ook niet willen missen. Zowel bij de data cleaning als bij de analyses heb ik 
statistische ondersteuning genoten. Data cleaning is een (eindeloze) klus. Ik heb 
inmiddels van een ervaren onderzoeker begrepen dat dit iets is dat je maar één 
keer in je carrière wilt doen. Van de discussies over de analyses van de data heb 
ik meer genoten en uit de contacten met de collega's in de internationale groep 
heb ik kunnen opmaken dat ik het goed getroffen had. Gedurende de rit heb ik met 
drie statistici samen gewerkt: Jan van Doremalen, Jan Mulder en Jan 
Koetsenruijter. Ik bewonder het geduld dat we voor elkaar konden opbrengen. 
Ondersteuning is wellicht een voorwaarde maar er moeten wel gegevens zijn om 
mee te werken. Daarvoor zijn we alle deelnemende huisartsen en hun 
praktijkmedewerkers dankbaar en ook al die patiënten die vragenlijsten hebben 
ingevuld en hun huisarts toestemming gaven dossiergegevens ter beschikking te 
stellen. Binnen EPA Cardio werd er het nodige van de deelnemende huisartsen 
gevraagd maar bij de afsluitende telefonische interviews werd daar - in ieder 
geval in de gesprekken die ik gevoerd heb - niet of nauwelijks over geklaagd. 
De laatste twee artikelen in dit proefschrift hebben betrekking op hartfalen-
projecten. Beide zijn gefinancierd door Robuust, het samenwerkingsverband de 
regionale ondersteuningsstructuren (ROSsen) in Zuid-Nederland. Ook hiervoor 
ben ik een groot aantal mensen dank verschuldigd. Harry Coenders was vanuit 
Robuust bij zowel het pilot onderzoek als bij het vervolgprogramma betrokken. De 
ondersteuning was weer in handen van Marjan Knippenberg. In de pilot zijn alle 
praktijkbezoeken gedaan door Louise Roebroeck. Het vervolg project is tot stand 
gekomen in samenwerking met Betty Steenkamer, regioadviseur van FAST (een 
van die zuidelijke ROSsen). Verder waren regio adviseurs van de afzonderlijke 
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ROSsen bij dit project betrokken, zowel voor de werving als voor de 
ondersteunende praktijkbezoeken. Franca van Rosmalen, Marjolein van den Berg, 
Sandra de Loos, Nicole de Baat, jullie betrokkenheid en enthousiasme was groot. 
Ook hier weer waren we volledig afhankelijk van deelnemende praktijken. De 
deelnemers in de pilot deden voor een deel en passant ook nog mee aan het 
onderzoek naar de informatienetwerken binnen die praktijken. 
IQ is een grote afdeling waarbij je niet met iedereen evenveel contact kunt 
hebben. Er heerst een sfeer van collegialiteit waar ook andere activiteiten een 
plaats innemen. Uitingen hiervan waren paintball, lasergame en karten (je kunt 
niet allemaal de snelste zijn) waar ik in ieder geval erg van genoten heb. 
Kamergenoten zijn belangrijk. Ik heb in mijn eerste maanden op de afdeling in de 
meeste kamers rond het koffieapparaat gezeten met veel verschillende mensen. Ik 
wil een enkele collega noemen wiens naam nog niet gevallen is. 
Linda, ik genoot van onze contacten en we maakten tegelijkertijd het proces door 
dat tot onze promoties moet leiden. Jij mag jouw proefschrift een week eerder 
verdedigen, maar beiden misten we de competitieve drang die sommigen ons 
probeerden op te dringen. Ik wens jou alle succes in je buitenlandse carrière. 
Mare, als het lukte om samen te fietsen was dat altijd erg leuk. We praatten over 
van alles, ook over het werk (daarmee zouden we de fietstijd nog wel als werktijd 
kunnen aanmerken). Jij begint een nieuwe carrière als surfdude down under; daar 
zul je je weg ook wel goed in vinden. Elvira, jij worstelt met je eerste artikelen en ik 
kan me goed inleven hoe je het ervaart. Rien, ook bij jouw werk herken ik veel. Je 
begint ook in een internationaal project, Vooralsnog' geen promotie (ja, ja). 
De bijdrage van Jolanda van Haren ligt op een heel ander vlak. Zonder jou zou dit 
proefschrift ongetwijfeld ook ooit afgekomen zijn maar niet noodzakelijkerwijs dit 
jaar. Ik zou niet geweten hebben waar te beginnen en je nauwgezette controle van 
alle delen van het manuscript was onmisbaar. En passant hield je me ook nog op 
de hoogte van het randgebeuren rond de vaderlandse voetbalcompetitie. 
En dan mijn paranimfen: Ben Kolnaar en Christien van Lieshout. 
Beste Ben, we hebben het nodige gemeen. Jij hebt ook een promotietraject 
doorgemaakt, we hebben ruim 5 jaar samen bij het NHG aan richtlijnontwikkeling 
gewerkt en we zijn allebei huisarts. Bij oppervlakkige beschouwing zou men 
kunnen denken dat hierin de reden ligt waarom ik je graag als mijn paranimf heb. 
Veel belangrijker is het plezier dat ik steeds tijdens onze contacten ervaar en het 
feit dat ik er alle vertrouwen in heb dat ik je aanwezigheid als een steun zal 
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ervaren. Het verbaasde me niet dat je even moest nadenken over het verzoek. Er 
rust namelijk wel een druk op je schouders met de extra rol van 
ceremoniemeester. Maar samen met Marja gaat het ongetwijfeld lukken. 
Lieve Christien, wat leuk dat je gelijk enthousiast reageerde toen ik vroeg of je 
mijn paranimf wilde zijn. Er moet nog van alles geregeld worden en ik ervaar al 
gelijk vanaf het begin veel steun hierin. Dat is natuurlijk niet zo raar; je hebt als 
grote zus altijd al deze rol voor mij gehad. Daarnaast vallen de keren dat onze 
gezinnen bij elkaar komen voor mij altijd in de categorie quality time. 
Dat onderzoek teamwork is en dat er veel mensen betrokken zijn bij mijn 
promotietraject is duidelijk. Zeker zo belangrijk was het voor mij als praktijk 
houdende huisarts dat ik min of meer onbekommerd op mijn Nijmeegse dagen de 
praktijk achter me kon laten. Ook hiervoor wil ik een aantal mensen bedanken. De 
eerste jaren werkten Kirsti Jakobs en ik samen in de praktijk, een zeer flexibele 
collega als ik weer wat wilde ruilen. Nu werk ik samen met Sonay Zainalabedin. 
We associëren op 1 april (geen grap) en ik verwacht veel van de voortzetting van 
onze samenwerking in een andere verhouding. Het afgelopen jaar waren het 
moeilijke tijden voor beide assistentes, Lisette en Marie elise (volgens mij heb ik 
het nu goed geschreven). Ondanks dat bleven jullie grote betrokkenheid en inzet 
tonen. José heeft de zaak draaiende gehouden door vanaf de eerste dag dat we 
met 100% ziekteverzuim zaten weer in de praktijk mee te werken, aanvankelijk 
(ruim) full time, later samen met Tahera en Xenja, en alle anderen in de unit. José, 
je inzet was van onschatbare waarde. 
Ik verbeeld me niet dat ik uitputtend ben geweest. Veel mensen volgden 
geïnteresseerd mijn vorderingen en hebben me gestimuleerd. Ook hen wil ik 
bedanken. 
Menig promovendus gebruikt zijn of haar dankwoord als gelegenheid openlijk 
excuses aan te bieden aan gezinsleden die de dupe zijn geworden van het 
promotietraject. Ik denk dat dat hier niet nodig is. Niet omdat ik dat niet publiekelijk 
zou willen doen - wat in het voorkomende geval ook zo zou kunnen zijn - maar 
vooral omdat het hele proefschriftgebeuren nauwelijks invloed thuis heeft gehad. 
Overigens maakt het daarbij ongetwijfeld ook nog een wereld van verschil in welke 
fase van het gezinsleven je promoveert. 
Onze beide dochters verblijdden me op de eerste Vaderdag dat ik op onze 
afdeling werkte met een mok met een foto van hen allebei in Vitesse-shirt. Het was 
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volgens mij deels wat provocerend bedoeld maar heeft nimmer dit effect gehad. 
Verder is jullie relatie tot de wetenschap en daarmee tot dit aspect van mijn werk 
zeer verschillend. Sanne lonkt naar een promotieplek en heeft geholpen met 
correcties van het Engels en het vertalen van de samenvatting. Ellen is meer van 
het tastbare. Toen ik met een exemplaar van The American Journal of Managed 
Care (wiens lijfblad is het niet) thuis kwam en met mijns inziens gepaste trots mijn 
eerste internationale publicatie liet zien was de eenvoudig gestelde maar lastig te 
beantwoorden vraag: Krijg je daar wat voor? We hebben samen op de top van de 
Kilimanjaro gestaan en dat was echt top. Het bereiken van deze top was 
overigens zwaarder dan mijn promotietraject, oftewel het beklimmen van de 
overdrachtelijke Olympus. 
Karel, jij vond dat je niet genoemd hoefde te worden, een onjuiste gedachte. 
Bedankt voor je last minute inspanningen. 
Lieve José, sommigen verbazen zich er over dat jij de laatste plaats in dit 
dankwoord krijgt. Waarom niet thuis beginnen en dan langzaam naar de 
promotoren toewerken? Deze opbouw zal wel ingegeven zijn door de 
auteursvolgorde bij artikelen waarbij de laatste plaats een van de belangrijkste is! 
Jouw bijdrage aan dit proefschrift ligt meer besloten in het randvoorwaardelijke 
maar vooral in de andere aspecten van het leven. Zullen we nu eerst maar weer 
een vakantie plannen? 
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Stellingen behorende bij het proefschrift 
Improving cardiovascular primary care 
Jan van Lieshout 
1. Er bestaat een ongewenste variatie in de scores op kwaliteitsindicatoren voor 
cardiovasculair risicomanagement tussen praktijken binnen landen en tussen verschillende 
landen, (dit proefschrift) 
2. De kwaliteit van de zorg met betrekking tot cardiovasculair risicomanagement wordt meer 
bepaald door praktijkkenmerken dan door kenmerken van het gezondheidsysteem in een 
land. (dit proefschrift) 
3. Evaluatie is een integraal onderdeel van een goed implementatieprogramma voor 
cardiovasculair risicomanagement, (dit proefschrift) 
4. Praktiserende artsen zijn kritischer dan andere betrokkenen in hun beoordeling van 
kwaliteitsindicatoren. Bij het ontwikkelen van indicatoren moet men zich hier van tevoren 
rekenschap van geven en bedenken welke rol verschillende panels krijgen (dit proefschrift) 
5. Zelfmanagement ondersteuning bevordert de autonomie van de patient; dit alleen is reden 
genoeg om dit bevorderen. Daarenboven is zelfmanagement ondersteuning - naast het 
gebruik van informatie technologie - ook gerelateerd aan een betere kwaliteit van 
cardiovasculair risicomanagement, (dit proefschrift) 
6. "Let je op de kosten, dan gaat de kwaliteit omlaag Let je op de kwaliteit, dan gaan de 
kosten omlaag " (Wim van de Meeren, directeur CZ, 2010) 
7. Patiëntenstatistiek is ook statistiek: "Ik voelde me helemaal naar worden en vloog het bed 
uit De meeste mensen gaan immers dood in bed." 
8. Jaarlijks 'eenmalig' gedurende drie maanden de ondersteunende middelen bij stoppen met 
roken programma's vergoeden is een interventiestrategie met veel gezondheidswinst 
9. Meten is weten en dan verbeteren, (open deur, maar geen gemeengoed) 
10. Er is veel aandacht voor het snel beantwoorden van de spoedlijn in de huisartsenpraktijk en 
er is veel bewijs voor de effectiviteit van cardiovasculaire risicomanagement. 
11. It All Adds Up: From the Dim Past to the Uncertain Future. (Saul Bellow, 1994) Hoewel hij 
dit met bedoelde is dit wel precies wat wetenschap moet zijn: voortschrijdend inzicht met 
stappen waarvan de uitkomst met op voorhand vast staat. 
12. Promoveren kan gezien worden als het beklimmen van de wetenschappelijk Olympus. De 
Kilimanjaro is hoger dan deze overdrachtelijke Olympus, (persoonlijke ervanng) 
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